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Abstract 
The highly conserved eukaryotic elongation factor 1A (eEF1A) plays a canonical role in 
translation elongation, where it is responsible for delivering the aminoacylated tRNA to the 
A-site of the 80S ribosome. Further to this essential role it is reported to be involved in a 
plethora of moonlighting functions that are not fully characterised or understood. One of the 
human isoforms, eEF1A2, is known to induce cancer when expressed in non-native tissues, 
although the mechanism by which it promotes tumour growth is not yet known. 
In this study we have characterised eEF1A overexpression in yeast and provided evidence to 
suggest that elevated levels of eEF1A result spindle defects which lead to chromosomal 
abnormalities that have the potential to induce uncontrolled cell growth in human cells. 
Moreover, we have confirmed conservation of this chromosomal abnormality in human cell 
lines suggesting that the mechanism that eEF1A utilises to induce these effects are highly 
conserved. We have also observed that in yeast, eEF1A overexpression results in increased 
metabolic activity, a hallmark of cancer cells. 
We hypothesise that eEF1A interacts with the dynactin complex, a regulator of spindle 
dynamics, resulting in aberrant spindle formation. This in turn leads to chromosomal 
abnormalities that appear toxic to the cell. Cells appear to overcome the toxicity induced by 
eEF1A by suppressing plasmid copy number to the lowest levels possible. This however, brings 
its own problems and appears to result in synthetic effects together with eEF1A 
overexpression.   
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Chapter 1: Introduction 
  




1.1 Translation in eukaryotes 
The process of protein synthesis, translation, is a highly conserved mechanism throughout 
the living world.  
Following gene transcription, the mRNA exits the nucleus to undergo translation in the 
cytoplasm. The primary translation complex is the eukaryotic 80S ribosome. The 80S 
ribosome consists of two subunits, the large 60S and the small 40S.  Translation can be divided 
into four stages; initiation, elongation, termination and recycling. Beginning with initiation, 
the 80S ribosome along with a methionyl tRNAi bound in its petidyl (P) site is assembled at 
the AUG start codon of the mRNA. During elongation, the aminoacyl tRNAs enter the acceptor 
(A) site allowing decoding to take place. Cognate tRNAs form a peptide bond whilst non-
cognate tRNAs are ejected from the ribosome. Following translocation of the tRNA to the P 
site, and shifting of the mRNA codons, the process is repeated. Termination occurs when a 
stop codon is encountered resulting in the completed peptide being released from the 
ribosome. The final stage is recycling, this is when the ribosomal subunits dissociate, resulting 
in the release of the mRNA and the deacylated tRNA ready for another further rounds of the 
process. 
1.1.1 Translation Initiation 
The majority of the mRNAs in the cell undergo translation in a cap-dependent manner. The 
process of translating an mRNA transcript in this manner begins with the initiation step of 
translation.  
A pool of small 40S subunits associate with eIF3, and bind to the ternary complex 
(eIF2·GTP·Met-tRNAi) resulting in the 43S pre-initiation complex (PIC). eIF4F binds ĂƚƚŚĞ ? ?-
cap of the mRNA and ATP-dependent activation of the mRNA allows for loading on to the 43S 




PIC. The 43S W/ƚŚĞŶ ƐĐĂŶƐ ƚŚĞŵZE ŝŶĂ  ? ? ƚŽ  ? ?ĚŝƌĞĐƚŝŽŶƵŶƚŝů ŝ  ƌĞĂĐŚĞƐ ƚŚĞ ŝŶŝƚŝĂƚŝŽŶ
codon. Once the start codon is positioned in the P site the ternary complex is hydrolysed 
resulting in the release of the initiation factors facilitating binding of the 60s ribosomal 
subunit. 
1.1.2 Translation elongation 
Translation elongation (see Figure 1.1) is a highly conserved stage of translation across all 
three domains of life, eukaryotes, bacteria and archaea, making it an excellent process to 
understand using model systems. 
Peptide chain elongation starts upon translocation of the tRNAi to the P site leaving the A site 
vacant. A ternary complex consisting of eEF1A, GTP and an aminoacyl tRNA (aa-tRNA), 
delivers the aa-tRNA to the A site, where, if cognate, enters the next step of elongation. The 
interaction between the mRNA and cognate tRNA in the A site induces a conformational 
change of the 40s ribosomal subunit allowing for interrogation between cognate and near 
cognate pairs ?dŚŝƐĂĐƚŝǀŝƚǇŝŶƚƵƌŶĂĐƚŝǀĂƚĞƐĞ& ? ?Ɛ'dWĂƐĞĂĐƚŝǀŝǇ ?ƌĞƐƵůƚŝŶŐŝŶƚŚĞůŝďĞƌĂƚŝŽŶ
of the aminoacyl tRNA from eEF1A·GDP to the A site to continue its peptide bond formation. 
The peptide bond between the incoming amino acid and the peptidyl tRNA is then catalysed 
by the ribosomal peptidyl transfer centre (Moore and Steitz, 2003), resulting in both the 
deacylated tRNA and the peptidyl-tRNA being in hybrid states, spanning multiple sites across 
both the large and small ribosomal subunits (Green and Noller, 1997). Eukaryotic elongation 
factor 2 (eEF2) facilitates complete movement of the deacylated tRNA to the E site, 
translocation of the peptidyl tRNA to the P site and movement of the mRNA by three 
nucleotides thus placing the next codon in the A site, hydrolysing GTP in the process 




(Wintermeyer et al., 2001). This process is repeated until a stop codon is encountered at 
which point termination commences. 
 
Figure 1.1 A schematic view of translation elongation in yeast. A cyclical view of the elongation step, 
showing entry, and translocation of the tRNA in the ribosome. Also illustrated is the cycling of the active and 
inactive eEF1A whose activation state is dependent on GDP exchange catalysed by the eEF1B complex. 
 
1.1.3 Translation termination 
Upon recognition of a stop codon in the ribosomal A-site, formation of a quaternary complex 
comprising of the ribosome, release factors 1 (eRF1) and 3 (eRF3),and GTP, triggers peptidyl-
tRNA hydrolysis releasing the nascent peptide (Drugeon et al., 1997). 




1.2 Eukaryotic elongation factor 1A 
The highly characterised eukaryotic translation elongation factor 1A (eEF1A), previously 
known as eEF- ?ɲ(Thornton et al., 2003), is one of the most abundant cytoplasmic proteins in 
the cell, accounting for between 3 and 10% of all soluble protein (Merrick, 1992). It is encoded 
for by highly conserved genes resulting in near identical proteins across all three domains of 
life. It is a 50 kDa G-protein whose canonical role is in the delivery of aminoacylated tRNA to 
the A site of the ribosome during translation elongation. However, further roles have been 
well characterised for this moonlighting protein, from actin bundling and nuclear export, to 
induction of tumour growth (Grosshans et al., 2000; Munshi et al., 2001; Thornton et al., 
2003). 
1.2.1 Genes encoding eEF1A 
eEF1A is encoded by highly conserved genes from prokaryotes to eukaryotes, with many 
species possessing two or more genes encoding identical or similar proteins. Escherichia coli 
has two genes encoding the eEF1A equivalent EF-Tu (Jaskunas et al., 1975), the yeasts 
Saccharomyces cerevisiae and Candida albicans both possess two genes Tef1 and TEF2 
(Schirmaier and Philippsen, 1984; Sundstrom et al., 1990), and Schizosaccharomyces pombe 
is known to have three genes Tef101, Tef102 and Tef103 (Mita et al., 1997). In mammals there 
are two actively transcribed genes eEF1A1 and eEF1A2 which share a 75% similarity in coding 



















eEF1A1-H.sapiens      ATGGGAAAGGAAAAGACTCATATCAACATTGTCGTCATTGGACACGTAGATTCGGGCAAG 60 
eEF1A2-H.sapiens      ATGGGCAAGGAGAAGACCCACATCAACATCGTGGTCATCGGCCACGTGGACTCCGGAAAG 60 
Tef1                  ATGGGTAAAGAGAAGTCTCACATTAACGTTGTCGTTATCGGTCATGTCGATTCTGGTAAG 60 
TEF2                  ATGGGTAAAGAGAAGTCTCACATTAACGTTGTCGTTATCGGTCATGTCGATTCTGGTAAG 60 
                      ***** ** ** *** * ** ** *** * ** ** ** ** ** ** ** ** ** *** 
 
eEF1A1-H.sapiens      TCCACCACTACTGGCCATCTGATCTATAAATGCGGTGGCATCGACAAAAGAACCATTGAA 120 
eEF1A2-H.sapiens      TCCACCACCACGGGCCACCTCATCTACAAATGCGGAGGTATTGACAAAAGGACCATTGAG 120 
Tef1                  TCTACCACTACCGGTCATTTGATTTACAAGTGTGGTGGTATTGACAAGAGAACCATCGAA 120 
TEF2                  TCTACCACTACCGGTCATTTGATTTACAAGTGTGGTGGTATTGACAAGAGAACCATCGAA 120 
                      ** ***** ** ** **  * ** ** ** ** ** ** ** ***** ** ***** **  
 
eEF1A1-H.sapiens      AAATTTGAGAAGGAGGCTGCTGAGATGGGAAAGGGCTCCTTCAAGTATGCCTGGGTCTTG 180 
eEF1A2-H.sapiens      AAGTTCGAGAAGGAGGCGGCTGAGATGGGGAAGGGATCCTTCAAGTATGCCTGGGTGCTG 180 
Tef1                  AAGTTCGAAAAGGAAGCCGCTGAATTAGGTAAGGGTTCTTTCAAGTACGCTTGGGTTTTG 180 
TEF2                  AAGTTCGAAAAGGAAGCCGCTGAATTAGGTAAGGGTTCTTTCAAGTACGCTTGGGTTTTG 180 
                      ** ** ** ***** ** *****  * ** ***** ** ******** ** *****  ** 
 
eEF1A1-H.sapiens      GATAAACTGAAAGCTGAGCGTGAACGTGGTATCACCATTGATATCTCCTTGTGGAAATTT 240 
eEF1A2-H.sapiens      GACAAGCTGAAGGCGGAGCGTGAGCGCGGCATCACCATCGACATCTCCCTCTGGAAGTTC 240 
Tef1                  GACAAGTTAAAGGCTGAAAGAGAAAGAGGTATCACTATCGATATTGCTTTGTGGAAGTTC 240 
TEF2                  GACAAGTTAAAGGCTGAAAGAGAAAGAGGTATCACTATCGATATTGCTTTGTGGAAGTTC 240 
                      ** **  * ** ** **  * **  * ** ***** ** ** **  *  * ***** **  
 
eEF1A1-H.sapiens      GAGACCAGCAAGTACTATGTGACTATCATTGATGCCCCAGGACACAGAGACTTTATCAAA 300 
eEF1A2-H.sapiens      GAGACCACCAAGTACTACATCACCATCATCGATGCCCCCGGCCACCGCGACTTCATCAAG 300 
TEF1                  GAAACTCCAAAGTACCAAGTTACCGTTATTGATGCTCCAGGTCACAGAGATTTCATCAAG 300 
TEF2                  GAAACTCCAAAGTACCAAGTTACCGTTATTGATGCTCCAGGTCACAGAGATTTCATCAAG 300 
                      ** **    ****** *  * **  * ** ***** ** ** *** * ** ** *****  
 
eEF1A1-H.sapiens      AACATGATTACAGGGACATCTCAGGCTGACTGTGCTGTCCTGATTGTTGCTGCTGGTGTT 360 
eEF1A2-H.sapiens      AACATGATCACGGGTACATCCCAGGCGGACTGCGCAGTGCTGATCGTGGCGGCGGGCGTG 360 
TEF1                  AACATGATTACTGGTACTTCTCAAGCTGACTGTGCTATCTTGATTATTGCTGGTGGTGTC 360 
TEF2                  AACATGATTACTGGTACTTCTCAAGCTGACTGTGCTATCTTGATTATTGCTGGTGGTGTC 360 
                      ******** ** ** ** ** ** ** ***** **  *  ****  * ** *  ** **  
 
eEF1A1-H.sapiens      GGTGAATTTGAAGCTGGTATCTCCAAGAATGGGCAGACCCGAGAGCATGCCCTTCTGGCT 420 
eEF1A2-H.sapiens      GGCGAGTTCGAGGCGGGCATCTCCAAGAATGGGCAGACGCGGGAGCATGCCCTGCTGGCC 420 
TEF1                  GGTGAATTCGAAGCCGGTATCTCTAAGGATGGTCAAACCAGAGAACACGCTTTGTTGGCT 420 
TEF2                  GGTGAATTCGAAGCCGGTATCTCTAAGGATGGTCAAACCAGAGAACACGCTTTGTTGGCT 420 
                      ** ** ** ** ** ** ***** *** **** ** **  * ** ** **  *  ****  
 
eEF1A1-H.sapiens      TACACACTGGGTGTGAAACAACTAATTGTCGGTGTTAACAAAATGGATTCCACTGAGCCA 480 
eEF1A2-H.sapiens      TACACGCTGGGTGTGAAGCAGCTCATCGTGGGCGTGAACAAAATGGACTCCACAGAGCCG 480 
TEF1                  TTCACCTTGGGTGTTAGACAATTGATTGTTGCTGTCAACAAGATGGACTCCGTCAAATGG 480 
TEF2                  TTCACCTTGGGTGTTAGACAATTGATTGTTGCTGTCAACAAGATGGACTCCGTCAAATGG 480 
                      * ***  ******* *  **  * ** ** *  ** ***** ***** ***    *     
 
eEF1A1-H.sapiens      CCCTACAGCCAGAAGAGATATGAGGAAATTGTTAAGGAAGTCAGCACTTACATTAAGAAA 540 
eEF1A2-H.sapiens      GCCTACAGCGAGAAGCGCTACGACGAGATCGTCAAGGAAGTCAGCGCCTACATCAAGAAG 540 
TEF1                  GACGA-ATCCAGA-----TTCCAAGAAATTGTCAAGGAAACCTCCAACTTTATCAAGAAG 534 
TEF2                  GACGA-ATCCAGA-----TTCCAAGAAATTGTCAAGGAAACCTCCAACTTTATCAAGAAG 534 
                        * * * * ***     *   * ** ** ** ******  *  *   *  ** *****  
 
eEF1A1-H.sapiens      ATTGGCTACAACCCCGACACAGTAGCATTTGTGCCAATTTCTGGTTGGAATGGTGACAAC 600 
eEF1A2-H.sapiens      ATCGGCTACAACCCGGCCACCGTGCCCTTTGTGCCCATCTCCGGCTGGCACGGTGACAAC 600 
TEF1                  GTTGGTTACAACCCAAAGACTGTTCCATTCGTCCCAATCTCTGGTTGGAACGGTGACAAC 594 
TEF2                  GTTGGTTACAACCCAAAGACTGTTCCATTCGTCCCAATCTCTGGTTGGAACGGTGACAAC 594 
                       * ** ********    ** **  * ** ** ** ** ** ** *** * ********* 
 
eEF1A1-H.sapiens      ATGCTGGAGCCAAGTGCTAACATGCCTTGGTTCAAGGGATGGAAAGTCACCCGTAAGGAT 660 
eEF1A2-H.sapiens      ATGCTGGAGCCCTCCCCCAACATGCCGTGGTTCAAGGGCTGGAAGGTGGAGCGTAAGGAG 660 
TEF1                  ATGATTGAAGCTACCACCAACGCTCCATGGTACAAGGGTTGGGAAAAGGAAACCAAGGCC 654 
TEF2                  ATGATTGAAGCTACCACCAACGCTCCATGGTACAAGGGTTGGGAAAAGGAAACCAAGGCC 654 
                      *** * **  *     * ***   ** **** ****** *** *          ****   
 
eEF1A1-H.sapiens      GGCAATGCCAGTGGAACCACGCTGCTTGAGGCTCTGGACTGCATCCTACCACCAACTCGT 720 
eEF1A2-H.sapiens      GGCAACGCAAGCGGCGTGTCCCTGCTGGAGGCCCTGGACACCATCCTGCCCCCCACGCGC 720 
TEF1                  GGTGTCGTCAAGGGTAAGACTTTGTTGGAAGCCATTGACGCCATTGAACAACCATCTAGA 714 
TEF2                  GGTGTCGTCAAGGGTAAGACTTTGTTGGAAGCCATTGACGCCATTGAACAACCATCTAGA 714 
                      **    *  *  **     *  ** * ** **  * ***  ***    *  **  *  *  
 
eEF1A1-H.sapiens      CCAACTGACAAGCCCTTGCGCCTGCCTCTCCAGGATGTCTACAAAATTGGTGGTATTGGT 780 
eEF1A2-H.sapiens      CCCACGGACAAGCCCCTGCGCCTGCCGCTGCAGGACGTGTACAAGATTGGCGGCATTGGC 780 
TEF1                  CCAACTGACAAGCCATTGAGATTGCCATTGCAAGATGTTTACAAGATTGGTGGTATTGGT 774 
TEF2                  CCAACTGACAAGCCATTGAGATTGCCATTGCAAGATGTTTACAAGATCGGTGGTATTGGT 774 
                      ** ** ********  ** *  ****  * ** ** ** ***** ** ** ** *****  
eEF1A1-H.sapiens      ACTGTTCCTGTTGGCCGAGTGGAGACTGGTGTTCTCAAACCCGGTATGGTGGTCACCTTT 840 
eEF1A2-H.sapiens      ACGGTGCCCGTGGGCCGGGTGGAGACCGGCATCCTGCGGCCGGGCATGGTGGTGACCTTT 840 
TEF1                  ACTGTGCCAGTCGGTAGAGTTGAAACCGGTGTCATCAAGCCAGGTATGGTTGTTACTTTT 834 
TEF2                  ACTGTGCCAGTCGGTAGAGTTGAAACCGGTGTCATCAAGCCAGGTATGGTTGTTACTTTC 834 




                      ** ** ** ** **  * ** ** ** **  *  *    ** ** ***** ** ** **  
 
eEF1A1-H.sapiens      GCTCCAGTCAACGTTACAACGGAAGTAAAATCTGTCGAAATGCACCATGAAGCTTTGAGT 900 
eEF1A2-H.sapiens      GCGCCAGTGAACATCACCACTGAGGTGAAGTCAGTGGAGATGCACCACGAGGCTCTGAGC 900 
TEF1                  GCCCCAGCTGGTGTTACCACTGAAGTCAAGTCCGTTGAAATGCATCACGAACAATTGGAA 894 
TEF2                  GCCCCAGCTGGTGTTACCACTGAAGTCAAGTCCGTTGAAATGCATCACGAACAATTGGAA 894 
                      ** ****      * ** ** ** ** ** ** ** ** ***** ** **     **    
 
eEF1A1-H.sapiens      GAAGCTCTTCCTGGGGACAATGTGGGCTTCAATGTCAAGAATGTGTCTGTCAAGGATGTT 960 
eEF1A2-H.sapiens      GAAGCTCTGCCCGGCGACAACGTCGGCTTCAATGTGAAGAACGTGTCGGTGAAGGACATC 960 
TEF1                  CAAGGTGTTCCAGGTGACAACGTTGGTTTCAACGTCAAGAACGTTTCCGTTAAGGAAATC 954 
TEF2                  CAAGGTGTTCCAGGTGACAACGTTGGTTTCAACGTCAAGAACGTTTCCGTTAAGGAAATC 954 
                       *** * * ** ** ***** ** ** ***** ** ***** ** ** ** *****  *  
 
eEF1A1-H.sapiens      CGTCGTGGCAACGTTGCTGGTGACAGCAAAAATGACCCACCAATGGAAGCAGCTGGCTTC 1020 
eEF1A2-H.sapiens      CGGCGGGGCAACGTGTGTGGGGACAGCAAGTCTGACCCGCCGCAGGAGGCTGCTCAGTTC 1020 
TEF1                  AGAAGAGGTAACGTCTGTGGTGACGCTAAGAACGATCCACCAAAGGGTTGCGCTTCTTTC 1014 
TEF2                  AGAAGAGGTAACGTCTGTGGTGACGCTAAGAACGATCCACCAAAGGGTTGCGCTTCTTTC 1014 
                       *  * ** *****   *** ***   **    ** ** **   **     ***   *** 
 
eEF1A1-H.sapiens      ACTGCTCAGGTGATTATCCTGAACCATCCAGGCCAAATAAGCGCCGGCTATGCCCCTGTA 1080 
eEF1A2-H.sapiens      ACCTCCCAGGTCATCATCCTGAACCACCCGGGGCAGATTAGCGCCGGCTACTCCCCGGTC 1080 
TEF1                  AACGCTACCGTCATTGTTTTGAACCATCCAGGTCAAATCTCTGCTGGTTACTCTCCAGTT 1074 
TEF2                  AACGCTACCGTCATTGTTTTGAACCATCCAGGTCAAATCTCTGCTGGTTACTCTCCAGTT 1074 
                      *   *    ** **  *  ******* ** ** ** **    ** ** **  * ** **  
 
eEF1A1-H.sapiens      TTGGATTGCCACACGGCTCACATTGCATGCAAGTTTGCTGAGCTGAAGGAAAAGATTGAT 1140 
eEF1A2-H.sapiens      ATCGACTGCCACACAGCCCACATCGCCTGCAAGTTTGCGGAGCTGAAGGAGAAGATTGAC 1140 
TEF1                  TTGGATTGTCACACTGCTCACATTGCTTGTAGATTCGACGAATTGTTGGAAAAGAACGAC 1134 
TEF2                  TTGGATTGTCACACTGCTCACATTGCTTGTAGATTCGACGAATTGTTGGAAAAGAACGAC 1134 
                       * ** ** ***** ** ***** ** ** *  ** *  **  **  *** ****  **  
 
eEF1A1-H.sapiens      CGCCGTTCTGGTAAAAAGCTGGAAGATGGCCCTAAATTCTTGAAGTCTGGTGATGCTGCC 1200 
eEF1A2-H.sapiens      CGGCGCTCTGGCAAGAAGCTGGAGGACAACCCCAAGTCCCTGAAGTCTGGAGACGCGGCC 1200 
TEF1                  AGAAGATCTGGTAAGAAGTTGGAAGACCATCCAAAGTTCTTGAAGTCCGGTGACGCTGCT 1194 
TEF2                  AGAAGATCTGGTAAGAAGTTGGAAGACCATCCAAAGTTCTTGAAGTCCGGTGACGCTGCT 1194 
                       *  * ***** ** *** **** **    ** ** * * ******* ** ** ** **  
 
eEF1A1-H.sapiens      ATTGTTGATATGGTTCCTGGCAAGCCCATGTGTGTTGAGAGCTTCTCAGACTATCCACCT 1260 
eEF1A2-H.sapiens      ATCGTGGAGATGGTGCCGGGAAAGCCCATGTGTGTGGAGAGCTTCTCCCAGTACCCGCCT 1260 
TEF1                  TTGGTCAAGTTCGTTCCATCTAAGCCAATGTGTGTTGAAGCTTTCAGTGAATACCCACCA 1254 
TEF2                  TTGGTCAAGTTCGTTCCATCTAAGCCAATGTGTGTTGAAGCTTTCAGTGAATACCCACCA 1254 
                       * **  *  * ** **    ***** ******** **    ***    * ** ** **  
 
eEF1A1-H.sapiens      TTGGGTCGCTTTGCTGTTCGTGATATGAGACAGACAGTTGCGGTGGGTGTCATCAAAGCA 1320 
eEF1A2-H.sapiens      CTCGGCCGCTTCGCCGTGCGCGACATGAGGCAGACGGTGGCCGTAGGCGTCATCAAGAAC 1320 
TEF1                  TTAGGTAGATTCGCTGTCAGAGACATGAGACAAACTGTCGCTGTCGGTGTTATCAAGTCT 1314 
TEF2                  TTAGGTAGATTCGCTGTCAGAGACATGAGACAAACTGTCGCTGTCGGTGTTATCAAGTCT 1314 
                       * **  * ** ** **  * ** ***** ** ** ** ** ** ** ** *****     
 
eEF1A1-H.sapiens      GTGGACAAGAAGGCTGCTGGAGCTGGCAAGGTCACCAAGTCTGCCCAGAAAGCTCAGAAG 1380 
eEF1A2-H.sapiens      GTGGAGAAGAAGAGCGGCGGCGCCGGCAAGGTCACCAAGTCGGCGCAGAAGGCGCAGAAG 1380 
TEF1                  GTTGACAAGA---CTGAAAAGGCCGCTAAGGTTACCAAGGCTGCTCAAAAGGCTGCTAAG 1371 
TEF2                  GTTGACAAGA---CTGAAAAGGCCGCTAAGGTTACCAAGGCTGCTCAAAAGGCTGCTAAG 1371 
                      ** ** ****     *     ** *  ***** ****** * ** ** ** **    *** 
 
eEF1A1-H.sapiens      GC---TAAATGA 1389 
eEF1A2-H.sapiens      GCGGGCAAGTGA 1392 
TEF1                  ------AAATAA 1377 
TEF2                  ------AAATAA 1377 
                            ** * * 
Figure 1.2 ORF alignment between human eEF1A1 and eEF1A2, and S.cerevisiae TEF1 and TEF2. 
eEF1A1 is more similar to both TEF1 and TEF2, however conservation across the species is highly conserved. 
eEF1A1 shares 70.5% identity to TEF1 and 70.4% identity to TEF2, and eEF1A2 shares 66.8% identity with 
TEF1 and 66.6% identity with TEF1. 
 
Despite the similarity between eEF1A1 and eEF1A2 these genes have different expression 
patterns throughout the body. In higher eukaryotes eEF1A1 is expressed in all tissues during 
development, but is no longer present at detectable levels in the muscles and heart tissue of 




adults (Lee et al., 1992; Chambers et al., 1998). Instead high level expression of eEF1A2 is 
switched on in these tissues, as well as in motor neurons of the medulla. Lower levels of 
eEF1A2 expression is also detectable in the islet cells of the pancreas, and endocrine cells of 
the digestive tract (Newbery et al., 2007). 
Strict regulation of differential eEF1A gene expression has been observed during 
developmental stages. In mice, eEF1A1 is downregulated during the first two weeks of life to 
undetectable levels in muscular tissues by 25 days (Khalyfa et al., 2001), with eEF1A2 
gradually being upregulated. Ablation of eEF1A2 by deletion of the locus results in mice 
exhibiting the mutant wasted phenotype (wst)(Chambers et al., 1998). These mice present 
wasting and neurological and immunological abnormalities at 21 days old, and mortality 
occurs by 28 days (Shultz et al., 1982). 
1.2.2 eEF1A Proteins 
eEF1A exists as two variant, tissue-specific, isoforms, eEF1A1 and eEF1A2, in all higher 
vertebrates. In humans these proteins share 92% identity and 98% similarity (Tomlinson et 
al., 2005)(see figure 1.4). It is not however only human eEF1A isoforms that show 
considerable similarity with eEF1A in other mammals, including mice and rats, differing by 
only one amino acid compared to that of humans, and rabbits share 100% identity with 
humans (Lee et al., 1994; Kahns et al., 1998). 
 




Figure 1.3 Four structural surface renditions of human eEF1A1. Models are rotated 180° about the y-axis 
1a) shows the three domain boundaries, domain I is blue, domain II is yellow and domain III is orange. 1b) 
shows some of the conserved and mutated residues from yeast eEF1A, to human eEF1A1 and eEF1A2. Green 
shows the variant residues between eEF1A1 and eEF1A2, cyan shows conserved residues from yeast to humans 
that have been shown to reduce eEF1A dependence on eEF1Bp, red shows conserved residues from yeast to 
humans that have been shown to affect translational fidelity, magenta shows conserved residues from yeast 
to humans that have been shown to affect actin binding, and purple shows residues that have been shown to 
affect actin binding in yeast, are not conserved through to humans, and are also mutated from human eEF1A1 
to eEF1A2. 
 
The amino acids that differ between isoforms however, may give us insight into the differing 
functional profiles of eEF1A proteins. A high degree of conservation between the varying 




amino acids exists across species (see figure 1.3) indicating unique functions of both eEF1A 
isoforms, probably arising through evolutionary selection (Lee et al., 1994).  
When compared, the human eEF1A1 and eEF1A2 variant residues to the residues of known 
function in yeast eEF1A it is interesting to note that several of the variations are in actin 
binding domains (see table 1.1 and figure 1.3). This is compelling evidence to suggest that at 
least the actin binding function of eEF1A isoforms is altered as yN329, yK333 and yY355 are 
all known to affect the growth of cells and eEF1As ability to bundle actin (Gross and Kinzy, 
2007). 
Table 1.1 - Actin binding residues in yeast that are not conserved in human eEF1A isoforms 
Human eEF1A1 Human eEF1A2 Yeast eEF1A 
N331 S331 N329 
M335 Q335 K333 
A358 S358 Y355 
Residues listed are known actin binding residues in yeast eEF1A but are not conserved in human isoforms. 
 
1.2.3 Phosphorylation states of eEF1A 
Once it has hydrolysed GTP and released its aminoacyl tRNA to the A site of the ribosome, 
eEF1A·GDP is released to be recycled to its GTP bound, active form allowing it to participate 
in further rounds of elongation. Nucleotide exchange on eEF1A is catalysed by its guanine-
nucleotide exchange factor (GEF) eEF1B. In yeast, eEF1B is a multifactor complex composed 
ŽĨĞ& ?ɲĂŶĚĞ& ?ɶ ?ǁŝƚŚĞ& ?ɴŝŶƉůĂŶƚƐ ?ĂŶĚĞ& ?ɷŝŶŵĞƚĂǌŽĂŶƐ. Despite significant 
sequence identity eEF1A1 and eEF1A2 exhibit differences in their relative affinities for GTP 
and GDP (Kahns et al., 1998). eEF1A1 binds GTP more strongly than GDP, with the opposite 




being true for eEF1A2. This suggests there should be a greater reliance of eEF1A2 on its GEF, 
the eEF1B complex, the opposite however, is true. eEF1A2 shows very little affinity with any 
component of the eEF1B complex (Mansilla et al., 2002), indicating a primary role for eEF1A2 
that differs to its canonical function. However, it is important to note that in neurons and 
muscle where eEF1A2 is the only form of eEF1A it must still have the ability to carry out its 
canonical GTP bound roles, with evidence from both the Abbott and Zhang labs that eEF1B 
does still act as the GTP exchange factor for eEF1A2 (Cao et al., 2009; Soares et al., 2009). 
 




Figure 1.4 Polypeptide alignment of human, rabbit, mouse, rat and yeast eEF1A isoforms . Red boxes 
show conserved differences between eEF1A1 and eEF1A2 from yeast to human. Blue boxes show conserved 
differences between eEF1A1 to eEF1A2 from mouse to human. The black box shows the single amino acid 
variation between human and rabbit, and mouse and rat eEF1A1. The green box shows the single amino acid 
variation between human and rabbit, and mouse and rat eEF1A2. The highly conserved GTP binding motif 
NKMD is outlined in orange, residues 152-156. 
 




1.2.4 Non-canonical functions of eEF1A 
As discussed in the abstract eEF1A is a multifunctional protein and performs a wide variety of 
roles with in the cell. In addition to its canonical role in translation, eEF1A has several other 
roles, some well characterised, others not so well which appear to be conserved across 
species. Understanding the functional differences between eEF1A1 and eEF1A2 could assist 
in our understanding of differential tissue expression of these proteins and how eEF1A2 
induces tumour growth. 
1.2.4.1 eEF1A as a nuclear exporter 
One of the more contentious roles that eEF1A is reported to be involved in, is that of nuclear 
export. There have been separate studies that have linked eEF1A to nuclear export during 
both protein synthesis and transcription. Reported by both the Kutay and Görlich labs, eEF1A 
is actively exported from the nucleus when it is recruited to the exportin-5/RanGTP complex 
via aa-tRNA. Although it is not understood how eEF1A could be trapped in the nucleus as no 
nuclear transporter has yet been characterised, and under normal conditions eEF1A is 
excluded from the nucleus (Bohnsack et al., 2002; Calado et al., 2002). However, in Exp5 
depleted cells, and in mutant ȴŵƐŶ ? (orthologue of Exp5) yeast cells, it is known that eEF1A 
does enter the nucleus (Lund et al., 2004; Murthi et al., 2010). Another study into the 
mammalian nuclear export signal, transcription dependant nuclear export mechanism (TD-
NEM), suggested that eEF1A mediated export of a range of proteins including, the von Hippel-
Lindau (VHL) tumour suppressor and the poly(A)-binding protein (PABP1). They suggested 
that eEF1A mediated export was stimulated from the cytoplasmic side of the nuclear 
envelope, without eEF1A physically entering the nucleus (Khacho et al., 2008). 




1.2.4.2 eEF1A, protein degradation and aggresome formation 
Thinking of eEF1A as a component in protein degradation initially seems counterintuitive. 
However, when considering the abundance of eEF1A in close proximity to the ribosome, and 
so, the nascent polypeptide, this function seems plausible. eEF1A is also proposed to be an 
excellent candidate to recognise damaged proteins and shuttle them to the proteasome, due 
to its central role in translation elongation (Sasikumar et al., 2012). A role for eEF1A in protein 
degradation was initially identified for ubiquitin-dependent degradation of certain Nɲ-
acetylated proteins (Gonen et al., 1994). Further in vitro studies showed eEF1A can interact 
with nascent polypeptides whilst they are still undergoing synthesis (Hotokezaka et al., 2002). 
eEF1A can also interact with the unfolded protein once released from the ribosome and act 
as a chaperone to help mediate protein folding. In vivo evidence for eEF1A acting on protein 
degradation came from the Madura lab in 2005. They demonstrated high-copy number eEF1A 
rescued the slow growth phenotype observed upon deletion of the RAD53 and RPN10 genes 
that are involved in the proteolytic pathway (Chuang et al., 2005). eEF1A was shown to 
interact with Rpt1p, a subunit of the proteasome 19S regulatory particle, with the ȴƌƉƚ ? 
mutant showing a reduction in the interaction between eEF1A and the proteasome. A more 
recent study highlights a further role for eEF1A in aggresome formation. It was demonstrated 
that upon accumulation of newly synthesised aberrant proteins, eEF1A would bind with them, 
with a reduction of eEF1A resulting in reduced aggresome formation (Meriin et al., 2012). 
When taken together these data suggest a role for eEF1A in not only detecting and 
chaperoning damaged or misfolded proteins from the ribosome to the proteasome, but also 
in sensing the accumulation of defective products upon decreased proteasomal activity, and 
signalling to activate the heat shock response and a putative aggresome formation pathway. 




1.2.4.3 eEF1A has both pro- and anti-apoptotic effects. 
eEF1A has been reported to have both pro- and anti-apoptotic effects. A correlation was 
initially observed between the levels of eEF1A and the rate of apoptosis, followed by an 
observation made during a cDNA screen, that elevated levels of eEF1A result in resistance to 
apoptosis (Duttaroy et al., 1998; Talapatra et al., 2002). The explanation for these contrasting 
results may be that eEF1A is present in higher eukaryotes in two isoforms, eEF1A1 and 
eEF1A2. During muscle differentiation eEF1A1 was revealed as pro-apoptotic, whereas 
eEF1A2 was anti-apoptotic (Ruest et al., 2002). Further studies have found that increased 
levels of eEF1A2 or decreased levels of eEF1A1 correlates to ER stress-induced apoptosis 
(Talapatra et al., 2002).  
Findings from a recent medical study have found that the expression level of eEF1A2 in 
prostate cancer tissues was significantly higher than in healthy tissue (Sun et al., 2014). 
Reduction of eEF1A2 expression was coupled to a large inhibition of proliferation and 
elevated levels of apoptosis. Further analysis revealed that suppression of eEF1A2 led to an 
increase of apoptosis pathway proteins caspase3, BAD, BAX and PUMA, with levels of eEF1A2 
being inversely correlated to caspase3 levels in prostate cancer tissues. 
1.2.4.4 eEF1A and viral propagation 
For a virus to thrive it needs to not only synthesise its own proteins, but it must also rely on 
host proteins to replicate. It makes sense that many studies suggest an interaction between 
viruses and eEF1A, as eEF1A is one of the most abundant cellular proteins and the fact the 
some viruses have evolved to utilise it is unsurprising. eEF1A·GTP interacts with aa-tRNA as 
well as other mammalian RNA species, so, it is also unsurprising that eEF1A is able to bind 




some RNA structures of in the untranslated regions of viral genomes (Mateyak and Kinzy, 
2010; Li et al., 2013). 
1.2.5 The role of eEF1A in cancer 
Despite recent medical advances using traditional cytotoxic treatments, the global burden of 
cancer has continued to increase, and it remains the leading cause of morbidity and mortality 
(Siegel et al., 2013). Understanding of translation, and the many translation factors involved, 
is considered as being an important step in elucidating cancer progression (Scheper et al., 
2007). eEF1A is a translation elongation factor whose roles have been studied extensively, 
but although eEF1A1 and eEF1A2 share a high degree of structural and functional similarity, 
only one of the isoforms has been directly implicated as being an oncogene. 
1.2.5.1 eEF1A1 is not an oncogene 
There is no evidence to implicate eEF1A1 as an oncogene. It maps to chromosome 6q14 and 
this region is frequently lost in many cancers (Kobayashi et al., 2008; Siddiq et al., 2012). This 
had led to speculation that 6q14 may contain a tumour suppressor gene (Thornton et al., 
2003) with several studies suggesting U50 snuRNA could be a primary candidate (Williams 
and Farzaneh, 2012). 
Induction of eEF1A1 overexpression has been observed in some cancer cell lines that have 
been treated with pharmacological compounds indicating it as a potential therapeutic target. 
Greater than two-fold changes in expression levels were seen in erythroblastic leukaemia, 
osteosarcoma, and pancreatic cancer cell lines that are resistant to methotrexate, relative to 
the methotrexate sensitive lines (Selga et al., 2009). Increased levels of eEF1A1 mRNA has 
been identified in a cisplatin resistant, head and neck carcinoma cell line (UMSCC 10b/Pt-S15) 
(Johnsson et al., 2000). Increased expression of eEF1A1 RNA has also been detected in various 




tumours and cancer cell lines without treatment, such as, primary glioblastoma, prostate 
cancer and hepatocellular carcinoma (Mohler et al., 2002; Grassi et al., 2007; Scrideli et al., 
2008). 
1.2.5.2 eEF1A2 is a true oncogene 
Although it seems that eEF1A1 possesses little or no oncogenic properties, there is strong 
evidence implicating eEF1A2 as a true oncogene (Anand et al., 2002). eEF1A2 exhibits the true 
hallmarks of an oncogene, it is not only detected at elevated levels in breast, ovarian and lung 
cancers, to name a few, but it is also able to transform mammalian cells (Kallioniemi et al., 
1994; Anand et al., 2002; Lam et al., 2006).  
eEF1A2 is located at loci 20q13.3, a region which is subject to chromosomal amplification in 
5-10% of breast cancers (Hodgson et al., 2003). There are several putative oncogenes located 
in the region 20q13, and dependent upon the loci amplified, the prognosis varies (Kallioniemi 
et al., 1994; Ginestier et al., 2006).  
eEF1A2 is overexpressed in approximately 30% of ovarian cancers and ectopic expression in 
NIH3T3 cells results in enhanced growth rate, anchorage-independent growth, and induced 
tumour formation when xenografted in nude mice  (Anand et al., 2002). Further studies have 
revealed overexpression of eEF1A2 in more than 85% of serus and endometroid cancers 
(Pinke et al., 2008). eEF1A2 has been shown to be an independent prognostic marker for 
survival in serous cancers, with patients with elevated levels of eEF1A2 expected to have an 
increased probability of 20 year survival (Pinke et al., 2008). 
20q13 amplification is used as a marker for breast cancer and is linked to a poor prognosis 
and enhanced tumour aggressiveness (Kallioniemi et al., 1994; Courjal et al., 1996). The 




eEF1A2 locus (loci 20q13.3) is some 10 Mb away from the 20q13 amplification used to predict 
prognosis, however surprisingly eEF1A2 mRNA and protein are detectable in breast cancers 
(Gonçalves and Malta-Vacas, 2005; Kulkarni et al., 2007). It is also surprising is that eEF1A2 
levels indicate a good prognosis for patients, contrary to amplification of the 20q13 locus 
(Kulkarni et al., 2007). Levels of eEF1A2 in malignant tumours is 30 times higher than healthy 
breast tissue, and benign breast tumours (Tomlinson et al., 2005). 
Comparative genomic hybridisation studies have identified eEF1A2 as playing a role in lung 
cancer (Li et al., 2006; Zhu et al., 2007). eEF1A2 gene, mRNA and protein are all found to be 
elevated in lung adenocarcinomas, and are correlated to disease progression, decreased 
lifespan of the patient, and a poor prognosis (Li et al., 2006). 
It is interesting that eEF1A2 appears to confer different effects dependent on the tissue it is 
expressed in. It has been observed as an oncogene in ovary, breast and lung cancer, but 
appears as a good prognostic marker in some cases, and a bad prognostic marker in others. It 
is also interesting that ablation of eEF1A2 in lung cancer, using short-interfering RNA reduces 
cell proliferation and promotes apoptosis. However, in ovarian cancer, eEF1A2 
overexpression increases cell proliferation, but has no effect on drug-induced cell death or 
anoikis (Pinke et al., 2008). These data suggest that the tissue that eEF1A2 is expressed in has 
a dramatic effect on its interactions and its functions. 
1.2.6 The role of eEF1A in other diseases 
As previously discussed in section 1.2.5 eEF1A2 is involved in the progression of several 
cancers when expressed at elevated levels, but studies have also revealed that deletion and 
mutations in eEF1A2 also result in various disease states. 




1.2.6.1 Deletion of a 15.6 kb region causes the inactivation of eEF1A2 resulting 
in the wasted mouse 
Spontaneous deletion of a 15.6 kb region upstream of eEF1A2 results in the removal of all 
promoter regions and its first non-coding exon causing complete inactivation of the gene 
(Chambers et al., 1998). Loss of eEF1A2 in this fashion results in the wasted mouse phenotype. 
Mice with this mutation grow normally to approximately 21 days, at this point eEF1A2 should 
be expressed at sufficient levels to counter the decline in eEF1A1 expression. However, in the 
wst mouse a lack of eEF1A2 expression results in the mouse losing weight, as well as 
developing tremors and progressive atrophy of the spleen and thymus, resulting in mortality 
by 28 days (Shultz et al., 1982). 
/ŶŝƚŝĂůůǇŝĚĞŶƚŝĨŝĞĚĂƐŶĞƵƌŽŶĚĞŐĞŶĞƌĂƚŝŽŶďǇƚŚĞDŽƐĞƐůĂďŝŶ ? ? ? ? ?ƚŚĞ “ǁĂƐƚĞĚ ?ŵƵƚĂƚŝŽŶ
was originally associated with hindlimb paralysis and tremors (Lutsep et al., 1989). Lutsep et 
al. observed vacuolar degeneration within the neurons of wst/wst mice and the accumulation 
of neurofilaments. They suggested that it may be the phosphorylation of the neurofilaments 
that is important in the onset of the observed neuron degeneration. 
1.2.6.2 De novo mutations in eEF1A2 are recorded to cause neurological 
abnormalities 
Three unique de novo mutations have been observed in four patients each exhibiting 
neurological afflictions. The first mutation characterised c.208G>A resulted in the substitution 
of glycine 70 for serine. Two patients have been recorded as possessing this mutation, the 
first exhibited severe intellectual disability and myoclonic seizures, and the second had 
epileptic encephalopathy (de Ligt et al., 2012; Veeramah et al., 2013). Two further mutations 
were characterised in 2014, c.754G>C, p.D252H and c.364G>A p.E122K. These two patients 




exhibited similar facial features including a depressed nasal bridge, tented upper lip, everted 
lower lip, and downturned corners of the mouth. All patients exhibited severe intellectual 
disability, autistic behaviour, absent speech, neonatal hypotonia, epilepsy and progressive 
microcephaly (Nakajima et al., 2014). Nakajima et al recommend that based on the 
characterisation of these mutations a new neurological syndrome be classified. 
1.3 The yeast actin cytoskeleton 
Part of the main cellular machinery, actin is involved in a range of cellular functions. Both the 
yeast protein and gene ACT1 were discovered over 30 years ago and have been highly 
characterised (Water et al., 1980; Shortle et al., 1982). Within the yeast cell actin can exist in 
one of three ultra-structures, patches, cables, and in the contractile ring (Moseley and Goode, 
2006). 
Similar to eEF1A, actin is a highly conserved, abundant protein essential for the survival of the 
cell (Pollard, 2000). It exists as both globular monomeric (G-actin) and filamentous polymeric 
(F-actin) forms. G-actin is a 42kDa protein encoded for by ACT1 and consists of two large 
domains, that are each composed of two subdomains (Water et al., 1980; Shortle et al., 1982; 
Kabsch et al., 1990). The large domains form a hinged molecule with a deep cleft which 
provides a nucleotide binding site. F-actin forms a right-handed double helix in a polar 
manner. These two forms of actin co-exist in a dynamic cycle, making and breaking filaments 
as required.  
Polymerisation of actin is limited by the initial nucleation event, the binding of three G-actin 
monomers. Once the hurdle of nucleation is overcome, polymerisation rapidly progresses. 
Preferential addition of ATP bound actin to the barbed end results in polarised growth. This 
is followed by the hydrolysis of the ATP subunit resulting in ADP+Pi (inorganic phosphate) 




bound actin and a conformational change in the monomers structure (Pollard, 1986; 
Kudryashov et al., 2010). Pi is then liberated, to leave ADP-bound actin (Pollard, 2000). Once 
dissociated from the pointed end the ADP-actin monomers are free to exchange ADP for ATP 
and commence the cycle once more (see figure 1.5). 
Figure 1.5 A schematic view of actin treadmilling. ATP-actin is shown in blue, ADP+Pi-actin is red, and 
ADP-actin is yellow. 
 
1.4 The actin cytoskeleton and translation 
Research from the Gourlay lab and previously published in the literature has established 
significant functional links between the protein translational machinery and the cytoskeleton.  
The cytoskeleton regulates the spacial and temporal organisation of the translational 
apparatus including ribosomes and polysomes (Wolosewick and Porter, 1976; Ramaekers et 
al., 1983). It has also been shown that disruption of F-actin, by latrunculin, reduces translation 
levels whilst disruption of microtubules does not (Stapulionis et al., 1997). The effects of the 
translational machinery on the actin cytoskeleton are discussed below. 
1.4.1 Initiation factors and the actin cytoskeleton 
A lot remains to be discovered regarding the localisation of translation initiation factors, as 
they play intrinsic roles in development, cell polarity and cell migration. The translation 




initiation factor eIF3 is known associate with the actin binding protein Sla2p and with 
membranes via actin filaments, although nothing is understood about the functional 
significance of this (Palecek et al., 2001; Pincheira et al., 2001). 
The double mutant ȴĞ/& ? ?ȴĞ/& ? has been demonstrated to disrupt actin organisation. Cells 
exhibited an almost total loss of actin filaments and cables, resulting in severely retarded 
growth and 85% of cells stalling at the G2/M transition (Komar et al., 2005). The single ȴĞ/& ? 
and ȴĞ/& ? mutants had a reduced effect on actin polymerisation and growth relative to the 
ĚŽƵďůĞŵƵƚĂŶƚ ?,ŽǁĞǀĞƌ ?ĐŽŶƚƌĂƌǇƚŽƚŚĞĂƵƚŚŽƌƐ ?ŚǇƉŽƚŚĞƐŝƐ ?ďŽƚŚƚŚĞĚŽƵďůĞĂŶĚƚŚĞƐŝŶŐůĞ
mutants showed increased levels of actin. It was expected that the mutants would exhibit 
reduced translation and so, a lower abundance of actin. The increased levels were explained 
by eIF2A acting as a suppressor of cap-independent translation processes. This indicated that 
no direct link existed between actin and the translation initiation machinery, but that actin 
levels were changed due to altered expression of regulatory proteins (Komar et al., 2005). 
The eIF4F complex is found in the non-soluble fraction of lysed fibroblasts that suggests an 
association with the cytoskeleton, although no association was observed in intact cells 
visualized by fluorescence microscopy (Willett et al., 2006). Functional domains of eIF4G, a 
subunit of eIF4F, was overexpressed in S.pombe resulting in aberrant cytokinesis, and causing 
a loss of cell polarity and disruption of actin patches (Hashemzadeh-Bonehi et al., 2003). 
1.4.2 Elongation factors and the actin cytoskeleton 
Other than eEF1A, to be discussed later in section 1.4.4, little evidence exists for interactions 
between other translation elongation factors and the actin cytoskeleton. eEF2 has been 
observed to co-localise with actin in fibroblasts, but there is no evidence of a strong 
association between the two. It was suggested that the interaction is likely to be indirect, and 




rather due to association of the entire translational machinery and the mRNA anchored to 
actin (Shestakova et al. 1991). 
1.4.3 Release factors and the actin cytoskeleton 
A decrease in the levels of eRF3 in S.cerevisiae is known to result in large budded cells with a 
reduced growth rate and an increase in nonsense codon suppression (Valouev et al., 2002). A 
mutant expressing only the C-terminal domain of eRF3 (eRF3c) was generated by Valouev at 
al. The eRF3c mutation conferred an increase in nonsense codon expression but not to the 
same level as the full length eRF3, suggesting that the N-terminal domain of eRF3 has 
deleterious effects on the termination function of eRF3. The eRF3c mutant also conferred a 
severe actin aberration. Cells visualized by fluorescent microscopy were completely devoid of 
phalloidin staining, indicating the absence of any detectable actin. 
In the same paper (Valouev et al., 2002) it was demonstrated the repression of eRF1 causes 
an accumulation of unbudded cells with 2C and higher genomic content, suggesting an 
uncoupling of DNA replication and cell budding. 
These data suggest a robust link between the actin cytoskeleton and the translational 
machinery, although there are still significant holes in our knowledge. One further link 
between these two processes is that of eEF1A and actin. This is undoubtedly the strongest 
link, and has far reaching implications for many areas of research. 
1.4.4 eEF1A and the actin cytoskeleton 
As previously described in section 1.2 the canonical role of eEF1A is the delivery of 
aminoacylated tRNA to the A site of the ribosome during translation elongation. eEF1A is also 
known to be an actin-binding protein across a range of species from the yeasts S. cerevisiae 




and S. pombe, and the slime mould Dictyostelium amoebae to mammals (Yang et al., 1990; 
Edmonds et al., 1996; Suda et al., 1999; Gross and Kinzy, 2005). It is also known that eEF1A 
not only binds, but can also cross link F-actin, and in doing so generates actin bundles that 
possess a unique structure excluding all other actin crosslinkers (Owen et al., 1992). It is 
estimated more than 70-90% of D. amoebae GTP-eEF1A is bound to actin (Edmonds et al., 
1998), suggesting a unique actin-eEF1A environment within the cytoplasm that could 
correlate to changes in cell size or motility, and mRNA translation.  
Genetic manipulations of eEF1A have begun to elucidate the mechanism of eEF1A 
interactions with actin, with studies from the Kinzy lab demonstrating that residues in 
domains II and III of eEF1A are involved in eEF1As ability to bundle actin (Gross and Kinzy, 
2005; Gross and Kinzy, 2007). Their studies revealed two classes of mutations, the first were 
those which did not affect the rate of protein synthesis, but resulted in a disorganised actin 
cytoskeleton and reduced actin bundling, although actin binding was unaltered in vitro (Gross 
and Kinzy, 2005). The second class of mutations caused severe actin phenotypes along with 
slowed growth and decreased levels of translation initiation (Gross and Kinzy, 2007). These 
data along with that from the Condeelis lab suggests that the binding sites on eEF1A for aa-
tRNA and actin overlap (Liu et al., 1996), meaning the functions of actin binding and 
translation may be mutually exclusive. This indicates there could be two pools of eEF1A in the 
system; an actin bound, translation incompetent pool, and an actin free pool that is 
translationally competent. This also means however that at any time there could be a pool of 
eEF1A, ready for rapid release from the cytoskeleton to increase protein translation. 




1.5 Research objectives 
Due to the highly conserved nature of eEF1A, and of the translational and cytoskeletal 
machinery, we sought to utilise the budding yeast S.cerevisiae to elucidate novel interactive 
partners of eEF1A. Using this information we aimed to see if these interactions were 
conserved through to humans by overexpressing the oncogenic human isoform eEF1A2. It 
was hoped that this study may assist in understanding the differences between the two eEF1A 
isoforms and their origins, as well as the mechanism of tumourigenesis induced by high levels 
of eEF1A2. 




Chapter 2: Materials and methods 
  




2.1 Media and growth conditions for Escherichia coli, Saccharomyces 
cerevisiae and HEK293 cells 
All media, unless specified, was sterilised in a Prestige medical bench-top autoclave at 121 °C, 
15 lb/ in2 for 11 minutes. For agar plates 2 % w/v of granulated agar (Difco) was added to 
broth recipes prior to autoclaving. Escherichia coli was grown at 37 °C with liquid cultures 
grown with rapid aeration at 200 rpm. Saccharomyces cerevisae was grown at 30 °C with 
liquid cultures grown with rapid aeration at 180 rpm. HEK293 cells were grown in a static 
incubator at 37 °C and 5 % CO2. 
2.1.1 Yeast media 
2.1.1.1 Yeast extract, peptone, dextrose (YPD) medium 
2 % w/v glucose, 1 % w/v yeast extract (Difco), 2 % w/v bactopeptone (Difco) 
2.1.1.2 Synthetic complete (SC) drop-out medium 
2 % glucose, 0.67 % Yeast Nitrogen Base without Amino Acids (Formedium), Yeast Synthetic 
Complete Drop-out Media Supplement (Formedium) added to manufacturers ? guidelines. 
2.1.1.3 Media for microscopy 
Because of issues with auto-fluorescence generating background noise during microscopy all 
strains grown for microscopy were done so in low fluorescence media with sterilisation 
achieved through filtration rather than autoclaving. The low fluorescence media consisted of 
2 % w/v glucose, 0.69 % Yeast Nitrogen Base without Amino Acids and without Folic Acid and 
Riboflavin - LoFlo (Formedium), Yeast Synthetic Complete Drop-out Media Supplement 
 ?&ŽƌŵĞĚŝƵŵ ?ĂĚĚĞĚƚŽŵĂŶƵĨĂĐƚƵƌĞƌƐ ?ŐƵŝĚĞůŝŶĞƐ ?dŚŝƐǁĂ ĨŝůƚĞƌĞĚƚŚƌŽƵŐŚĂ ? ? ?ʅŵĨŝůƚĞƌƚŽ
prevent caramelisation of the glucose. 




2.1.2 Bacterial media 
2.1.2.1 Yeast, Tryptone (YT) medium 
1% yeast extract, 1.6 % tryptone, 0.5% NaCl 
2.1.3 Cell culture media 
2.1.3.1 Media for HEK293 cells prior to Flp-In transfection 
DMEM, High Glucose, GlutaMAX (Invitrogen, 6195-026) with 2 mM glutamine (Invitrogen, 
21765-029), 10 % FBS (Invitrogen 16000-044) and 1/1000 Zeocin (Invitrogen) 
2.1.3.2 Media for HEK293 cells post Flp-In transfection 
DMEM, High Glucose, GlutaMAX (Invitrogen, 6195-026) with 2 mM glutamine (Invitrogen, 
21765-029), 10 % FBS (Invitrogen 16000- ? ? ? ? ĂŶĚ  ? ? ? ʅŐ ?ŵů ,ǇŐƌŽŵǇĐŝŶ B (Invitrogen, 
10687-010) 
2.1.3.3 HEK293 cell maintainance 
HEK293 cells were grown in DMEM medium as described in 2.1.3.2. Cells were maintained in 
T25 flasks and upon reaching 75 % confluence they were split 1:10. Cell splitting was carried 
out by enzymatic trypsinisation of the focal adhesions using Trypsin-EDTA (0.05 % Trypsin, 
0.53 mM EDTA.4Na, Invitrogen). The medium that cells were grown in was aspirated off and 
discarded, 0.75 ml of Trypsin-EDTA was added to the cells and they were incubated at 37 °C 
for 3 minutes. To detach the cells from the surface of the flask, the flask was hit five to seven 
times and then 0.75 ml of DMEM was added to neutralise the Trypsin-EDTA. 7 ml of DMEM 
was put in a new T25 flask and then 150 µl of the cell suspension was added to this. Cells were 
grown at 37 °C and 5 % CO2. 
 





2.2.1 Yeast strains 
Table 2.1 ʹ Teast strains used in this study 
Strain Genotype Source/ Reference 
BY4741 DdĂŚŝƐ ?ȴ ?ůĞƵ ?ȴ ?ŵĞƚ ? ?ȴ ?ƵƌĂ ?ȴ ? CWG collection 
ȴĂďƉϭϰϬ BY4741 abp140::KANMX Mat a knockout collection 
ȴĂĐĨϰ BY4741 acf4::KANMX Mat a knockout collection 
ȴĂŝŵϮϭ BY4741 aim21::KANMX Mat a knockout collection 
ȴĂŝŵϯ BY4741 aim3::KANMX Mat a knockout collection 
ȴĂŝŵϳ BY4741 aim7::KANMX Mat a knockout collection 
ȴĂŝƉϭ BY4741 aip1::KANMX Mat a knockout collection 
ȴĂĚƉϭ BY4741 adp1::KANMX Mat a knockout collection 
ȴĂƌĐϭϴ BY4741 arc18::KANMX Mat a knockout collection 
ȴĂƌŬϭ BY4741ark1::KANMX Mat a knockout collection 
ȴĂƌƉϭ BY4741 arp1::KANMX Mat a knockout collection 
ȴĂƌƉϱ BY4741 arp5::KANMX Mat a knockout collection 
ȴĂƌƉϲ BY4741 arp6::KANMX Mat a knockout collection 
ȴĂƌƉϴ BY4741 arp8::KANMX Mat a knockout collection 
ȴďĂŐϳ BY4741 bag7::KANMX Mat a knockout collection 
ȴďďĐϭ BY4741 bbc1::KANMX Mat a knockout collection 
ȴďŝƚϮ BY4741 bit2::KANMX Mat a knockout collection 
ȴďŝƚϲϭ BY4741 bit61::KANMX Mat a knockout collection 
ȴďŶŝϭ BY4741 bni1::KANMX Mat a knockout collection 
ȴďŶƌϭ BY4741 bnr1::KANMX Mat a knockout collection 
ȴďƐƉϭ BY4741 bsp1::KANMX Mat a knockout collection 
ȴďƵĚϲ BY4741 bud6::KANMX Mat a knockout collection 
ȴďǌǌϭ BY4741 bzz1::KANMX Mat a knockout collection 
ȴĐĂƉϭ BY4741 cap1::KANMX Mat a knockout collection 
ȴĐĂƉϮ BY4741 cap2::KANMX Mat a knockout collection 
ȴĐƌŶϭ BY4741 crn1::KANMX Mat a knockout collection 
ȴĐǇŬϯ BY4741 cyk3::KANMX Mat a knockout collection 
ȴĞŶĚϯ BY4741 end3::KANMX Mat a knockout collection 
ȴĞŶƚϭ BY4741 ent1::KANMX Mat a knockout collection 
ȴĞŶƚϮ BY4741 ent2::KANMX Mat a knockout collection 
ȴgea1 BY4741 gea1::KANMX Mat a knockout collection 
ȴŐŝƉϯ BY4741 gip3::KANMX Mat a knockout collection 
ȴũŶŵϭ BY4741 jnm1::KANMX Mat a knockout collection 
ȴůƐďϲ BY4741 lsb6::KANMX Mat a knockout collection 
ȴŵƐďϯ BY4741 msb3::KANMX Mat a knockout collection 
ȴŵǇŽϰ BY4741 myo4::KANMX Mat a knockout collection 




ȴƉůƉϭ BY4741 plp1::KANMX Mat a knockout collection 
ȴƌŐĚϭ BY4741 rgd1::KANMX Mat a knockout collection 
ȴƌǀƐϭϲϳ BY4741 rvs167::KANMX Mat a knockout collection 
ȴƐĂĐϲ BY4741 sac6::KANMX Mat a knockout collection 
ȴƐĂĐϳ BY4741 sac7::KANMX Mat a knockout collection 
ȴƐĐƉϭ BY4741 scp1::KANMX Mat a knockout collection 
ȴƐŝǁϭϰ BY4741 siw14::KANMX Mat a knockout collection 
ȴƐůĂϭ BY4741 sla1::KANMX Mat a knockout collection 
ȴƐůŽϭ BY4741 slo1::KANMX Mat a knockout collection 
ȴƐƉĂϮ BY4741 spa2::KANMX Mat a knockout collection 
ȴƚƉŵϮ BY4741 tpm2::KANMX Mat a knockout collection 
ȴƚƐĐϭϭ BY4741 tsc11::KANMX Mat a knockout collection 
ȴƚǁĨϭ BY4741 twf1::KANMX Mat a knockout collection 
ȴǀƌƉϭ BY4741 vrp1::KANMX Mat a knockout collection 
ȴǇŬĞϮ BY4741 yke2::KANMX Mat a knockout collection 
ȴǇƐĐϴϰ BY4741 ysc84::KANMX Mat a knockout collection 
ARP1-GFP BY4741 Yeast GFP Clone collection 
TUB4-GFP BY4741 Yeast GFP Clone collection 
TKY881 DĂƚɲƵƌĂ3-52, leu2-3, 112 trp1-delta1, lys2-
20, met2-1, his4-713, tef1::LEU2, tef2delta, 
pTEF1-URA3 TRP1 
(Gross and Kinzy, 2007) 
TKY882 TKY881 pTEF1-URA3 TRP1 N329D Y355C (Gross and Kinzy, 2007) 
TKY883 TKY881 pTEF1-URA3 TRP1 K333E (Gross and Kinzy, 2007) 
TKY885 TKY881 pTEF1-URA3 TRP1 H924A Q296R (Gross and Kinzy, 2007) 
TKY886 TKY881 pTEF1-URA3 TRP1 F308L (Gross and Kinzy, 2007) 
TKY887 TKY881 pTEF1-URA3 TRP1 N305S (Gross and Kinzy, 2007) 
TKY888 TKY881 pTEF1-URA3 TRP1 S405P (Gross and Kinzy, 2007) 
TKY889 TKY881 pTEF1-URA3 TRP1 N329S (Gross and Kinzy, 2007) 
 
 The yeast MATa knockout collection was generated by the yeast genome project consortium 
(http://www-sequence.stanford.edu/group/yeast_deletion_project/consortium.html) and 
purchased from Open Biosystems (now part of GE Healthcare). 
2.2.2 Bacterial strains 
,ϱɲ F-deoR endA1 relA1 gyrA96 hsdT17(rk- mk+) phoA supE44 thi- ?ȴ(lacZYA-
ĂƌŐ& Zh ? ? ?ʔ ? ?ɷůĂĐȴD ? ? 
2.2.3 Mammalian cell lines 
Flp-in HEK293 Adherent Human embryonic kidney (Graham et al., 1977). pFRT/lacZeo 





Table 2.2 ʹ Plasmids used in this study 
Name Description Source/Reference 
pCG124 pAG425GPD-ccdB, Gateway 
expression vector, Leu2, 2µ 
Invitrogen 
pTHE53 pENTR/TEV/D-TOPO TEF1 TvdH collection 
pCG454 pCG124 containing pTHE53 
Leu2::TEF1, 2µ 
This study 
pcDNA5.0/ Flp-In control plasmid, 
hygromycin resistance 
Invitrogen 
pcDNA3/1A2 Plasmid used for amplification 
of human eEF1A2  
(Anand et al., 2002) 




2.4 DNA and RNA methods 
2.4.1 Gateway cloning 
All yeast overexpression vectors were generated using the Gateway PCR Cloning System 
(Invitrogen). The entry clones were generated in donor vector, pDONR221, with the addition 
of a gene of interest. The TEF1 entry vector was generated in our lab by Claudia Solscheid, 
with all others being generated during this project. Entry clones were created by amplifying a 
GOI flanked by attB sites using PCR. Recombination of the donor vector and attB-flanked PCR 
product was catalysed by the addition of BP clonase enzyme mix. The BP clonase reaction 
results in recombination of the attB-PCR product and the linearised donor vector creating the 
attL containing entry clone and an attR by product. 
Yeast expression clones were generated by recombining the entry clone with a destination 
vector. Recombination of the attL entry clone and attR-destination vector was catalysed by 
the addition of LR clonase enzyme mix. The LR clonase reaction results in recombination of 




the attL entry clone and the attR destination vector donor vector creating the attB containing 
expression clone and an attP by product (see figure 2.1) 
 
Figure 2.1, Overview of Gateway BP and LR reactions. The BP reaction catalyses a reaction between attB 
flanked PCR product and a Donor Vector to generate an Entry Clone. The LR reaction catalyses a reaction 
between an Entry Clone and a Destination Vector to generate an Expression Clone. 
2.4.2 Insertion of DNA into a yeast cell 
2.4.2.1 Yeast transformation 
Table 2.3 - Yeast transformation reagents 
Reagent Stock Concentration Final Concentration 
TE 10 x 1 x 
LiAc 1 M 0.1 M 
PEG 50 % 40 % 
ssDNA 10 mg/ml 0.1 mg/ml 
Plasmid DNA 100  W  ? ? ?ʅŐ ?ŵů 0.4  W  ?ʅŐ ?ŵů 
 
A freshly streaked yeast colony was picked and inoculated into 5 ml of appropriate media. 
This was grown overnight at 30 °C with shaking at 180 rpm. 1 ml of overnight culture was 
collected in a 1.5 ml eppendorf and pelleted using a bench-top centrifuge at 3000 rpm for 4 
ŵŝŶƵƚĞƐ ?dŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĚŝƐĐĂƌĚĞĚĂŶĚƚŚĞƉĞůůĞƚǁĂƐƌĞƐƵƐƉĞŶĚĞĚŝŶ ? ? ?ʅůŽĨd ?ĞůůƐ
were pelleted again at 3000 rpm for 4 minutes and the supernatant was discarded. Cells were 
ƚŚĞŶƌĞƐƵƐƉĞŶĚĞĚŝŶ ? ? ?ʅůŽĨ 0.1 M LiAc in TE and pelleted for a final time at 3000 rpm for 4 




ŵŝŶƵƚĞƐ ?ƚŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĚŝƐĐĂƌĚĞĚ ?ĞůůƐǁĞƌĞƌĞƐƵ ƉĞŶĚĞĚŝŶ ? ? ?ʅů ? ? ?D>ŝĐŝŶd
ĂŶĚƚŚĞŶ ? ?ʅůŽĨƐƐEĂŶĚ ?ʅůŽĨƉůĂƐŵŝĚE ǁĂƐĂĚĚĞĚ ? ? ? ?ʅůŽĨ ? ?A?W'ǁŝƚŚ ? ? ?D
LiAc in TE was added and cells were briefly vortexed at full speed. The eppendorfs were placed 
in a heat block at 42 °C and left to incubate for 15 minutes. Following heat shock cells were 
ƉĞůůĞƚĞĚĂƚ ? ? ? ?ƌƉŵĨŽƌ ?ŵŝŶƵƚĞƐĂŶĚŐĞŶƚůǇƌĞƐƵƐƉĞŶĚĞĚŝŶ ? ? ?ʅůŽĨƐĞůĞĐƚŝǀe media before 
 ? ? ?ʅůŽĨĐĞůůƐƵƐƉĞŶƐŝŽŶǁĂƐƉůĂƚĞĚŽŶƚŽĂƉƉƌŽƉƌŝĂƚĞƉůĂƚĞƐ ?WůĂƚĞƐǁĞƌĞŝŶĐƵďĂƚĞĚĂƚ ? ? ?
for 3 days and colonies were re-streaked onto appropriate synthetic complete drop-out 
selection medium. 
2.4.2.2 Preparation of competent cells 
10 ml of YT was inoculated with DH5-ɲĐĞůůƐĂŶĚŐƌŽǁŶŽǀĞƌŶŝŐŚƚĂƚ ? ? ?ǁŝƚŚƐŚĂŬŝŶŐĂƚ ? ? ?
ƌƉŵ ? ?ʅůŽĨŽǀĞƌŶŝŐŚƚĐƵůƚƵƌĞǁĂƐŝŶŽĐƵůĂƚĞĚŝŶƚŽ ? ?ŵůŽĨzdďƌŽƚŚĂŶĚŝŶĐƵďĂƚĞĚĂƚ ? ? ?
with shaking at 200 rpm for approximately 4.5 hours. 5 minutes prior to reaching an OD600 of 
0.5, 3.75 ml of sterile, warm 100% glycerol was slowly added whilst still shaking the flask. The 
cells were chilled on ice for 10 minutes and then pelleted at 4000 rpm and 4 °C for 10 minutes. 
The supernatant was discarded and cells were resuspended in an equal volume of ice cold 0.1 
M MgCl2 plus glycerol. Cells were pelleted at 3800 rpm and 4 °C for 8 minutes before re-
suspending in 6.25 ml of ice cold T-salts. Cells were incubated on ice for 20 minutes with 
occasional mixing. Cells were pelleted for a final time at 3600 rpm and 4 °C for 6 minutes. 
Cells were resuspended in 1.25 ml of T-salts and aliquoted into pre-cooled 0.5 ml eppendorfs. 
The eppendorfs were stored immediately at -80 °C until required. 
2.4.2.3 Escherichia coli transformation with plasmid DNA 
Competent cells (as previously described) were thawed on ice and gently mixed. 0.2  W  ?ʅŐŽĨ
EǁĂƐĂĚĚĞĚƚŽ ? ?ʅ>ŽĨĐŽŵƉĞƚĞŶƚĐĞůůƐ ?dŚĞƚƌĂŶƐĨŽƌŵĂƚŝŽŶǁĂƐŝŶĐƵďĂƚĞĚŽŶŝĐĞĨŽƌ ? ?




minutes and then heat shocked at 42 °C for 90 seconds. The cells were pelleted at 4000 rpm 
for 3 minutes and the supernatant was discarded. Cells were resuspended in  ? ? ?ʅůŽĨzd
ďƌŽƚŚĂŶĚǁĞƌĞĂůůŽǁĞĚƚŽƌĞĐŽǀĞƌĂƚ ? ? ?ǁŝƚŚƐŚĂŬŝŶŐĂƚ ? ? ?ƌƉŵĨŽƌ ?ŚŽƵƌ ? ? ? ?ʅůŽĨĐĞůů
suspension was plated onto YT plates containing the appropriate antibiotic and plates were 
incubated at 37 °C overnight. 
2.4.3 Plasmid amplification and purification 
An E.coli colony that contained the plasmid of interest was inoculated into 5 ml of YT broth 
with the appropriate antibiotic and grown overnight at 37 °C with shaking at 200 rpm. 1 ml of 
cells was harvested in a 1.5 ml eppendorf by centrifugation at 13,000 rpm for 60 seconds. The 
plasmid DNA was isolated from the pellet using a Qiagen QIAprep Spin Miniprep Kit as per the 
ŵĂŶƵĨĂĐƚƵƌĞƌƐ ?ŝŶƐƚƌƵĐƚŝŽŶƐ ? 
2.4.4 DNA quantification 
A BMG Labtech SPECTROstar Nano was used to measure and calculate DNA concentration. 1 
ʅůŽĨƐample was loaded onto the LVis Plate, with upto 15 samples loaded at a time plus an 
Elution Buffer blank. A reading at OD260 was measured allowing measurement of DNA 
ĐŽŶĐĞŶƚƌĂƚŝŽŶŝŶʅŐ ?ŵů ? 
2.4.5 DNA digestion using restriction enzymes 
Restriction endonucleases for the digestion of DNA plasmids at specific sites were acquired 
from New England Biolabs, Roche and Promega. Digestions were carried out as per the 
ŵĂŶƵĨĂĐƚƵƌĞƌƐ ?ŐƵŝĚĞůŝŶĞƐďƵƚƚǇƉŝĐĂůůǇĐŽŶƐŝƐƚĞĚŽĨƚŚĞĨŽůůŽǁŝŶŐƌĞĂŐĞŶƚƐƉĞƌƌĞĂĐƚŝŽŶ P 
 
 




Table 2.4 - Regents for restriction digest 
Reagent Amount 
10 x Enzyme Buffer  ? ? ?ʅ> 
Restriction Enzyme  ? ? ?ʅ> 
DNA  ?ʅŐ 
ddH2O hƉƚŽ ? ?ʅ> 
 
All components were added to a 0.5 ml eppendorf and incubated at 37 °C typically for 2 hours 
but overnight incubation was sometimes required. 
2.4.6 PCR amplification of DNA fragments 
PCR reactions were required to amplify desired DNA sequences. The PCR utilised the DNA 
polymerase Taq (Roche), a DNA template, primers and nucleotides. Reactions were 
performed at optimal conditions dependent upon the length of the fragment to be amplified 
and the nature of the primers used. A typical PCR reaction consisted of: 
Table 2.5 - Reagents for PCR amplification 
Reagent Amount 
10 x Taq Buffer  ? ? ?ʅ> 
10 mM dNTPs  ? ? ?ʅ> 
10 mM Primers  ? ? ?ʅ>ŽĨĞĂĐŚ 
Template DNA  ?ʅŐ 
Taq polymerase  ? ? ? ? ?ʅ> 









A typical program for a 2 kilobase fragment would be: 
94 °C for 3 minutes, initial denaturation of temple DNA 
94 °C for 30 seconds, short denaturation 
54 °C for 1 minute, annealing (varies upon primer length and GC content)  Repeat for  
72 °C for 2 minutes, elongation       30 cycles 
72 °C for 10 minutes, final elongation 
2.4.7 Agarose gel electrophoresis 
Gels were prepared by adding the desired quantity (typically 0.7 g) of molecular biology grade 
agarose (Melford) to 1 x TAE buffer (40 mM tris, 1 mM EDTA and 20 mM Acetic acid, pH 8.5) 
ĂŶĚŚĞĂƚŝŶŐƵŶƚŝůĚŝƐƐŽůǀĞĚ ?  ? ? ?ʅůŽĨ  ? ?ŵŐ ?ŵůĞƚŚŝĚŝƵŵďƌŽŵŝĚĞǁĂƐĂĚĚĞĚƉĞƌ  ? ?ŵůŽĨ
agarose TAE and then poured into casts with a comb being added following an inspection for 
bubbles in the molten gel. Once set the comb was removed and the get was transferred to an 
electrophoresis tank and covered in TAE. A 1 kb ladder was used for sample identification and 
DNA preps were mixed with 6 x loading buffer prior to loading into the gel. Typical gels were 
run at 70 V for 45 minutes. Gel analysis was performed using a shortwave transilluminator 
(312nm) with the image capture by digital camera. 
2.4.8 DNA gel extraction 
DNA fragments were purified from agarose gels using the Qiagen QIAquick Gel Extraction Kit. 
Following image capture of the agarose gel it was transferred to a flatbed shortwave 
transilluminator (312 nm) and the desired bands were excised using a sterile scalpel. DNA was 
isolatĞĚĨƌŽŵƚŚĞŐĞůĨƌĂŐŵĞŶƚƐĂƐƉĞƌƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌƐ ?ŵĂŶƵĂů ? 




2.4.9 DNA ligation 
Fragments of DNA were excised from the agarose gel as described in 2.4.8 and the purified 
E ǁĂƐ ůŝŐĂƚĞĚ ƵƐŝŶŐ ƚŚĞ ZŽĐŚĞ ZĂƉŝĚ E >ŝŐĂƚŝŽŶ <ŝƚ ĂƐ ƉĞƌ ƚŚĞ ŵĂŶƵĨĂĐƚƵƌĞƌƐ ?
instructons. 
2.4.10 Whole cell RNA extraction 
Whole yeast cell RNA extraction for microarray analysis was performed using the Qiagen 
ZEĞĂƐǇDŝŶŝ<ŝƚĂƐƉĞƌƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌƐ ? manual. 
2.4.11 Flp-In recombination 
Stable HEK293 cell lines were generated using the Invitrogen Flp-In Recombination System, 
ĂƐƉĞƌƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌƐ ?ŐƵŝĚĞůŝŶĞƐ ? 
2.5 Protein methods 
2.5.1 Whole cell protein extraction 
Whole cell protein extraction was performed as described in (von der Haar, 2007). A cell count 
was performed on cells in the desired phase of growth and 1 x 108 cells were harvested by 
centrifugation in a bench-top centrifuge at 13,000 rpm for 1 minute. They were resuspended 
ŝŶ  ? ? ? ʅů ůǇƐŝƐ ďƵĨĨĞƌ  ? ? ? ? D EĂK, ?  ? ? ? ? D d ?  ? A? ^^ ?  ? A? ɴ-mercaptoethanol) and 
ŝŶĐƵďĂƚĞĚ Ăƚ  ? ?  ? ĨŽƌ  ? ? ŵŝŶƵƚĞƐ ?  ? ʅů ŽĨ  ? D ĂĐĞƚŝĐĂĐŝĚ ǁĂƐ ĂĚĚĞĚ ĂŶĚ ƐĂŵƉůĞƐ ǁĞƌĞ
vortexed for 30 seconds before being incubated for a ĨƵƌƚŚĞƌ  ? ?ŵŝŶƵƚĞƐĂƚ ? ?  ? ? ? ?ʅůŽĨ
loading buffer (0.25 M Tris-HCl pH 6.8, 50 % glycerol, 0.05 % bromophenol blue) was added 
to each sample and they were stored at -20 °C until needed. 




2.5.2 Protein separation by SDS-PAGE 
Proteins were separated by molecular mass using SDS-PAGE. Gels were composed of a  
resolving layer with acrylamide concentrations of 10  W 12.5 % and a stacking layer of 5 % (see 
recipes in table 2.3). The gels were prepared by pouring the resolving gel mixture into the 
ATTO Gel system cast and overlaying with isopropanol. Once the resolving layer had 
polymerised the isopropanol was discarded and the stacking gel mixture was poured on top 
followed by insertion of the comb. Once the stacking layer had polymerised the comb was 
removed and the gasket removed from the cast. 
Table 2.6 - Reagents for acrylamide gels 
 Acrylamide concentration 
10 % 12.5 % 5 % (stacking) 
Acrylamide 40 % 2 ml 2.5 ml 0.375 ml 
1.5 M Tris (pH8.8) 2 ml 2 ml - 
0.5 M Tris (pH6.8) - - 0.75 ml 
H2O 4 ml 3.5 ml 1.875 ml 
TEMED  ?ʅů  ?ʅů  ? ? ?ʅů 
10 % APS  ? ?ʅů  ? ?ʅů  ? ?ʅů 
 
The gel was then transferred to the electrophoresis tank and the tank was filled with 1 x TGS 
running buffer (10x TGS; 250 µM Tris pH8, 1.92 M glycine, 1% SDS, pH8.3). Samples were run 
at 90 volts until they had passed through the stacking layer, at which point the power was 
increased to 120 volts and run for a further 2 hours, or until the sample buffer ran off the gel. 
2.5.3 Protein detection by western blotting and ECL detection 
Following separation by SDS-PAGE proteins were detected by western blot and enhanced 
chemiluminescence (ECL) detection. 




2.5.3.1 Semi-dry protein transfer 
The first stage of western blotting was the semi-dry transfer of proteins from the SDS gel to 
the Polyvinylidene Fluoride (PVDF) membrane. To do this PVDF membrane and 2 sheets of 
blotting paper were cut to the same dimensions as the SDS gel; the PVDF was soaked in 
methanol and then placed in transfer buffer together with the blotting paper for 15 minutes. 
The first piece of the blotting paper was placed on the bottom electrode of a BioRad semi-dry 
transfer machine and any air bubbles removed. Next the PVDF membrane was placed on top, 
again removing air bubbles to ensure uniform transfer. The SDS gel was removed from the 
electrophoresis tank and the cast, and the stacking layer was removed using a scalpel and 
then discarded. The resolving gel was then gently placed on top of the PVDF membrane 
ensuring no air bubbles were present. The final piece of blotting paper was placed on top and 
then the top electrode was locked in place. The power pack was set to 25 V and would be run 
for 15 minutes per blot. When the transfer was complete the PVDF was removed for use in 
immunoblotting. 
2.5.3.2 Immunoblotting 
Immunoblotting was used to detect desired proteins. The PVDF membrane (from the Semi-
dry transfer) was placed in blocking buffer (5 % w/v dried milk in PBST [PBS with 0.2% Tween]) 
and shaken for 45 minutes at room temperature. The membrane was rinsed in PBST and 
placed in a flat tray containing 20 ml blocking buffer with the appropriate anti-body at the 
concentration recommended by the manufacturer. This was left shaking at 4 °C overnight. 
Following the primary anti-body conjugation the membrane was rinsed with PBST and then 
given one 15 minute, and two 5 minute washes in PBST. The membrane was then placed into 
a clean flat tray and covered with 20 ml of blocking buffer containing the secondary anti-body 
at the appropriate concentration. This was left to shake at room temperature for 30 minutes. 




Following the secondary anti-body conjugation the membrane was rinsed again in PBST and 
then given a further 15 minute wash and three 5 minute washes in PBST.  
Table 2.7 - Antibodies used for immunoblotting 
Name Raised against Raised in Concentration used at 
ɲ-eEF1A1 Human eEF1A1 Rabbit 1/3000 
ɲ-eEF1A2 Human eEF1A2 Rabbit 1/3000 
ɲ-Rabbit HRP Rabbit IgG Goat 1/5000 
 
2.5.3.3 ECL detection 
Detection of proteins on the PVDF membrane was performed using ECL detection. The 
following procedures were carried out in a dark room with red light as the only light source. 
The two developing solutions (see table 2.4) were mixed at a 1:1 ratio and poured over the 
PVDF membrane in a clean box, they were left for 1 minute at room temperature and the 
membrane was then drained and placed between two sheets of plastic wrap inside a 
developing cassette. A sheet of X-ray film was placed on top of the plastic sheet and the 
developing cassette was closed for the appropriate amount of time to acquire the desired 
exposure (approximately 1 minute). The x-ray film was removed and placed into the 










Table 2.8 - Reagents for ECL solutions 
Reagent Stock concentration Solution I Solution II 
Luminol 250 mM 1 ml - 
p-coumaric acid 90 mM 0.44 ml - 
TRIS. HCl (pH8.5) 1 M 10 ml 10 ml 
H2O2 30% - 64 µl 
H2O - Up to 100 ml Up to 100 ml 
 
2.5.4 Metabolite detection 
To characterise the cellular metabolome in yeast, cells were grown to the desired phase of 
growth and either had their entire metabolome extracted, or just that of the vacuole. 
Detection of metabolites was carried out using proton and carbon based NMR. 
2.5.4.1 Whole cell metabolite extraction 
50 ml cultures were grown to the desired phase of growth and a cell count was performed for 
quantification purposes. Cells were decanted into 50 ml falcons and cooled on ice before 
pelleting at 3000 g and 4 °C for 5 minutes. They were then washed twice in 25 ml of ice cold 
water and the biomass was weighed for quantification purposes. 5ml of boiling 75 % EtOH 
was added to the pellet together with 2 ml of 0.3 mm glass beads. The samples were vortexed 
for 30 seconds and then incubated at 80 °C for 3 minutes followed by another 30 second 
vortex. Samples were decanted into a 15 ml falcon leaving the beads in the 50 ml falcon for a 
second wash with a further 2 ml of 75 % EtOH that was then combined with the remainder of 
the sample in the 15 ml falcon. Samples were then aliquoted into 2 ml eppendorfs and 
centrifuged at 16,000 g for 10 minutes to remove cell debris. Samples were transferred to 
clean 2 ml eppendorfs and dried overnight in a Rotorvac at 37 °C. Samples were resuspended 
ŝŶ ? ? ?ʅůŽĨ,2O and spun at 5000 rpm for 10 minutes to remove any further debris, before 




combining the supernatant into a single 1.5 ml eppendorf. Samples were frozen at -20 °C 
before being freeze dried overnight. Samples were stored at -20 °C until required. 
2.5.4.2 Vacuolar metabolite extraction (adapted from Destruelle et al., (1995)) 
100 ml cultures were grown to the desired phase of growth, decanted into 50 ml falcons and 
cooled on ice. Cells were pelleted at 3000 g and 4 °C for 5 minutes before being washed twice 
in 25 ml of ice cold water. They were resuspended in 10 ml amino acids buffer (2.5 mM 
potassium phosphate buffer, pH 6, 0.6 M sorbitol, 10 mM glucose, and 0.2 mM CuCl2), and 
incubated at 30 °C for 10 minutes. CeůůƐƵƐƉĞŶƐŝŽŶƐǁĞƌĞŚĂƌǀĞƐƚĞĚďǇĨŝůƚƌĂƚŝŽŶŽŶ ? ? ? ?ʅŵ
membrane filters (Millipore) and washed five times with amino acid buffer lacking 0.2 mM 
CuCl2. Cells retained on the filter were resuspended in H2O and boiled for 15 minutes. The cell 
suspension was then centrifuged at 100,000 g for 1 hour and the supernatant was collected 
as the vacuolar fraction. 
2.5.4.3 Metabolite detection by NMR 
Nuclear Magnetic Resonance (NMR) spectroscopy was used to analyse the metabolite preps. 
Experiments were performed at 298 K on a Bruker AVANCE 3 600 MHz spectrometer, 
equipped with a QCI-F cryoprobe. Data sets were acquired with 64k points and a proton 
window size of 16 ppm. Spectra were referenced against an internal standard of DSS. The 
excitation sculpting method was used to suppress the water peak using pulsed field gradients. 
2.5.4.4 Metabolite analysis 
Analysis of data acquired by NMR spectroscopy was performed using Bruker TopSpin and 
AMIX data analysis software, as well as CcpNmr Analysis (Vranken et al., 2005). Identification 
of metabolites was performed by comparison to previously published data on the Madison 
Metabolomics Consortium Database, peak assignment of 2D spectra, and the generation of a 




new metabolite database at the University of Kent that now contains 47 metabolite 
standards. 
2.5.4.5 Metabolite quantification 
Addition of a DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) standard of known 
concentration to the sample gave us the ability to quantify the concentration of other 
metabolites in the NMR spectrum. We utilised Bruker TopSpin to quantify peak intensity, the 
total area under a peak of interest, for peaks that were known to be unique to assigned 
metabolites and compared them to the intensity of the DSS standard. Using this method gave 
us relative values, but for absolute concentrations we needed to know how many protons 
accounted for each peak. Once we had peak intensities for the DSS standard and the 
metabolite of interest, and the proton number we were able to use the equation below to 
calculate the concentration, where X is the peak of interest. 
Concentration (µM) = 
peak X intensity/((DSS peak intensity/9 protons)*peak X protons)*50 
 
2.6 Phenotypic analyses 
2.6.1 Fluorescence microscopy 
All fluorescence microscopy was performed on an Olympus IX81 inverted research 
microscope. Images were captured through a Hamamatsu photonics ORCA AG cooled CCD 
digital camera, with light excitation from an Olympus MT20 illumination system. Control of 
the system was through the Olympus Cell^R imaging software. Images were processed using 




Huygens deconvolution software from Scientific Volume Imaging. All images were captured 
using a 60x objective. 
2.6.1.1 GFP and RFP tagged proteins 
Observation of proteins in yeast is facilitated by the generation of the GFP library (Huh et al., 
2003) that has three quarters of the yeast proteome individually tagged to GFP. This was the 
primary source for GFP strains, with the remainder of the GFP/RFP strains generated during 
this project being plasmid based expression systems.  
2.6.1.2 Actin visualisation using Rhodamine Phalloidin 
Actin was visualised by staining cells with Rhodamine Phalloidin (Invitrogen). Cells were 
grown to the desired growth phase and 1 ml of culture was transferred to a 1.5 ml eppendorf. 
Cells were fixed in 5 % formaldehyde and left at room temperature for 1 hour. Cells were 
pelleted at 3000 rpm for 4 minutes and then washed twice with PBS + 1 mg/ml BSA + 0.1 % 
TX-100. dŚĞ ƉĞůůĞƚ ǁĂƐ ƌĞƐƵƐƉĞŶĚĞĚ ŝŶ  ? ? ʅů ŽĨ ƚŚĞ ǁĂƐŚ ƐŽůƵƚŝŽŶ A?  ? ʅů ŽĨ ZŚŽĚĂŵŝŶĞ
Phalloidin and incubated in the dark for 30 minutes. Following staining, cells were washed in 
PBS + 1 mg/ml BSA and finally resuspended in an appropriate volume of PBS/BSA ready for 
visualisation. 
2.6.1.3 Immnuofluorescence of yeast cells 
Cells were grown to the desired phase of growth and fixed in 5 % formaldehyde for 1 hour. 
The cells were pelleted by centrifugation at 3000 rpm for 4 minutes and washed twice in 
sorbitol buffer (1.2 M sorbitol, 0.1 M potassium phosphate buffer pH7.5), centrifugation 
during the wash steps was performed at maximum speed in an IEC clinical centrifuge. Cells 
ǁĞƌĞ ƌĞƐƵƐƉĞŶĚĞĚ ŝŶ   ? ? ? ŵů ƐŽƌďŝƚŽů ďƵĨĨĞƌ A?  ? ʅůɴ-ŵĞƌĐĂƉƚŽĞƚŚĂŶŽů A?  ? ? ʅů  ? ŵŐ ?ŵů
zymolyase and incubated at 37 °C for 40 minutes. During the incubation, slides were prepared 




ďǇůŽĂĚŝŶŐ ? ?ʅůƉŽůǇ-L-lysine (PLL) to the centre and leaving to sit for 2 minutes. Excess PLL 
was rinsed off with H2O and the slides were left to air dry. Cells concentration was adjusted 
ƚŽƚŚĞĚĞƐŝƌĞĚůĞǀĞůĂŶĚ ? ?ʅůŽĨĐĞůůƐƵƐƉĞŶƐŝŽŶǁĂƐĂĚĚĞĚƚŽĞĂĐŚƐůŝĚĞĂŶĚĂůůŽǁĞĚƚŽƐĞƚƚůĞ
for 5 minutes before excess suspension was aspirated off.  ? ?ʅůŽĨ ? ? ?A?^^ǁĂƐĂĚĚĞĚƚŽ
each slide for 30 seconds and slides were washed ten times with PBS + 1 mg/ml BSA. Slides 
were handled in a moist environment to prevent dehydration from this point. The primary 
anti-body was dilutĞĚĂƐƌĞƋƵŝƌĞĚŝŶW^ ?^ĂŶĚ ? ?ʅůǁĂƐĂĚĚĞĚƚŽĞĂĐŚƐůŝĚĞďĞĨŽƌĞďĞŝŶŐ
incubated in a damp box overnight at 4 °C. Slides were washed a further ten times with 
W^ ?^ďĞĨŽƌĞĂĚĚŝŶŐ ? ?ʅůŽĨƚŚĞƐĞĐŽŶĚĂƌǇĂŶƚŝ-body in PBS/BSA and leaving to incubate 
in the dark at room temperature for 1 hour. Slides were washed ten more times and then a 
drop of phenylenediamine mounting solution containing DAPI at 1 mg/ml was placed on top 
of the cells. A cover slip was gently but firmly put in place ensuring the exclusion of all air 
bubbles and the edges were sealed with nail varnish ready for visualisation. 
2.6.1.4 Immunofluorescence of HEK293 cells 
HEK293 cells were grown to 70 % confluence and trypsinised as described in 2.1.3.3. 
Coverslips placed into 6 well plates, coated with sterile poly-L-lysine 1 mg/ml (Invitrogen-
P4707) and left to settle for 15 minutes, the excess PLL was aspirated off, coverslips were 
washed three times with 2 ml sterile water and left to dry at room temperature. 2 ml of 
DMEM was added to each well and then 50 µl of cells was added. These were left to grow for 
24 hours. Once cells were at 70 % confluence the media was removed, cells were washed with 
PBS and fixed with 1 ml of 4 % paraformaldehyde in PBS for 15 minutes. Following fixation 
cells were permeabalised with 0.1 % TX-100 in PBS for 5 minutes and then blocked in 250 µl 
3 % BSA/PBS for 15 minutes at room temperature. 25 µl droplets of the primary antibody 
were applied to a sheet of parafilm and the coverslips were placed cell side down on the drops 




and left in a moist environment overnight at 4 °C. Coverslips were then placed on four 100 µl 
droplets of PBS/0.1 % Tween sequentially and left on each for 5 minutes to wash. During 
washing the secondary antibody was prepared to the desired concentration and spun down 
for 10 minutes at 16100 x g to remove any aggregates. 25 µl droplets of the secondary 
antibody were arranged on a sheet of parafilm in a damp box and the coverslips were placed 
cell side down and left to incubate at room temperature in the dark for 2 hours. Coverslips 
were washed a further four times on 100 µl droplets of PBS/ 0.1% Tween as previously 
described and then placed cell side down onto 25 µl droplets of DAPI for 1 minute followed 
by two 10 minute washes with PBS. 100 µl 0.1 % p-Phenylenediamine anti-fade (Sigma P6001-
50G) was mixed with 900 µl 10 % mowiol mounting solution (Sigma 81381-50G), 5 µl droplets 
of this mounting mix were added to glass slides and the coverslips were placed, cell side down, 
on top of the droplets, ensuring no air bubbles were present. Prepared slides were left at 4 
°C overnight for the mounting solution to set before sealing with nail varnish ready for 
visualisation. 
2.6.2 Growth analysis 
2.6.2.1 Absorbance assays for growth rate analysis of yeast strains 
A 5 ml overnight culture was grown in the appropriate medium and the cell density of each 
culture was determined by absorbance at OD600 in an Eppendorf BioPhotometer plus. Cells 
were diluted to a starting OD600 of 0.1 in 1 ml of the appropriate media in a greiner bio-one 
24 well cell culture plate (Greiner bio-one 662 160) Growth of strains was performed in a BMG 
LABTECH SPECTROstarNano plate reader. Protocol settings for growth analysis were are 
outlined in the table below. All data were exported to excel for further analysis. 




Prior to any further analysis all data were blank corrected. Data was then log transformed and 
the maximal growth rate was calculated over a 3 hour period. This was calculated by 
subtracting the OD at the earliest point within the three hour window from the final point, 
and dividing by 3 (the number of hours between points). Conversion of growth rate to 
doubling time was performed for ease of data presentation and was calculated by dividing 
0.693 by the growth rate. Quantification of lag phase was performed by measuring the time 
it took for cultures to double their initial OD. 
Protocol settings for yeast growth analysis in 24 well plates 
Cycle time (sec): 1800  
Flashes per well: 3 
Excitiation: 600 
Shaking frequency (rpm): 400 
Shaking mode: double orbital 
Additional shaking time: 30 sec before each cycle 
Target temperature (°C): 30 
Posistioning delay: 0.5 sec 
2.6.2.2 Spotting assay for yeast colony size analysis 
A 5 ml overnight culture was grown in the appropriate medium and a cell count was 
performed. Cells were diluted to 1 x 107 cells/ml and were diluted 1000 fold over three serial 
dilutions. Cells were then plated onto the appropriate media and allowed to grow at 30 °C for 
48-72 hours. Following growth, visual analysis was performed to assess the differences in 
growth. 




2.6.2.3 Viability assay for yeast 
A 5 ml overnight culture was grown in the appropriate medium and a cell count (see section 
2.6.2.5) was performed. Cells were diluted to 2 x 103 ĐĞůůƐ ?ŵůĂŶĚ ? ? ?ʅů ?ĂƉƉƌŽǆŝŵĂƚĞůǇ ? ? ?
cells) was plated on to the appropriate media. Cells were left to grow at 30°C for 36-72 hours 
before colony formation was assessed. Colony forming units (CFUs) were counted and the 
percentage viability was calculated by dividing the number of observed CFUs by the number 
of expected colonies (300), this was then multiplied by 100. 
2.6.2.4 Growth analysis of HEK293 cells 
Cells were grown at 37 °C to 70 % confluence in a T75 flask containing the appropriate media. 
They were trypsinised as described in section 2.1.3.3 a cell count was performed and cells 
were diluted to 5x104 ?ŵů ? ? ? ?ʅ>ŽĨŵĞĚŝĂǁĂƐĂĚĚĞĚƚŽƚŚĞǁĞůůƐŽĨƚŚĞyĐĞůůŝŐ ŶĐĞƉůĂƚĞĂŶĚ
allowed to equilibrate at room temperature before a base line cell index (CI) reading was 
ƚĂŬĞŶ ? ? ? ?ʅ>ŽĨĚŝůƵƚĞĚĐĞůůƐǁĂƐƚŚĞŶĂĚĚĞĚƚŽĞĂĐŚǁĞůůƌĞƐƵůƚŝŶŐŝŶĂĨŝŶĂůĐŽŶĐĞŶƚƌĂƚŝŽŶŽĨ
5x103 cells per well, these were again allowed to equilibrate at room temperature for 30 
minutes before beginning the assay. Cells were placed in the plate reader at 37°C for the 
duration of the assay, typically 4-5 days. All data were exported to Excel for analysis. 
Prior to any further analysis all data were blank corrected. Data was then log transformed and 
the maximal growth rate was calculated over a 3 hour period. Conversion of growth rate to 
doubling time was performed for ease of data presentation.  
2.6.2.5 Yeast cell counting 
Cell counts were performed using a haemocytometer. An overnight culture was diluted 1/25 
ĨŽƌĞĂƐĞŽĨĐŽƵŶƚŝŶŐ ?ůŽŐĐƵůƚƵƌĞƐǁĞƌĞĐŽƵŶƚĞĚǁŝƚŚŽƵƚĚŝůƵƚŝŽŶ ? ? ?ʅ>ŽĨĐƵůƚƵƌĞǁĂƐůŽĂĚĞĚ
onto the haemocytometer and then counted under a light microscope. Cells with buds greater 




than one third the size of the mother cell were counted as two cells, otherwise buds were not 
counted. Only cells contained within, or on the bottom or left hand line of the box were 
counted. Where possible a minimum of 300 cells were counted. 
2.7 Health and Safety 
All work was carried out following the health and safety guidelines outlined in the relevant 









Chapter 3: Yeast as a model organism to study the 
effects of eEF1A overexpression 
  




3.1 Introduction: Overexpression of eEF1A in yeast results in 
pleiotropic effects 
Previous studies on the function of eEF1A in yeast have suggested that not only does it play a 
role during protein synthesis, but it also moonlights in a variety of other roles. Studies have 
characterised eEF1A as an actin binding protein capable of bundling actin into unique 
structures that exclude all other actin cross linkers (Yang et al., 1990; Owen et al., 1992). It 
has also been suggested to be involved in protein degradation (Gonen et al., 1994; 
Hotokezaka et al., 2002), nuclear export (Bohnsack et al., 2002; Calado et al., 2002), viral 
replication (Mateyak and Kinzy, 2010), aggresome formation (Meriin et al., 2012), possess 
both pro- and anti-apoptotic properties (Duttaroy et al., 1998; Talapatra et al., 2002) and 
promote tumour growth (Anand et al., 2002). 
The mechanisms of many of these functions are not yet fully understood and this study aimed 
to elucidate novel interactions between eEF1A and the cellular machinery to assist in the 
understanding of eEF1A ?s plethora of functions within the cell. 
This chapter presents data suggesting that elevated levels of eEF1A are toxic to the cell and 
are under strict regulation facilitated by rapid plasmid loss of the overexpression plasmid 
when selective pressures in favour of keeping the plasmid are lifted. 
3.2 Growth analysis of yeast cells overexpressing eEF1A isoforms 
3.2.1 eEF1A levels influence lag and log phase yeast cells  
Previous studies on TEF1 overexpression have showed that increased levels of eEF1A cause a 
slow growth phenotype that is not the result of an altered rate of translation (Munshi et al., 
2001). It has been proposed that this growth defect may be the result of altered actin 




distribution and cell morphology, as elevated levels of eEF1A increases the fraction of un-
budded cells, and resulted in larger and rounder cells. 
Our studies focussed on the overexpression of one of the two genes encoding eEF1A in yeast, 
TEF1, ŽŶĂ ?ʅ ?ŚŝŐŚĐŽƉǇ ? plasmid (pCG454) conferring leucine prototrophy (see figure 3.1). 
To confirm that overexpression of TEF1 induced an alteration in growth rate a spotting assay 
was performed on both, selective minimal media, and non-selective media (see figure 3.2). 
This revealed that cells overexpressing eEF1A resulted in fewer, slower growing colonies 
compared to the wild type when grown on -leu. However, growth on non-selective media 
showed no growth difference between the wild type and TEF1 overexpression strain 
suggesting that either, cells overexpressing TEF1 were defective in leucine synthesis and non-
selective media alleviated this defect, or TEF1 was highly toxic and selected against inducing 
plasmid loss. 





Figure 3.1. Western blot showing increased levels of eEF1A. a) eEF1A levels in yeast as detected by the 
anti-human eEF1A1. b) Expression levels are only increased by approximately 80% suggesting that eEF1A 
levels are under tight regulation by the cell. 
 
 





Figure 3.2.Spotting assay of wild type cells and TEF1 overexpressing cells. Cells were plated onto 
selective -leu and non-selective YPD media. A growth defect was observed in the TEF1 overexpressing cells 
when on selective media, When plated onto rich media however, growth was rescued. Cells were serially 
diluted from 2*10^6/ml to 2*10^3/ml. 
 
 
Further, high resolution, growth analysis was performed using a BMG Spectrostar Nano, 
microplate absorbance reader, as described in Material and Methods (section 2.6.2.1). This 
method allowed for in depth analysis of various stages of growth, including, lag, log and post 
diauxic phases (see figure 3.3). 
 
 





Figure 3.3 Representation of a logarithmic growth curve. The optical density of cells is measured at OD600 
and then expressed logarithmically. The initial lag phase of the curve is when the cells are adapting to a new 
environment. Log phase is when the cells are growing exponentially and are undergoing fermentation, 
converting sugars within the media to alcohol. Post diauxic is the stage that, when all sugars are depleted, the 
yeast cells begin to respire in the ethanol rich environment. Eventually all nutrients within the media are 
depleted and the cell cycle arrests resulting in stationary phase. 
 
When analysed using this technique it was observed that TEF1 overexpression induced not 
only a reduction in the growth rate of cells (see figures 3.4 -a and -b), but also an increase in 
the lag phase (see figures 3.4  Wa and  Wc). As previously discussed, an increase in doubling time 
when eEF1A is overexpressed has been well characterised and our observations correlated 
with this. We observed an increase in doubling time of 17.6% when eEF1A was overexpressed. 
We also found that the lag phase of these cells was increased by approximately 26%. We 
hypothesised the increase in lag could have been due to corruption of signalling or 
biosynthesis pathways, or because of a reduction of cell viability in the presence of elevated 
levels of eEF1A, therefore fewer viable cells were in the initial inoculum delaying the cultures 
entry into log phase growth. 





Figure 3.4 Growth data for wild type and TEF1 overexpressing strains. a) Logarithmic growth curve of 
wild type cells in blue and TEF1 overexpressing cells in red. b) The doubling time of wild type cells in blue, and 
TEF1 overexpressing cells in red. TEF1 overexpressing cells exhibit an increase in doubling time of 17.6% 
compared to wild type cells. c) The lag time of wild type cells in blue, and TEF1 overexpressing cells in red. 
TEF1 overexpressing cells exhibit an increase in lag time of 26% compared to wild type cells. 
 
3.2.2 Lag phase of TEF1 overexpressing cells increases in media without 
leucine following growth in media with leucine 
The observed increase in lag phase led us to hypothesise that the population may be 
composed of a high proportion of cells that are dead. In response to this we devised an assay 
to monitor lag phase over a period of time in selective and non-selective media by sub-




culturing cells from -leu to +leu and vice versa over a period of five days (see figure 3.5). An 
initial overnight plate was grown in liquid media containing wild type and TEF1 overexpressing 
cells in biological duplicate and technical triplicate with and without leucine. Cells that were 
grown in -leu overnight were re-inoculated into a plate with media both with and without 
leucine, and similarly for cells grown in media with leucine, they were re-inoculated into a 
separate plate containing media with and without leucine. This process of re-inoculation to 
and from media with and without leucine was repeated over a 5 day period with continual 
high resolution growth analysis taking place. This allowed us to monitor the lag phase in cells 
grown in +leu media while simultaneously monitoring cells maintained in selective -leu media. 
This assay was generated to allow us to visualise the viability of cells coming directly from 
overnight night cultures grown in -leu, compared to those grown in +leu media. We 
hypothesised that cells grown in media lacking leucine had reduced viability and our aim was 
to see if addition of leucine to the media rescued either doubling time or the duration of the 
lag phase. And if there was an observable rescue was this due to an alleviation of the toxic 
effects of the TEF1 overexpression plasmid. 
 





Figure 3.5 Assay for screening cells growth rate in media with and without leucine. Cells were grown 
overnight in a 24 well plate, in media with or without leucine. The overnight cultures were then re-inoculated 
into media with or without leucine and this process was repeated over a 5 day period. 
 
During the course of this experiment both wild type cells and cells overexpressing TEF1 that 
were maintained in selective media without leucine exhibited consistent growth rates, as 
measured during both lag and log phases (see figures 3.6 a and b respectively). Wild type cells 
maintained a doubling time of approximately 1.68 hours and had a lag time of 6.7 hours while 
cells overexpressing TEF1 maintained a doubling time of approximately 2 hours with a lag 
time of approximately 8.25 hours throughout the duration of the experiment. 
Cells overexpressing TEF1, grown in media supplemented with leucine over a period of 1-4 
days and then re-inoculated into media lacking leucine exhibited an increasing trend in both 
their lag and log phase growth rates dependent on the duration of growth in non-selective 
media with leucine. TEF1 overexpressing cells re-inoculated from leucine rich media to -leu 
on day 1 had a doubling time of approximately 2.45 hours. Following sub-culturing into 
leucine rich media and further re-inoculation into -leu over a period of 4 days, we observed 




an increase in doubling time to 2.86 hours. The lag time was affected in a similar, incremental, 
but more extreme manner. Lag time of TEF1 overexpressing cells taken from media with 
leucine and inoculated into -leu media on day 1 was 9.75 hours. After 4 days of sub-culturing 
into media with leucine and then re-inoculating into -leu, cells over expressing TEF1 had a 
doubling time of approximately 20 hours. Wild type cells saw a mild increase in both lag and 
log growth phase, but these were muted when compared to that of the TEF1 overexpressing 
cells. The log phase doubling time for wild type cells increased from approximately 1.88 hours 
on day 1 to 2.11 hours on day 4. Lag phase increased from 5.75 hours on day 1 to 8 hours on 
days 3 and 4. 




Figure 3.6 a) & b) Doubling and lag time of cells re-inoculated over a period of 5 days. Cells were grown 
in media with or without leucine added over a period of 1 to 5 days. Every 24 hours cells were re-inoculated 
into media with or without leucine and allowed to grow for a further 24 hours. a) shows the doubling time and 
b) shows the lag time for these cultures over the 5 day period in both media types. Dark blue and light blue 
show the wild type grown in -leu and +leu media respectively, red and pink show the TEF1 overexpressing 
strain grown in -leu and +leu media respectively. p-values are represented by asterisks, *=<0.5, **=<0.05. 
 
These data strongly suggested that when allowed to grow in non-selective media, there was 
a strong selective pressure against cells with elevated levels of TEF1. Although this assay 




allowed us to quantify the rate that lag phase increased without any selective pressure it did 
not elucidate the mechanism that drove this. To further examine this result we checked the 
viability of cells grown in selective and non-selective media, and quantified plasmid and 
protein levels during growth in both selective and non-selective media. These assays were 
chosen because they would allow us to demonstrate if cells grown in -leu have an increased 
lag phase due to cell death or quiescence, and if this is the result of plasmid loss resulting 
from eEF1A toxicity. 
3.2.3 Viability of yeast is unaffected by eEF1A levels 
To confirm the viability of yeast cells overexpressing eEF1A a viability assay was performed. 
An overnight culture was re-inoculated to 2 x 103 ĐĞůůƐ ?ŵůĂŶĚ ? ? ?ʅů ?ĂƉƉƌŽǆŝŵĂƚĞůǇ ? ? ?ĐĞůůƐ ?
was plated onto selective, -leu, or non-selective, agar plates. These were left to incubate at 
30 °C for 36 hours and the colonies were then counted to allow quantification of colony 
forming units (CFUs). The wild type cells plated onto -leu showed 92% apparent viability 
compared to just 14% of TEF1 overexpressing cells, representing a six and a half fold reduction 
in colony formation in the presence of elevated levels of eEF1A (see figure 3.7). When plated 
onto +leu plates the wild type and TEF1 overexpressing cells both had approximately a 106% 
viability. The ability of TEF1 overexpressing cells to grow on +leu but not on -leu suggested 
that eEF1A was not having an effect on cell viability. The TEF1 overexpressing cells may 
instead have a defect in a signalling or biosynthesis pathway, or the plasmid could be highly 
toxic and rapidly selected against when the requirement for the leucine marker is removed. 
It is possible cells with fewer copies of the plasmid were able to out compete their higher 
copy number counterparts, or simply that the higher copy cells are non-dividing. 





Figure 3.7 Percentage of cells forming colonies from wild type and TEF1 overexpressing strains plated 
on selective and non-selective media. Overexpression of TEF1 resulted in a decrease in colony forming units 
when plated onto -leu media. TEF1 overexpression had no effect on colony forming units when plated onto 
+leu media meaning that the cells are still viable and are simply quiescent. 
 
3.2.4 TEF1 overexpression induces increased whole cell respiration 
Because cells with elevated levels of eEF1A exhibited slower growth and a decreased capacity 
to form colonies on selective media, we checked cellular respiration to to ask whether cells 
were still respiring. Cells were grown overnight in -leu and counted before 1 x 108 cells were 
loaded into the respirometer. The respirometer allowed detection of intact cell respiration by 
placing the cells into a sealed compartment and measuring oxygen levels in the media over a 
time course.  
Compared to the wild type cells, cells with increased levels of eEF1A exhibited approximately 
a 25% increase in cell respiration (see figure 3.8). This observable difference in respiration, in 
addition to the rescue of colony forming units when grown on non-selective media, suggests 
that when grown in -leu, cells are not dying, but are metabolically active whilst not actually 
growing, indicating they are entering a quiescent state. 





Figure 3.8, Whole cell respiration of wild type and TEF1 overexpression cells. Whole cell respiration was 
measured as outlined in the materials and methods. Upon overexpression of TEF1 cells exhibited an increase 
in respiration approximately 25% greater than the wild type cells. 
3.3 Non-selective media has different effects on eEF1A protein levels 
and TEF1 gene copy nuber 
Because overexpression of TEF1 resulted in cell growth defects that were rescued upon 
addition of leucine we checked whether levels of TEF1 and eEF1A were constant throughout 
growth, both with and without leucine in the media. It was expected that the rescue observed 
in the growth rate of TEF1 overexpressing cells could be attributed to a reduction in protein 
levels and that when grown in non-selective media the selective pressure against cells with 
higher levels of eEF1A would result in rapid suppression of protein levels. 
3.3.1 eEF1A levels appear to remain constant throughout early log when 
grown in both selective and non-selective media 
eEF1A levels were detected by western blot. Cells were grown overnight in -leu and re-
inoculated to an OD600 of 0.2 in media with and without leucine. Cultures were grown at 30 
°C and 5 OD600 units were harvested at an OD600 of approximately 0.3, 0.7 and 1.2. Separation 




and detection of eEF1A was achieved by SDS-PAGE gel, western blotting and ECL detection as 
outlined in the materials and methods.  
 
Figure 3.9 Detection of eEF1A levels during logarithmic growth. eEF1A levels were detected using ɲ-
human eEF1A1. Samples were grown overnight in -leu and inoculated to an OD600 of 0.2 in media with (+) and 
without (-) leucine. Protein samples were harvested from 5 OD units at optical densities of approximately 0.3 
(blue) 0.7 (red) and 1.2 (yellow)  
 
The samples taken at OD600 0.3 grown in both media, with or without leucine, showed that 
the TEF1 overexpressing cells expressed eEF1A at a levels higher than wild type cells. As the 
cells passed through exponential growth, those grown in -leu maintained the elevated levels 
of eEF1A in the TEF1 overexpressing strain. The cells that were grown in media supplemented 
with leucine showed a gradual decline in eEF1A levels in the TEF1 overexpressing strain, but 
levels were still higher than the wild type cells. This suggests that although there is a selective 
pressure against cells with elevated levels of eEF1A the decline observed during growth in 
media with leucine was probably not rapid enough to induce the rescue in lag phase growth 
upon the addition of leucine to the media. 




3.3.2 TEF1 overexpression is suppressed upon addition of leucine to the growth 
media 
As little change in the levels of eEF1A was observed upon addition of leucine to the media we 
hypothesised that TEF1 may possess toxic properties and so the cell may be selecting against 
the plasmid itself. To check plasmid levels qPCR was performed with plasmid levels being 
monitored relative to a genomic standard during early log growth in media both with and 
without leucine. Cells were grown overnight in -leu and re-inoculated to an OD600 of 0.2, they 
were grown in media both with and without leucine at 30°C and 2OD units were harvested at 
OD600 of approximately 0.4, 0.8 and 1.6. Plasmid levels were assessed using a pair of LEU2 
primers to quantify plasmid copy number and the genomic control was measured using LEU3 
primers allowing quantification of a chromosomal reference gene. 
 





Figure 3.10, Normalised expression levels of LEU2 in the wild type and TEF1 overexpression strains. 
LEU2 plasmid levels relative to genomic LEU3 levels at different stages of growth in selective and non-selective 
media in (a) Wild type (b) TEF1 overexpression and (c) TEF1 relative to wild type. Values highlighted by an 
asterisk denote the p-value when comparing the WT and TEF1 overexpression data at the relevant optical 
densities. 
 
Genomic and plasmid signals were quantified using the genomic based LEU3 and the plasmid 
based LEU2. The signal for the LEU2 gene was then normalised to the chromosomal LEU3 
gene (see figures 3.10 a and b). When grown in +leu media, wild type cells exhibited a gradual 




reduction to plasmid number with cells at the final time point possessing plasmid levels 
approximately 55% that of the starting cells. When grown in selective media without leucine 
wild type cells showed a similar rate of plasmid loss but they had significant variation in 
plasmid levels suggesting that this loss was entirely random. TEF1 overexpressing cells 
exhibited a greater rate of plasmid loss when there was no selective pressure to keep the 
plasmid with plasmid number approximately 25% that of the starting overnight culture at the 
final time point. When grown in selective media, cells overexpressing TEF1 maintained a 
constant, low, plasmid level with no detectable decrease in levels throughout growth. 
Interestingly, plasmid levels in the wild type and the TEF1 overexpression strain were 
significantly different, with TEF1 overexpression appearing to have such a strong suppressive 
effect on plasmid levels that they were only about 5% that of the wild type levels throughout 
the assay. When expressed relative to the wild type plasmid number (see figure 3.10 c), TEF1 
overexpression still resulted in plasmid levels dropping by 50% throughout growth in non-
selective media suggesting that the cells were selecting against the plasmid due to the toxic 
effects it conferred. 
3.4 Discussion of results 
It is known that eEF1A plays a wide variety of roles in the cell, and that many of these roles 
are crucial to cell survival. It appears counterintuitive therefore that elevated levels of eEF1A 
should be viewed as toxic to the cell, but the data presented in this chapter suggests just that. 
Increased levels of eEF1A are known to result in a decrease in growth rate of yeast cells 
(Munshi et al., 2001), and we have demonstrated that only a modest increase in the levels of 
eEF1A induces an almost 20% increase in doubling time. Removal of the selective pressure for 
the plasmid, by growing in media with leucine, results in recovery of the growth rate which 




appears, in part, to be due to the loss of the TEF1 plasmid. How elevated TEF1 levels caused 
the growth defect is not fully understood, but it is clear that eEF1A had a strong influence 
over cell cycle dynamics and cell metabolism. 
The viability assay outlined, demonstrated that in addition to rescuing growth rate, 
supplementing the media with leucine also rescues a previously uncharacterised quiescent 
state that is induced upon overexpression of TEF1. The cells lack of ability to grow on media 
without leucine was demonstrated to not simply be caused by cell death as they were 
observed to still be respiring, and at an increased level to wild type cells, suggesting that there 
may be a nutrient signalling defect, leading the cells to assume they are starving. 
 The qPCR result, together with the long-term growth assay, indicate that in the absence of 
the selective pressure of media lacking leucine, a culture of TEF1 overexpressing cells 
preferentially select for cells with the lowest levels of eEF1A. These two experiments 
demonstrate that when grown in non-selective media, TEF1 overexpressing cells see plasmid 
loss rates of about 25% per population doubling, which in turn, causes the increase in lag 
phase observed when cells are re-inoculated into selective -leu. When quantified using qPCR 
the plasmid number in the TEF1 overexpression strain were approximately 20 times lower 
than in the wild type. This is due ƚŽ ƚŚĞ ƐƚŽĐŚĂƐƚŝĐĚŝƐƚƌŝďƵƚŝŽŶŽĨĂ  ?ʅƉůĂƐŵŝĚĚƵƌŝŶŐĐĞůů
division and plasmids conferring toxic effects do so in a dose dependent manner. This results 
in the average plasmid level decreasing over time as cells with lower copy numbers have a 
growth advantage over those with a higher copy number (Moriya et al., 2006). The 
discrepancy observed in these levels is further evidence to suggest that TEF1 overexpression 
is strongly selected against, and it seems that the population overexpressing TEF1 maintains 
the plasmid at the minimum level required to grow on -leu. Together with the data from the 




long term growth assay it is clear that growth in media with leucine results in loss of the TEF1 
plasmid to levels so low that the population is unable to rapidly respond when leucine is 
removed from the growth media, resulting in significantly increased lag phases. 
Although not detectable, it is possible that eEF1A levels are also affected by the addition of 
leucine to the media, but at such low levels that using a non-quantitative method we are 
unable to detect it. Another possibility is that eEF1A turnover is so low that a drop in plasmid 
levels may take several generations to manifest itself at the protein level across the 
population. 
Data presented in this chapter suggest that elevated TEF1/eEF1A levels have an inhibitory 
effect on a cells ability to proliferate, but removal of the selective pressure for keeping the 
TEF1 plasmid results in an instant rescue of all detectable defects. This rescue mainly appears 
to be due to rapid plasmid loss resulting in a minor decrease of the level of eEF1A. eEF1A 
appears to have a strong influence on cell cycle dynamics and cell metabolism in response to 
leucine levels suggesting a novel role for eEF1A in nutrient sensing. 




Chapter 4: eEF1A is involved in cell cycle 
regulation via dynactin-mediated interactions 
  




4.1 Introduction: The dynactin complex 
Because eEF1A has a well characterised interaction with actin we utilised the yeast knockout 
collection in an attempt to elucidate any proteins associated with actin that could play a role 
in facilitating eEF1A ?Ɛ ŝŶƚĞƌĂĐƚŝŽŶǁŝƚŚĂĐƚŝŶ ?tĞŽǀĞƌĞǆƉƌĞƐƐĞĚTEF1 in an array of strains 
deleted for genes that are known to interact with, or control the function of actin. Mutants 
that exhibited synthetic interactions, as assessed by growth, were candidates for further 
investigation. Many of the hits from this screening process were found to be components of 
the dynactin complex, an essential multi-subunit protein found in eukaryotes. It has an 
essential dynein-activating activity, facilitating bidirectional intracellular transport of cargoes 
and there are few, if any, processes that utilise dynein that do not also require dynactin. 
4.1.1 Dynactin structure 
Dynactin (figure 4.1) is an asymmetric molecule that consists of a 10 x 40 nm Arp1 rod and a 
50 nm p150glued side arm (Schafer et al., 1994), along with a 7 other polypeptide subunits. 
Resembling a short actin filament, the Arp1 rod is an octameric polymer of the actin-related 
protein Arp1. The rod binds to cellular cargo via its association with spectrin family proteins, 
ƐƵĐŚĂƐɴ///ƐƉĞĐƚƌŝŶ ?ĂƐƉĞĐŝĂůŝƐĞĚŝƐŽĨŽƌŵĨŽƵŶĚŽŶ'ŽůŐŝŵĞŵďƌĂŶĞƐ(Holleran et al., 1996; 
Holleran et al., 2001) ?dŚĞƌŽĚƚĞƌŵŝŶĂƚĞƐĂƚŝƚƐ “ďĂƌďĞĚ ?ĞŶĚǁŝƚŚ the actin capping protein 
CapZ (Schafer et al., 1994). The opposite end consists of a further actin-related protein Arp11 
(Eckley et al., 1999) and the dynactin subunit p62, bound to the two smallest subunits p25 
and p27. 
Projecting from the Arp1 rod is the flexible and extendable side arm that is made up of the 
remaining three subunits, p150glued, dynamitin, and p24/22. The elongated structure of the 
side arm of the dynactin complex means it has a large surface area relative to its mass. 





Figure 4.1 Diagram of the dynactin complex. Human and yeast protein names (yeast names in brackets) 
are given for each subunit. The three subunits in blue, p25, p27 and p62, are not known to exist in yeast. 
 
4.1.2 Binding partners of the dynactin subunits 
p150glued is the largest of all the dynactin subunits and ŝƐ ƉƌĞĚŝĐƚĞĚ ƚŽ ĂĚŽƉƚ ĂŶ ɲ-helical 
structure and self-associate via coiled coils. It is predicted to form an elongated dimer made 
from two central coils with a region of undefined structure in between. Within the globular 
heads at the tip of the arm are conserved CAP-Gly (cytoskeleton-associated protein, glycine 
rich) motifs (Riehemann and Sorg, 1993). This CAP-Gly motif is contained in the N terminus 
(aa1-110) and is involved in the binding of dynactin to microtubules, as has been shown both 
in vitro and in vivo (Waterman-Storer et al., 1995; Vaughan et al., 2002). Further binding 
partners of the p150glued CAP-Gly domain include the microtubule-binding proteins EB1 and 
CLIP-170, although it is unknown if it can bind these proteins and microtubules 
simultaneously, or if they are mutually exclusive functions. It is a possibility that dynactin 
activity is regulated by the binding of other proteins and protein kinases to the CAP-Gly 




domain as phosphorylation at S19 reduces p150glueds affinity for microtubules (Vaughan et al., 
2002). 
Binding interactions with microtubule-based motors, such as dynein, are supported by the 
middle portion of p150glued. Various studies have revealed different sites of potential dynein 
interaction (Vaughan and Vauee, 1995; Waterman-Storer et al., 1995; Vaughan et al., 2002; 
King et al., 2003) suggesting that there could be several regions, possibly in multiple dynactin 
subunits, that allow for dynein-dynactin interactions. 
The dynamitin subunit links dynactins two major components, the Arp1 rod, and the p150glued 
side arm. It exists as an assembly of four subunits that associate with each other, p150glued 
and p24/22 through three coiled-coil motifs (McMillan and Tatchell, 1994; Echeverri et al., 
1996). Overexpression of dynamitin results in collapse of the dynactin complex through 
disassociation of the Arp1 rod and the p150glued side arm, although the exact mechanism of 
disruption is, as yet, unknown. Overexpression of the N-terminal fragment (aa1-87) inhibits 
organelle movement via dynein without disrupting the structure of dynactin (Valetti et al., 
1999) suggesting the N terminus of dynamitin may act as an inhibitor of dynein-dynactin 
interactions. Other components reported to bind to the N-terminal region of dynamitin 
include, calmodulin together with MacMARKS (Jin et al., 2001), the kinetochore protein Zw10 
(Starr et al., 1998), and the Golgi-associated protein, BICD (Hoogenraad et al., 2001). These 
interactions suggest that the N terminus of dynactin is likely to be exposed on dynactins 
surface. 
P24/22 binds directly to dynamitin at a 1:2 ratio. It is speculated that p24/22 may also interact 
with p150glued as both of these proteins are liberated from the dynactin complex upon 
addition of excess dynamitin (Karki et al., 1998; Eckley et al., 1999). 




4.1.3 Functions of dynactin 
The array of functions that dynactin is involved in means that is has been found in a variety 
of subcellular localisations, from the centrosomes (spindle pole bodies in yeast), to a variety 
of endomembranes (Gill et al., 1991; Paschal et al., 1993; Habermann et al., 2001). At the 
centrosome, dynactin is reported to have involvement in microtubule anchoring (Quintyne et 
al., 1999). Endomembrane localisation includes membranes in the Golgi region and endocytic 
organelles (Habermann et al., 2001). Localisation to the nuclear membrane has been reported 
to be cell cycle dependant (Salina et al., 2002). Dynactin is able to control microtubule 
dynamics and recruit proteins to the plus ends of microtubules (Quintyne et al., 1999). 
Localisation to the cell cortex allows for dynactin to influence rotational movement of the 
mitotic spindle and direct movement of motile cells (Skop and White, 1998; Gönczy et al., 
1999; Dujardin et al., 2003). 
Although the data given (Gill et al., 1991; Paschal et al., 1993; Skop and White, 1998; Gönczy 
et al., 1999; Quintyne et al., 1999; Habermann et al., 2001; Salina et al., 2002; Dujardin et al., 
2003) suggests highly unique and specific roles for dynactin, in all examples highlighted 
dynactin is implicated in the regulation of dynein targeting and/or recruitment. However, 
given dynein is able to bind cellular cargo without dynactin (Tai et al., 1999), and that intact 
dynactin is essential for metazoan viability (Mcgrail et al., 1995), it would seem that dynactin 
does far more than bind dynein and facilitate motor processivity.  
4.2 eEF1A interacts with the dynactin complex in yeast 
4.2.1 eEF1A levels affect the growth dynamics of dynactin complex mutants 
As discussed eEF1A has a well characterised interaction with actin, because of this we 
overexpressed TEF1 in an array of strains deleted for genes that are known to interact with, 




or control the function of actin. Synthetic interactions between eEF1A and deleted gene 
products were initially assessed using the Singer Rotor high throughput screening robot. Cells 
were grown overnight in biological triplicate at 30 °C in 384 well plates. They were then plated 
at the same density onto agar plates and growth was assessed after 36 hours at 30 °C. Cells 
were plated as biological triplicates in rows, with the TEF1 overexpressing strains plated in 
the row below (for table see App.1) 
TEF1 overexpression resulted in varied effects across the array of strains with some colonies 
showing a dramatic reduction in growth and others showing no difference between the 
deletion strain and the strain overexpressing TEF1. It was observed that many of the deletions 
that resulted in significant differences in growth came from the essential activator of dynein, 
the dynactin complex (see figure 4.2) (for the full array see App.2). 
In the ȴarp1 and ȴĐĂƉ ? strains TEF1 overexpression had no significant effect on colony 
formation compared to the deletion strains suggesting these were potential interactive 
partners of eEF1A. However, in the ȴĐĂƉ ? and ȴũŶŵ ? strains the inhibitory effect of TEF1 
overexpression was greater than in the wild type further implicating eEF1A as an inhibitory 
interactive partner of one of the other components of the dynactin complex. 





Figure 4.2 Array of viable actin mutant strains with TEF1 overexpressed. Strains that had been deleted 
for genes known to interact with, or control the function of actin were assayed for synthetic interactions with 
eEF1A. Strains were arranged horizontally in biological triplicate. Cells containing the control plasmid were 
in the upper row, with the TEF1 overexpression vector in the row below. Shown are the ǲhitsǳ from this screen 
that are components of the dynactin complex. 
 
As a there were a number of interactions between eEF1A and different components of the 
dynactin complex, this was selected as the primary target for the experiments reported in the 
remainder of this chapter. Further interrogation of the dynactin complex was performed, with 
the addition of further deletion strains that were not present in the viable actin mutant 
screen; ȴŶŝƉ ? ? ?(p150glued) the largest of the dynactin subunits, and the major component of 
the extending arm, and ȴůĚď ? ? (p24) the smallest of all the dynactin subunits, and a 
component of the hinge joint between the arp1 rod and the nip100 arm. 
In total there were six viable deletion strains that were characterised using high resolution 
growth analysis (as previously described) ȴarp1, ȴcap1, ȴcap2, ȴjnm1, ȴldb18 and ȴnip100 
(see figure 4.3). When TEF1 was overexpressed in the wild type strain an increase of 




approximately 17% was observed in the doubling time. Deletion of ARP1, the major 
component of the dynactin backbone, resulted in a decrease in doubling time to 92% that of 
the wild type, but overexpression of TEF1 in the ȴĂƌƉ1 mutant resulted in a rescue of the 
doubling time similar to that observed in the wild type with TEF1 overexpression. Deletion of 
both CAP1 and CAP2 genes which encode orthologues of the mammalian capZ actin capping 
protein, resulted in an increase in doubling time to 124% and 113% respectively. TEF1 
overexpression in both of these strains resulted in a further increase in doubling time to 153% 
that of the wild type. Deletion of Jnm1, orthologue of dynamitin, caused an increase in 
doubling time of 114% relative to the wild type, with TEF1 overexpression resulting in a minor 
rescue to 110% of the wild type level. Deletion of Ldb18 had the most severe growth defect 
with an increase in doubling time of 139% relative to wild type, with TEF1 overexpression 
causing a further increase to 172% relative to the wild type. The final gene deletion, NIP100, 
orthologue of p150glued, resulted in no significant growth defect with an increase in doubling 
time to 104% of the wild type, overexpression of TEF1 in the ȴŶŝƉ ? ? ?mutant only had a minor 
effect on growth increasing it to 109% that of the wild type (see figures 4.3 -a and -c). 
Upon comparison of the lag time of these strains, a similar varied effect was observed, to that 
seen when the doubling time was quantified (see figures 3.8 -b and -c). TEF1 overexpression 
in the wild type resulted in a similar increase in the lag time to 117% that of the wild type, 
suggesting that TEF1 has a similar influence over both phases of growth. Unlike the effect of 
TEF1 in wild type cells, no correlation between lag phase and doubling time was observed in 
the dynactin mutants. With the exception of the ȴĐĂƉ ? mutant, TEF1 overexpression resulted 
in a decrease in lag phase in all the dynactin mutants. Lag phase in the ȴĂrp1 mutant was 
reduced to 78% of the wild type time, with TEF1 overexpression further decreasing the lag 




time to almost 50% the wild type duration. Interestingly, although the ȴĐĂƉ ? and ȴĐĂƉ ? 
mutants caused a similar reduction in lag time to 69% and 63% of the wild type respectively, 
TEF1 overexpression in these mutants had dramatically different effects on lag time. 
Overexpression of TEF1 in the ȴĐĂƉ ? mutant resulted in an increase in lag phase similar to the 
observed change in doubling time, increasing lag time to 160% that of the wild type. In the 
ȴĐĂƉ ? mutant the opposite effect was observed, with the lag time of ȴĐĂƉ ? cells with TEF1 
overexpressed exhibiting a reduction of lag time to 67% that of the wild type. Deletion of 
Jnm1 resulted in a reduction of the lag time to 65% that observed in the wild type with TEF1 
overexpression inducing a recovery of this to 89%. The ȴůĚď ? ? mutant had a lag phase similar 
to the wild type with TEF1 overexpression causing a reduction to 74% that of the wild type. 
The final mutant ȴŶŝƉ ? ? ?resulted in a reduction of the lag phase to 67% that of the wild type 
with TEF1 overexpression inducing a minor recovery up to 78% of the wild type rate. 
The variation observed upon comparing the growth dynamics of the dynactin mutants in the 
presence of endogenous and elevated levels of eEF1A indicate a high degree of interaction 
between these highly conserved proteins. eEF1A is a well characterised multifunctional 
protein that appears to play roles in many essential cellular functions and interaction between 
eEF1A and the dynactin complex, another highly conserved and interactive complex, makes 
logical sense allowing these two promiscuous components to allow further cross talk and 
interplay throughout a dynamic range of cellular functions and processes, offering eEF1A 
influence over a large array of regulatory mechanisms. 
To characterise the far reaching effects of eEF1A on several cellular components further 
analysis was performed utilising a varied array of techniques. 
 





Figures 4.3 Ȃa-c. Growth analysis of dynactin mutants with TEF1 overexpression. Ȃa shows the doubling 
time of the dynactin with and without TEF1 overexpression. Ȃb shows the lag time of the dynactin mutants 
with and without TEF1 overexpression. Ȃc is a compilation of the lag time and the doubling time of the dynactin 
mutants with the TEF1 overexpression values over the control plasmid values. p-values are represented by 
asterisks, *=<0.5, **=<0.05, ***=<0.005 
 




4.2.2 eEF1A levels effect chromosome segregation in dynactin complex 
mutants 
Dynactin is known to participate in chromosome alignment and nuclear positioning and it has 
been previously shown that deletion of dynactin subunits results in aberrant spindle pole 
body positioning and chromosome segregation (Maruyama et al., 2002; Yeh et al., 2012). To 
check for ploidy aberrations resulting from improper chromosome segregation cells were 
analysed using FACS to check intercalation of propidium iodide (PI), allowing for 
quantification of genomic content within individual cells. 
Cells were grown overnight and re-inoculated in selective -leu to an OD600 of 0.2. They were 
then grown at 30 °C until they reached an OD600 of 0.7. 1 x 107 cells were harvested and fixed 
by addition of 1 ml of 70% EtOH at -20 °C whilst vortexing. Cells were rehydrated and PI was 
ĂĚĚĞĚƚŽĂĨŝŶĂůĐŽŶĐĞŶƚƌĂƚŝŽŶŽĨ ?ʅŐ ?ŵů ?ŶĂůysis was performed using a FACSCalibur flow 
cytometer and fluorescence microscopy, as described in the Materials and methods (Section 
2.6.3) 
Using FACS analysis of PI stained cells we were able to show that TEF1 overexpression in wild 
type yeast cells resulted in no significant alteration to the distribution of cells during the cell 
cycle. It was observed however, that all peaks in the FACS spectrum shifted significantly to 
the right indicating increased levels of genomic content (see figure 3.9  Wa-f). Observation of 
these cells by fluorescence microscopy confirmed that cells in the presence of elevated levels 
of TEF1 exhibited larger and brighter nuclei, but had normal nuclear distribution (see figure 
3.10 a). 
 





Figure 4.4 Ȃa-f, FACS analysis of cells stained with propidium iodide. Data was captured using the BD 
FACSCalibur flow cytometer and analysed using BD FACSStation data management system. Further 
quantitative analysis was performed and is shown in figure 4.5. Data in purple represents parent strains, with 
TEF1 overexpressing strains in green. 
 
Analysis of the dynactin mutants revealed, that as previously discussed (section 4.2.2), 
deletion of some of the dynactin components results in aneuploidy, and we were able to 
observe a significant increase in multinucleate cells by fluorescence microscopy (see table 




4.2). Overexpression of TEF1 resulted in a similar observable shift in all peaks across the 
dynactin mutants (see figure 4.4), indicating that this aberration occurs independently of any 
phenotypes influenced by the interactions between eEF1A and the dynactin complex. When 
ARP1 was deleted, an extra peak to the right of the two main peaks was observed (see figure 
4.4  Wb), and when this was visualised by fluorescence microscopy it correlated to a population 
of multinucleate cells that was not seen in the wild type cells (see figure 4.5  Wc). 
Overexpression of TEF1 in the ȴĂƌƉ ? mutant resulted in the disappearance of the extra peak 
when analysed by FACS (see figure 4.4  Wb), however, this did not correlate with the 
fluorescence microscopy images as an increase in the occurrence of multinucleate cells was 
observed (see figure 4.5  Wd). Deletion of CAP1 and CAP2 resulted in a decrease in the quantity 
of cells in the haploid population compared to the wild type cells and there was also a 
noticeable shoulder to the right of this population indicating significant genomic 
heterogeneity within the sample (see figures 4.4 c and d). Overexpression of TEF1 in both 
these strains induced a rescue of both the unbalanced haploid-diploid populations and the 
heterogeneity observed in the mutants (see figures 4.4 c and d). Microscope analysis of these 
strains showed further similarity to the wild type strain with a very low occurrence of 
multinucleate cells and larger and brighter nuclei in the presence of elevated levels of eEF1A 
(see figures 4.5 e-h). The ȴũŶŵ ?and ȴŶŝƉ ? ? ?mutants exhibited similar genomic distribution 
to that of the wild type cells with the addition of a slight peak to the right of the diploid 
population (see figures 4.4 e and f). Overexpression of TEF1 in both these deletion strains 
resulted in an almost complete ablation of the third peak, with more cells present in the 
haploid population (see figures 4.4 e and f). Microscopy analysis of these strains differed 
however. In the ȴũŶŵ ? mutant nuclei appeared to be smaller and dimmer than in the wild 
type strain and in any of the other dynactin mutants. TEF1 overexpression in the ȴũŶŵ ? 




mutant resulted in larger, brighter nuclei, similar to those observed in the other strains with 
elevated levels of eEF1A (see figures 4.5 i and j). The ȴŶŝƉ ? ? ?mutant exhibited the highest 
proportion of multinucleate cells in the presence of endogenous levels of eEF1A, and TEF1 
overexpression had no significant effect on this (see figures 4.5 k and l). 
 
Figure 4.5 a-l, Microscopy of PI stained cells. Cells were stained with propidium iodide and visualised by 
fluorescence microscopy. The top row shows cells containing the control plasmid, with the bottom row 
corresponding to cells with TEF1 overexpression. Cells with elevated levels of eEF1A appeared to have larger, 















Table 4.2 - Proportion of cells quantified using FACS and microscopy 
 
 
FACS analysis* Microscopy 
Peak 1 Peak 2 Peak 3 Peak 4 % of cells  that 
appear 
multinucleate 
WT 32.69 54.19 7.05  0.46 
WT+TEF1^ 29.65 59.89 6.03  0.43 
ȴarp1 22.04 53.90 15.10 5.04 20.83 
ȴarp1+TEF1^ 3.68 37.93 49.29 7.34 30.52 
ȴcap1 22.53 46.75 17.73 9.86 3.66 
ȴcap1+TEF1^ 7.88 44.27 39.87 6.32 4 
ȴcap2 16.81 60.81 18.56  3.62 
ȴcap2+TEF1^ 41.74 54.62 2.12  4.18 
ȴjnm1 32.94 56.65 7.86  4.52 
ȴjnm1+TEF1^ 4.51 48.78 40.10 5.10 3.55 
ȴnip100 29.01 55.75 11.38 3.04 22.91 
ȴnip100+TEF1^ 36.43 42.16 7.94  23.88 
FACS analysis shows cells that were either haploid, diploid or possessed a different quantity of propidium 
iodide to either of those populations. Microscopic analysis shows the percentage of cells from 300 that 
possessed more than one nucleus at the incorrect point in its cell cycle. *These peaks may not correspond to 
each other due the shift observed upon TEF1 overexpression. 
 
4.2.3 eEF1A levels affect spindle organisation ȟ ? 
Dynactin plays a role in chromosome alignment and spindle organisation during mitosis, as 
well as driving spindle checkpoint inactivation (Echeverri et al., 1996; Howell et al., 2001). As 
the spindle check point is known to prevent aberrant chromosome segregation, and therefore 
aneuploidy we checked for aberrant spindle organisation in the presence of elevated levels 
of eEF1A as this would be indicative of eEF1A having a direct influence on cell ploidy. 




Spindle organisation was assessed using immunofluorescence with cells grown to mid log 
growth and then samples prepared as described in the Material and methods (section 
2.6.1.3). Tubulin was detected with a primary murine antibody raised against beta-tubulin. 
Beta-tubulin is encoded by the TUB2 gene and forms a dimer with alpha-tubulin that 
polymerises to form microtubules. The secondary antibody was an anti-mouse-TxRED 
conjugate allowing ease of distinction from the DNA dye, DAPI. 
When visualised using fluorescence microscopy wild type cells possessed normal spindle 
morphology with intact spindles originating from the spindle pole body and spanning the 
length of the cell from one tip in the mother cell, to the polar opposite tip in the daughter 
(see figure 4.6 a). TEF1 overexpression in wild type cells appeared to have no significant effect 
on spindle formation, and the majority of cells observed had normal spindles although the 
intensity was diminished in approximately 30% of the population (see figure 4.6 b). In both 
these strains spindle pole bodies also appeared to localise to the poles of the nucleus and 
migrated to the poles of the mother and daughter cells correctly. The ȴĂƌƉ ? mutant exhibited 
the most severe phenotype observed in the dynactin mutants with the majority of cells not 
possessing obvious spindle pole bodies. They also exhibited an apparent uncontrolled growth 
of spindles that frequently continued to grow upon reaching the cell pole. This caused 
spindles to wrap around the cell cortex and cells appeared to contain many overgrown 
spindles. These cells also had severe ploidy defects possessing multiple nuclei (see figure 4.6 
c). Interestingly TEF1 overexpression in the ȴĂƌƉ ? mutant appeared to induce a significant 
rescue of both the spindle pole body defect and the uncontrolled growth of spindles (see 
figure 4.6 d).  





Figure 4.6 a-ǡ      ȟ ?     
levels of eEF1A. Genomic content can be observed as blue, stained by DAPI, the spindles appear red as they 
were probed using a TxRed secondary conjugate. 
 
How elevated levels of eEF1A induce such a dramatic rescue in the ȴĂƌƉ ? mutant is, as yet, 
unknown. Deletion of ARP1 results in the collapse of the dynactin complex, which in turn 
results in the aberrant spindles observed in the ȴĂƌƉ ? mutant (figure 3.11 c). Arp1 forms short 
stable octameric polymers similar in structure to those formed by actin. As eEF1A is known to 
stabilise actin it is a possibility that actin could replace Arp1 in the Arp1 rod of the dynactin 
complex resulting in the restoration of the complex. Arp1 and Act1p share 47.1% identity at 
the polypeptide level and Arp1 and Arp11p are known to co-cycle with actin filaments (Eckley 
and Schroer, 2003). Furthermore, actin binds the dynactin components Arp1, Arp11p and p62 




in vitro (Garces et al., 1999) reinforcing its potential as a viable substitute for Arp1 in the 
dynactin complex. Whether it is the stabilisation of actin by eEF1A, or another, as yet, 
unknown mechanism that results in the potential ability of actin to replace Arp1 in the 
dynactin complex is unknown. 
Further analysis of the effect of eEF1A on the spindle pole bodies in wild type cells was 
conducted by utilising the yeast GFP collection, a collection that covers three-quarters of the 
S.cerevisiae proteome (Huh et al., 2003). The collection contains genes tagged at the carboxy 
terminal end of open reading frames with the coding sequence of Aequorea victoria GFP. 
These were tagged chromosomally using oligonucleotide-directed homologous 
recombination simultaneously introducing the c-terminal GFP tag and a selectable HIS3 tag. 
We used the TUB4-GFP strain to allow visualisation of the spindle pole bodies. TUB4 encodes 
gamma-tubulin, a conserved component of microtubule organising centres in eukaryotes and 
is involved in nucleating microtubules from the nuclear and cytoplasmic faces of the spindle 
pole body. The TUB4-GFP expressing strain was transformed with the control plasmid 
(pCG124) and the TEF1 overexpression plasmid (pCG454) and colonies were selected and 
grown to mid-log phase. Cells were visualised live by fluorescence microscopy as detailed in 
the Material and methods (section 2.6.1.3). 
sŝƐƵĂůŝƐĂƚŝŽŶŽĨɶƚƵďƵůŝŶ-GFP with both endogenous and elevated levels of eEF1A showed 
normal spindle pole body distribution throughout the cell cycle in concurrence with the 
observation made by immunofluorescence. TEF1 overexpression resulted in brighter spindle 
pole bodies and a greater cytoplasmic intensity suggesting an ŝŶĐƌĞĂƐĞ ŝŶ ƚŚĞ ůĞǀĞůƐ ŽĨ ɶ
tubulin. dŚĞŝŶĐƌĞĂƐĞŽďƐĞƌǀĞĚŝŶɶƚƵďƵůŝŶ levels could be explained by higher levels of eEF1A 




exerting stress on DNA replication. TUB4 levels have previously been observed to increase in 
abundance in response to various stresses exerted on DNA replication (Tkach et al., 2012). 
 
Figure 4.7 a and b, Fluorescence microscopy of Tub4GFP strains. 
 
4.2.4 Increased levels of eEF1A induce Arp1 translocation 
We have observed that upon deletion of ARP1 cells develop a severe aneuploidy phenotype 
with approximately 20% of cells appearing multinucleate when visualised by fluorescence 
microscopy (see table 4.2). Immunofluorescence results indicated that upon deletion of ARP1 
cells also develop severe microtubule defects (see figure 4.6 c), and it is reasonable to assume 
that this is what leads to the aneuploidy phenotype previously mentioned. Upon 
overexpression of eEF1A we observed a rescue of the spindle defect in the ȴĂƌƉ ? mutant (see 
figure 4.6 d) but a worsening of the aneuploidy with approximately 30% of cells appearing 
multinucleate (see table 4.2). This indicates that the defects in spindle formation and ploidy 
upon deletion of Arp1 are separable and interestingly although eEF1A overexpression can 
alleviate one it results in worsening of the other.  
To observe the direct effect of TEF1 overexpression on Arp1 we utilised the yeast GFP 
collection to visualise Arp1 in the presence of endogenous and elevated levels of eEF1A. 




When visualised by fluorescence microscopy Arp1-GFP was primarily cytoplasmic with several 
clearly defined features that were localised to the spindle pole bodies and microtubules as 
well as decorating what were actin filaments (see figure 4.7 a). Considering the canonical roles 
of dynactin in microtubule anchoring at the spindle pole body and regulation of microtubule 
dynamics (Quintyne et al., 1999), and that Arp1 is known to co-cycle with actin (Melki et al., 
1993), this localisation was to be expected. Overexpression of TEF1 induced a dramatic 
translocation of Arp1 to the nucleus but the mechanism that caused this is currently not 
understood (see figure 4.7 b). As previously discussed eEF1A has been reported to play a role 
in nuclear export but under normal conditions it has not been shown to enter the nucleus 
(Calado et al., 2002) and no known role for eEF1A in nuclear import exists. 
Analysis of the eEF1A and Arp1 sequences using nuclear localisation sequence (NLS) 
prediction software (Kosugi et al., 2009) indicated that Arp1 has no predicted NLSs, and eEF1A 
only has a single low scoring (5.2 out of 10) NLS. Analysis of the GFP-His3 C-terminally tagged 









Figure 4.8 a and b, Fluorescence microscopy of Arp1-GFP strains. a shows Arp1 decorating microtubules 
and actin filaments. b shows translocation of Arp1 to the nucleus in the presence of elevated levels of eEF1A. 
 
Further characterisation of the other dynactin components was attempted using other GFP 
strains but they all lacked a strong enough signal to be detected by fluorescence microscopy.  
4.3 Mutations in eEF1A cause spindle pole body defects and effect Arp1 
localisation 
Previous studies on eEF1A have primarily focussed on its canonical role during protein 
synthesis and its non-canonical role as an actin-binding protein. Work from the Kinzy lab 
focussed on introducing point mutations in eEF1A to elucidate residues that effect actin-
binding and rates of translation. As previously discussed they revealed two classes of 
mutations that rescued the growth defect observed upon eEF1A overexpression. The first 
were those which did not affect the rate of protein synthesis, but resulted in a disorganised 
actin cytoskeleton and reduced actin bundling, although actin binding was unaltered in vitro 
(Gross and Kinzy, 2005). The second class of mutations caused severe actin phenotypes along 
with slowed growth and decreased levels of translation initiation (Gross and Kinzy, 2007). We 
acquired the strains characterised in these studies, isolated the overexpression plasmids and 




using marker swapped GFP tagged strains were able to analyse the effects of the point 
ŵƵƚĂƚŝŽŶƐŽŶɶƚƵďƵůŝŶ and Arp1p localisation. 
4.3.1 Point mutations in eEF1A effect Arp1 localisation 
To see if the actin binding ability of eEF1A affected its influence on Arp1 location the Arp1-
GFP expressing strain was transformed with an array of eEF1A overexpression plasmids with 
point mutations introduced known to affect actin binding. These plasmids were a TEF1-URA3 
fusion to prevent degradation of eEF1A (Gross and Kinzy, 2005). 
Overexpression of the wild type eEF1A-Ura3p fused protein resulted in a similar translocation 
of Arp1 to the nucleus as was observed when eEF1A was overexpressed as an unfused product 
(see figure 4.9 a). The translocation was not as severe as with the unfused protein, but this 
was likely due to a lower level of eEF1A overexpression, even though the fusion was intended 
to drive higher levels of eEF1A. Four of the eEF1A mutations, N329D Y355C, F308L, N305S and 
S405P, resulted in a rescue of Arp1 localisation similar to the wild type, although some 
showed potential localisation to the mitochondria, which was not observed in the wild type 
cells (see figures 4.9 b,c,d and e). Dynactin is known to be involved in the regulation of 
subcellular mitochondrial location (Varadi et al., 2004) and it appears that eEF1A promotes 
the interaction between Arp1 and the mitochondria. The two other mutations K333E and 
N329S resulted in an almost complete loss of Arp1-GFP signal. Only very faint localisation to 
the actin filaments was visible (see figures 4.9 c and d) strongly indicating a requirement for 
eEF1A in Arp1 fulfilling its role as a member of the dynactin complex. These data suggest that 
the residues of eEF1A that affect its ability to bind actin also influence its ability to induce 
translocation of Arp1 to the nucleus, and, furthermore residues N329 and K333 are essential 
for normal Arp1 distribution. As can be seen in figure 4.10 N329 and K333 are in close 




proximity to each other close to the boundary between domains II and III suggesting this 
region is likely to be involved in the interaction between Arp1 and eEF1A. 
 
Figure 4.9 a-g, Arp1-GFP with eEF1A overexpressed with various point mutations. eEF1A fused to URA3 
was overexpressed in Arp1-GFP. Point mutations that are known to effect actin binding and translational 
fidelity were introduced to observe their effect on Arp1 localisation. All of the mutations resulted in a rescue 









Figure 4.10 Model of yeast eEF1A showing mutations known to rescue the growth defect observed 
when TEF1 is overexpressed. 
 
4.3.2 Point mutations in eEF1A have no significant effect on spindle pole bodies 
Further characterisation of the eEF1A mutants was carried out by expressing them in the 
Tub4-GFP expressing strain. Although no difference in spindle pole body localisation was 
observed when TEF1 was overexpressed (see figure 4.7), deletion of ARP1 resulted in spindle 
defects (see figure 4.6). Our aim was to utilise the eEF1A point mutations to see if altering the 
interaction between eEF1A and Arp1 had any observable effect on spindle pole bodies. 
When we overexpressed wild type eEF1A fused to URA3 a similar increase in Tub4-GFP 
fluorescence intensity was observed as in the unfused overexpression system, but there was 
no observable difference in Tub4 localisation. None of the point mutations appeared to have 
an observable effect on Tub4 localisation throughout the cell cycle. Similar to both the URA3 
fused and unfused overexpression strains, all the mutants resulted in an increase in 




fluorescence intensity relative to the wild type with exception of the F308L mutant that 
exhibited similar fluorescence intensity to the wild type. 
 
 
Figure 4.11 a-g Tub4-GFP with eEF1A overexpressed with various point mutations. eEF1A fused to URA3 
was overexpressed in Tub4-GFP. Point mutations that are known to effect actin binding and translational 
fidelity were introduced to observe their effect on Tub4p localisation. None of the mutations resulted in altered 
Tub4 location, but all but the F308L mutant caused an increase in Tub4 fluorescence. 
 
4.4 Discussion 
In this chapter we utilise results derived from a high throughput screening method to 
elucidate a novel, putative interactive partner of eEF1A. Through overexpression of TEF1 in 
an array of strains deleted for genes that are known to interact with or control the function 
of actin, we were able to identify a cluster of proteins that delivered a synthetic interaction 
with eEF1A that belonged to the dynactin complex. Further investigation into the interaction 
between eEF1A and other components of the dynactin complex yielded significant data that 
indicated an interaction between eEF1A and at least one component of the dynactin complex. 




4.4.1 eEF1A overexpression rescues dynactin dependant aberrations 
FACS and microscopy analysis of dynactin mutants with endogenous and elevated levels of 
eEF1A showed that deletion of components of the dynactin complex resulted in significant 
genomic heterogeneity, with TEF1 overexpression reducing the observable heterogeneity in 
all the dynactin mutants suggesting a role for eEF1A in regulating the cell cycle in response to 
genomic integrity. TEF1 overexpression also resulted in the ablation of the third peak 
observed in the ȴĂƌƉ ?mutant although when observed by microscopy TEF1 overexpression 
induced an increase in observable multinucleate cells. Because of the significant homology 
between Arp1 and Act1, and because of the strong functional and physical interactions 
between eEF1A and Arp1 we had observed up to this point, the remainder of our efforts were 
focussed on elucidating the mechanism that eEF1A utilised to interact with Arp1 and the 
dynactin complex. We observed that the ȴĂƌƉ ? mutant exhibited severe spindle aberrations, 
with most cells possessing seemingly uncontrolled spindle growth resulting in spindles 
positioned along the cell cortex, but also forming aberrant patterns throughout the 
cytoplasm. Overexpression of TEF1 in the ȴĂƌƉ ? mutant resulted in the rescue of the spindle 
aberrations, but not the aneuploidy as observed by microscopy. This demonstrated that 
overexpression of eEF1A was able to rescue the spindle defects, but not the aneuploidy 
induced upon deletion of Arp1. It is possible that eEF1A is able to stabilise actin in short 
filaments that are then able to substitute for Arp1 in the dynactin complex. This could result 
in the restoration of the complex that is then able to either fully or partially complete its roles. 
How eEF1A overexpression is able to rescue the spindle defect whilst causing a more severe 
aneuploidy defect is unclear. One possibility is that levels of eEF1A are involved in the 
regulation of cell cycle check points and elevated levels of eEF1A result in the bypass of these 
essential steps of cell growth, we do not however see a marked increase in aneuploidy in the 




wild type cells with elevated levels of eEF1A indicating that this may not be the case. It could 
also be true that Arp1 is involved in the regulation of cell cycle check points and deletion of 
Arp1 results in dis-regulation of controlled growth. Furthermore it may not be that be that 
Arp1 alone is involved in cell cycle regulation, but the entire dynactin complex. If TEF1 
overexpression is able to restore the dynactin complex it is possible that it does so in an 
inadequate manner in which it is unable to fulfil all of its roles. It may be able to restore correct 
positioning of the cytoplasmic spindles, but it is possible that due to the absence of actin 
fibres in the nucleus that actin is unable to substitute for Arp1 in the dynactin complex within 
the nucleus. This would result in correct positioning of the cytoplasmic spindles but aberrant 
nuclear spindles, potentially inducing aneuploidy. 
4.4.2 Domains II and III of eEF1A mediate Arp1 translocation to the nucleus 
It is well known that residues in domains II and III of eEF1A are essential for its ability to bundle 
actin (Gross and Kinzy, 2005). We have found that overexpression of eEF1A results in 
significant translocation of Arp1 to the nucleus via a mechanism that is yet to be defined. We 
have clearly demonstrated that the residues in domains II and III of eEF1A known to be 
involved in eEF1A binding to actin are also involved in its ability to mediate Arp1 translocation 
to the nucleus. Mutation of any of these residues resulted in eEF1A overexpression no longer 
causing Arp1 translocation to the nucleus. Upon overexpression of four of the six eEF1A 
mutants, N329D Y355C, F308L, N305S and S405P, Arp1 appeared to localise to actin, 
microtubules and spindle pole bodies, as observed in the wild type cells, as well as apparent 
localisation to the mitochondria although this was not confirmed using co-localisation 
microscopy. Two of the mutants, K333E and N329S resulted in the loss of defined Arp1-GFP 
fluorescence indicating an inability of Arp1 to bind to other cellular components suggesting 




that interactions between Arp1 and its interactive partners are facilitated by eEF1A in its 
native form.  
These data suggest that eEF1A plays a significant role in cell cycle dynamics via mediation of 
Arp1 interactions with the dynactin complex and other interactive partners. It is also possible 
that eEF1A is able to stabilise actin in a form that can substitute for Arp1 in the dynactin 
complex in the ȴĂƌƉ ? mutant. 




Chapter 5 Conservation of eEF1A interactions in 
humans 
  




5.1 Introduction: eEF1A2 is an oncogenic isoform of the eukaryotic 
elongation factor 1A 
As previously discussed, eEF1A is a highly conserved protein that is required during the 
elongation step of protein synthesis. Throughout eukaryotic species eEF1A has been 
characterised to fulfil the same canonical role, as well as other moonlighting functions. The 
different isoforms of eEF1A can be expressed at different stages of development or 
differentially expressed in various tissues. Although highly conserved, sharing 92% amino acid 
identity amongst isoforms in humans, these proteins display distinct expression patterns, and 
unique interaction profiles (see figures 5.1 a and b). The interaction profiles shown in figure 
5.1 suggest that eEF1A1 plays a greater role in translation, as can be seen by the cluster of 
ribosomal proteins (Rps8,Rpl3, etc), eEF1A2 appears to have a strong interactions with the 
nucleoporins (Ranbp1, Rangap1, etc) and also several proteins involved in responses to JAK-
STAT signalling (Ptpn1, Socs1, etc). 
Elevated levels of eEF1A2 have been found in many tumours, and expression of eEF1A2 in 
non-native tissues is known to induce tumourigenesis (Anand et al., 2002). Following on from 
our studies in yeast we aimed to characterise overexpression of the oncogenic eEF1A2 in 
human cells, and to ask whether eEF1A overexpression-related phenotypes are conserved in 
higher eukaryotes. To do this we utilised the Invitrogen Flp-in system, allowing us to rapidly 
generate stable cell lines overexpressing eEF1A2 maintained in the presence of the antibiotic 
Hygromycin. We used human embryonic kidney cells (HEK293) for several reasons; the first is 
that kidney cells do not normally express eEF1A2 and so overexpression should mirror 
expression of eEF1A2 in normal tissue during the onset of tumourigenesis. The second reason 
for using HEK293 cells is that they are a rapidly growing adherent cell line, facilitating 




observation of the cytoskeleton. Finally HEK293 cells were chosen over NIH3T3s (mouse 
fibroblasts) despite being transformed, because it has been reported that the CMV 
(cytomegalosvirus) promoter utilised in the Flp-In system is down-regulated over time in 
murine and rodent cells due to histone deacetylation, although the mechanism that mediates 
this is unknown. 





Figure 5.1 a and b, Known and predicted protein interactions with eEF1A1 and eEF1A2. Both a and b show the primary protein in red, with known and predicted 
protein interactions indicated by the connections. Generated using string.db.org (Franceschini et al., 2013). 




5.2 Generation of eEF1A2 overexpression HEK293 cells 
5.2.1 Cloning eEF1A2 into the pcDNA5/FRT expression vector 
To study the effects of eEF1A2 overexpression in human cells we generated a Flp-in 
expression vector that induced overexpression of eEF1A2 isolated from a human breast 
tumour (Anand et al., 2002). 
A pcDNA3.0 overexpression plasmid containing eEF1A2 was kindly provided by Jonathan Lee 
(University of Ottawa, Canada), using this and the pcDNA5/FRT expression vector we 
performed double digests with HindIII and XhoI, resulting in excision of eEF1A2 from the 
pcDNA3.0 vector, and a linearised fragment of pcDNA5/FRT that we ligated together (see 
figure 5.2 a and b) using the method described in section 2.4.9 
 
Figure 5.2,  a) Digest of pcDNA5/FRT and pcDNA3.0 containing eEF1A2 and, b) digestion of ligated products. 
a) shows a double digest of pcDNA5/FRT and of pcDNA3.0 containing eEF1A2, these were digested with 
HindIII and XhoI, A and B are duplicates of the pcDNA5 digest, and C and D are duplicates of the pcDNA3 
containing eEF1A2 digest, bands highlighted were excised and ligated together as described in the materials 
and methods. b) shows the ligated product (E), it also shows single cuts using HindIII (F) and XhoI (G), and it 
shows the double digest using both HindIII and XhoI (H), the highlighted band shows eEF1A2. 




5.2.2 Transfection of the pcDNA5/FRT-eEF1A2 overexpression vector into 
HEK293 Flp-in cells. 
HEK293 Flp-in cells were transfected as described in Chapter 2 (section 2.4.11). Cells 
containing the control vector (pcDNA5.0) or the eEF1A2 overexpression vector 
(pcDNA5.0/1A2) were confirmed by their ability to grow in media containing Hygromycin, and 
a sensitivity to Zeocin. eEF1A2 overexpression was confirmed by western blotting and probing 
for eEF1A2 using a rabbit polyclonal to eEF1A2 (abcam, ab82912), see figure 5.3. 
 
Figure 5.3, Western blot showing eEF1A2 overexpression in HEK293 cells. Western blots were probed 
with an antibody specific to eEF1A2. Total protein was detected using fluorescent sypro red. Three 
monoclonals were isolated for the eEF1A2 overexpressing cell line and for the wild type. All experiments were 
carried out with eEF1A2 monoclonal 3 as this had the highest levels of expression. 
 




5.3 Overexpression of eEF1A2 results in an increased growth rate in 
HEK293s 
Because we had observed alterations in growth rate, cytoskeletal defects and genomic 
aberrations in yeast cells, these were the primary targets for characterisation in the HEK293 
cells. We began by assessing growth using the ACEA Biosciences Xcelligence RTCA DP 
Analyser. This is an automated system that allows growth analysis of adherent cell lines by 
continuous measurement of the impedance of an electric current across a gold plated well 
(see figure 5.4) . As cells grow over the electrode at the bottom of the well the impedance 
increases and the system converts the impedance to an arbitrary value called Cell Index (CI). 
CI is also affected by the strength of a cell ?s adhesion to the surface and cells with more focal 
adhesions will result in a higher CI. 
Growth analysis on HEK293 cells was performed as described in the Chapter 2 (section 
2.6.2.4). 
 





Figure 5.4, Schematic view of the Xcelligence electrode with proliferating cells. Each plate for the 
Xcelligence system contains 16 wells with each well containing a gold electrode in the bottom as shown in this 
figure. The electrode is an incomplete gold mesh that when covered with growth media generates a baseline 
signal. Addition of cells to the well affects the ionic environment causing an increase in electrode impedance. 
The addition of more cells (proliferation) or the number of focal adhesions will increase the impedance. This 
value of impedance is converted to an arbitrary value known as the cell index (CI). Image taken from 
http://www.aceabio.com. 
 
Analysis of the wild type and eEF1A2 overexpressing cells revealed that in HEK293 cells 
elevated levels of eEF1A2 induced a reduction in doubling time, as previously reported to 
occur in NIH3T3 cells (Anand et al., 2002). HEK293 cells with endogenous levels of eEF1A2 had 
a doubling time of approximately 26 hours, with an increase in eEF1A2 levels inducing a 
reduction of 23% to approximately 20 hours (see figure 5.5-b). Cells overexpressing eEF1A2 
also adhered to the surface more rapidly (see figure 5.5-c). This rapid adherence may be due 
to the effect of the interaction of eEF1A2 with actin, promoting actin remodelling and a 
greater number of focal adhesions, however further experimentation would be required to 
test this possibility. Further evidence that eEF1A2 promotes stronger adhesion to the 
substrate can be observed at the peak of the growth curve (see figure 5.5-a) where it is clear 
that the eEF1A2 overexpression lines reach a higher CI than the wild type cells. There are two 




possible reasons for the higher CI observed at around 100 hours into the assay, the first, as 
discussed, is that eEF1A2 promoted stronger focal adhesions to the surface. The second is 
that eEF1A2 inhibited apoptosis and the cells were growing on top of each other resulting in 
multiple layers of cells for the current to pass through. However, either reason, indicates that 
HEK293 cells responded in an aberrant manner to elevated levels of eEF1A2. 
 
Figure 5.5 a-c Growth curve and doubling time of wild type and eEF1A2 overexpressing HEK293 cells. 
Growth analysis was performed using the Xcelligence plate reader, figure 5.5-a shows the entire growth curve 
over the period of almost 10 days, this allowed us to not only capture the growth of the cells, but also the death 
kinetics. Figure 5.5-b shows the doubling time of the wild type and eEF1A2 overexpressing cells taken during 
the maximal log phase of growth. Figure 5.5-c shows the first seven hours of the assay highlighting the rapid 
adherence by the cells overexpressing eEF1A2. 
 




5.3.1 HEK293 cells with increased levels of eEF1A2 respond to drugs 
To further understand the effect of increased levels of eEF1A2 on HEK293 cells growth 
analysis was performed in the presence of various inhibitory drugs. It was hoped that eEF1A2 
might confer sensitivity to some of the drugs and resistance to others, thereby elucidating a 
possible mechanism it utilises to effect cell growth. 
The drugs chosen were Nocodazole and Rapamycin. Nocodazole was chosen for its known 
effects on microtubule polymerization as we had observed effects on the spindles by TEF1 
overexpression in yeast (see section 4.2.3). Rapamycin was chosen for its inhibitory effect on 
the TOR (target of rapamycin) pathway. Components of the TOR pathway were elucidated as 
potential interactive partners of eEF1A during this study (not discussed in this thesis), TOR is 
also known to play a significant role in the development of cancer (For a review see 
Beauchamp & Platanias, 2013). 
When grown in the presence of Rapamycin wild type cells exhibited a moderate increase in 
doubling time of approximately 14% to 30 hours whether grown ŝŶ ? ?Žƌ ? ?ʅD ?ƐĞĞĨŝŐƵƌĞs 
5.6 a and b). Wild type cells also showed an increase in lag phase of almost 50 hours 
suggesting a dramatic effect on the TOR pathway and an inability of the cells to respond to its 
nutritional environment. Treatment of the eEF1A2 ŽǀĞƌĞǆƉƌĞƐƐŝŶŐ ĐĞůůƐ ǁŝƚŚ  ? ? ʅD
Rapamycin resulted in a similar increase in doubling time observed in the wild type cells to 
approximately 30 hours. However, ƵƉŽŶ ĂĚĚŝƚŝŽŶ ŽĨ  ? ? ʅD ŽĨ ZĂƉĂŵǇĐŝŶ ƚŽ ĐĞůůƐ
overexpressing eEF1A2 an increase in doubling time of 42% was observed, resulting in a 
doubling time of almost 38 hours. The lag phase of eEF1A2 overexpressing cells was affected 
similarly to the wild type cells with an increase in lag phase growth of almost 50 hours. 




Figure 5.6 a and b, growth analysis of HEK293 cells with endogenous and elevated levels of eEF1A2 
treated with Rapamycin. Treatment of HEK293 cells with Rapamycin caused a similar increase in lag and 
log phase growth rates. However treatment of the eEF1A2  ? ?Ɋ
observable sensitivity in this cell line. 
 
Addition of 2 mM Nocodazole to the growth media resulted in no effect on the maximal rate 
growth of wild type cells with a doubling time of approximately 26 hours (see figure 5.7 b). 
Upon addition of Nocodazole to wild type cells their growth dynamics mimicked that of the 
eEF1A2 overexpressing line with a more rapid adhesion to the substrate and an increase in 
the final peak intensity prior to cell death (see figure 5.7 a). However, it is not known if this is 




due to an increase in the rate of growth or simply due to an increase in focal adhesions made 
by the cell. eEF1A2 overexpressing cells exhibited sensitivity to Nocodazole with a decrease 
in both the rate lag time and log phases of growth, with an increase of a doubling time of 5% 
relative to the untreated eEF1A2 overexpressing cells taking the doubling time to 
approximately 23 hours. The initial adhesion phase of the eEF1A2 overexpressing cells was 
also affected with cells appearing to settle on, and attach to the substrate far slower and 
similar to that observed for wild type cells.  
eEF1A2 overexpression conferred sensitivity to both drugs suggesting that cells with elevated 
levels of eEF1A2 are unable to tolerate additional stress imparted by drug treatments. It is 
possible that eEF1A2 overexpression has deleterious effects on both pathways affected by 
the separate drug treatments. As discussed in chapter 3 (section 3.4) eEF1A may play a role 
in nutrient sensing, which in part, is mediated by TOR signalling, and in chapter 4 (section 4.2) 
it was documented that eEF1A also plays a significant role in facilitating the functions of 
dynactin, the activating complex of dynein, which in turn plays a role in spindle formation. It 
is therefore probable that in the presence of elevated levels of eEF1A2 cells, are already 
burdened and the extra stress from treatment with any drug is enough to further impede 
growth. 





Figure 5.7 a and b, growth analysis of HEK293 cells with endogenous and elevated levels of eEF1A2 
treated with Nocodazole. Treatment of HEK293 cells with Nocodazole, treatment appeared to have no 
significant effect on the growth of wild type cells but resulted in a decrease of both lag and log phase growth 
rates in eEF1A2 overexpressing cells. 
 
 




5.4 eEF1A2 overexpression results in similar genomic aberrations as 
observed in yeast. 
As discussed in the introduction (section 1.2.1) eEF1A2 expression is limited to certain tissue 
types in higher eukaryotes with expression in abnormal tissues promoting tumour 
development. Tumour development is known to occur because of aberrations in genomic 
content resulting in altered metabolism and constitutive growth signals resulting in 
uncontrolled proliferation. We observed in our yeast system that when analysed by FACS, 
overexpression of eEF1A resulted in a significant shift of DNA peaks to the right, when 
analysed by FACS (see figure 4.4) and bigger, brighter nuclei when visualised by microscopy 
(see figure 4.5), suggesting that cells contained increased levels of DNA, or that 
overexpression of TEF1  resulted in incomplete chromosome condensation and increased 
uptake of DNA staining dyes. To answer the question  “/Ɛthis phenotype is conserved through 
to higher eukaryotes ? ? we performed the same assay on HEK293 cells. 
Cells were grown in a T75 flask to 70% confluence and trypsinized, counted and 1x107 cells 
were pelleted and fixed in 1 mL of -20°C 70% EtOH whilst vortexing. The cells were then 
ƌĞŚǇĚƌĂƚĞĚĂŶĚW/ǁĂƐĂĚĚĞĚƚŽĂĨŝŶĂůĐŽŶĐĞŶƚƌĂƚŝŽŶŽĨ ?ʅŐ ?ŵ> ?ƐǁŝƚŚƚŚĞǇĞĂƐƚƐĂŵƉůĞƐ
all analysis was performed using the FACSCalibur flow cytometer.  
Analysis of the wild type cells by FACS revealed two peaks representing two complete haploid 
sets (2C) and cells that have undergone genome duplication (4C) in preparation for mitosis, 
(see figure 5.8 a). Analysis of these cells by fluorescence microscopy revealed most cells 
contained a single, spherical nucleus that filled approximately 60-70% of the total cell volume 
(see figure 5.8 b). Overexpression of eEF1A2 in the HEK293 cells resulted in a similar shift to 
the right in the FACS spectrum, as was observed in yeast upon overexpression of TEF1 (see 




figure 5.8 a). How eEF1A in yeast and eEF1A2 in HEK293 cells cause this change is not 
understood, but it appears to correlate with cells that possess larger nuclei when observed 
by microscopy (see figure 5.8 c) suggesting an inability of cells to correctly segregate 
chromosomes. Overexpression of eEF1A2 resulted in the majority of cells containing 
abnormal, elongated nuclei (see figure 5.8-c), and a small proportion that were multinucleate. 
 
Figures 5.8 a-c, HEK293 cells stained with PI and analysed by FACS and fluorescence microscopy.  
HEK293 cells expressing endogenous and elevated levels of eEF1A2 were stained with PI and then analysed 
using FACS (a) shows the peaks shift to the right in the cells containing elevated levels of eEF1A2. Fluorescence 
microscopy (b and c) shows a HEK293 cell with endogenous levels of eEF1A2, and HEK293 cell with elevated 
levels of eEF1A2 containing an elongated nucleus. Images were acquired using a 60x objective. Purple line 
represents the parental cell line, and the green line is the eEF1A2 overexpressing cell line.  




5.5 eEF1A2 overexpression induces microtubule aberrations in 
HEK293 cells 
As we had previously observed an interaction between yeast eEF1A and components of the 
dynactin complex resulting in microtubule defects, and the effects of eEF1A overexpression 
on genomic content appeared to be conserved from yeast to humans, we next asked the 
ƋƵĞƐƚŝŽŶ  “/Ɛ there was any observable interaction between eEF1A2 and microtubules in 
HEK293 cells? ? 
To assess microtubule integrity in HEK293 cells the cells had to be grown on coverslips coated 
with poly-lysine to facilitate adherence as they are only semi-adherent and do not stick to the 
glass coverslips. Cells were grown to 70% confluence and then immunofluorescence was 
performed as described in chapter 2 (section 2.6.1.4). Although repeated on several occasions 
this procedure yielded poor success rates, with very few cells adhering to the surface, and 
fewer of those acquiring the fluorescent signal. This meant there were not enough observable 
cells to generate any statistically significant conclusions (between 60-80 per sample). 
However, there were consistent differences observed between the samples as discussed 
below. 
Wild type cells exhibited a slightly more elongated, slender morphology compared to the 
eEF1A2 overexpressing cells that appeared larger, rounder and squatter. The wild type cells 
had longer, more defined microtubules that exhibited an ordered arrangement emanating 
from the cell poles in an astral array (see figure 5.9 a). The microtubules in the eEF1A2 
overexpressing cells lacked the organisation exhibited by the wild type cells with microtubules 
growing in aberrant patterns with no obvious point of origin (see figure 5.9 b). DAPI staining 
of the nucleus allowed the observation of the nuclei that were larger in the eEF1A2 




overexpressing cell line than in the wild type. This observation was in concurrence with the 
microscopy acquired from the PI staining (section 5.4). 
 
Figures 5.9 a and b, Immunofluorescence of HEK293 cells allowing visualisation of the microtubules 
and the nuclei. HEK293 cells were probed using an anti-tubulin primary anti-body with a TexRed secondary 
anti-body (red), they also stained with DAPI (blue). Arrows on 5.9-a show the origin point of many of the 
microtubules that can be seen to project along the length of the cell. Arrows on 5.9-b show highlight some of 
the microtubules that appear to be growing in a disordered manner. 
 
5.6 Human eEF1A isoforms expressed in yeast do not function to 
replace yeast eEF1A 
As we had seen conservation of eEF1A interactions from yeast to human cells we asked 
whether they were functionally redundant. To do this we utilised a yeast strain generated in 
:ŽŚŶDĐĂƌƚŚǇ ?Ɛlab (University of Warwick) (Firczuk et al., 2013) that had TEF2 deleted and 
where TEF1 was placed under control of a TetO7 promoter, allowing almost complete 
ablation of native eEF1A expression through addition of doxycycline to the growth medium. 
We transformed this strain with a plasmid expressing either yeast TEF1, or human eEF1A1 or 
eEF1A2 all under control of the strong constitutive TDH3 promoter (plasmids were provided 




by Chris Grant, University of Manchester). When growŶ ŝŶ ƚŚĞ ƉƌĞƐĞŶĐĞ ŽĨ  ? ? ʅŐ ?ŵ> 
Doxycycline, enough to suppress expression of native TEF1, the only source of eEF1A came 
from the plasmid based expression allowing us to observe the ability of human eEF1A 
isoforms to fulfil the role of yeast eEF1A. All analysis was performed by assessing growth rate 
as a measure of cell fitness. 
Knockdown of native TEF1 in the wild type strain resulted in very poor growth and cells that 
had a maximal doubling time of almost 8 hours, 3.5 times longer than the wild type  (see 
figure 5.10 a pale blue trace and 5.10 b). Because eEF1A was expressed at low levels we had 
hypothesised that cells would struggle to grow. Expression of TEF1 resulted in a slight increase 
in doubling time relative to the wild type, probably due to the toxicity associated with 
elevated levels of eEF1A as previously discussed (section 3.2). Knockdown of native eEF1A in 
the TEF1 overexpression strain had no effect on growth rate as the plasmid-based TEF1 was 
able to fully compensate for the loss of chromosomal expression (see figures 5.10 a red and 
pink lines and 5.10 b). Expression of eEF1A1 in the presence of native TEF1 levels resulted in 
an increase in doubling time of 53% suggesting that eEF1A1 induced increased levels of 
toxicity relative to yeast eEF1A. Suppression of TEF1 expression induced by Doxycycline 
resulted in severe growth retardation when eEF1A1 was the only form of eEF1A available to 
the cells, with an observed increase in doubling time of almost 4 times the wild type 
suggesting that eEF1A1 is unable to fulfil the essential roles required by the yeast cells (see 
figures 5.10 a dark and light green lines and 5.10 b). Expression of eEF1A2 in the presence of 
native eEF1A resulted in an increase of 40% in doubling time relative to the wild type 
suggesting, similar to eEF1A1 expression, that eEF1A2 is confers significant toxicity to yeast 
cells. Knock down of eEF1A leaving eEF1A2 as the only eEF1A isoform resulted in a greater 




increase in doubling time than with eEF1A1, resulting in an increase in doubling time to more 
than 4 times the wild type, and barely growing better than cells containing the control plasmid 
(see figures 5.10 a dark and light purple lines and 5.10 b). This suggests that eEF1A1 and 
eEF1A2 are able to carry out different roles in yeast cells, with eEF1A1 facilitating yeast 
proliferation better than eEF1A2. 
 
Figures 5.10 a and b, Growth analysis of yeast cells expressing different eEF1A isoforms. a- Cells 
containing either yeast eEF1A or human eEF1A1 or eEF1A2 were grown in the presence of Doxycycline which 
suppressed levels of native eEF1A allowing us to monitor the effect of different eEF1A isoforms on yeasts ability 
to proliferate. b- Doubling times for each of the strains analysed, it is clear to see that eEF1A1 and eEF1A2 are 
unable to fulfil the role of yeast eEF1A. . p-values are represented by asterisks, *=<0.5, **=<0.05, ***=<0.005. 
 




5.7 Discussion of results 
Because of the high degree of conservation between TEF1 and eEF1A2 we were able to 
perform rapid, inexpensive analysis of eEF1A overexpression in yeast to facilitate 
identification of interactive partners in higher eukaryotes. Here we have identified several 
effects of eEF1A overexpression in yeast that are conserved through to humans. 
We have demonstrated that similar to previously published data in NIH3T3 cells, eEF1A2 
overexpression induces an increase in growth rate in cells from higher eukaryotes. 
Furthermore we have demonstrated that overexpression of eEF1A2 in HEK293 cells results in 
similar effects as seen with eEF1A overexpression in yeast. 
We have confirmed that a shift to higher genomic content in FACS analysis of PI stained cells, 
as observed in yeast cells with elevated levels of eEF1A, is conserved through to HEK293 with 
elevated levels of eEF1A2. Although the reason for the shift is not understood, and likewise, 
the mechanism that mediates it, eEF1A2 overexpression also results in aberrations in 
microtubule arrangement, suggesting a conserved mechanism for eEF1A to modulate cell 
cycle dynamics although this clearly needs further investigation to confirm this hypothesis. 
Although we have demonstrated that several phenotypes induced by eEF1A overexpression 
are conserved through to human cells, we also demonstrated that yeast and human eEF1A 
isoforms appear to have unique functional profiles and that human isoforms are unable to 
substitute for yeast eEF1A in S.cerevisiae. By deleting TEF2 and knocking down TEF1 we were 
able to ensure that eEF1A expressed from a plasmid was the sole source of eEF1A in the cell. 
This gave us the ability to identify if eEF1A1 or eEF1A2 were able to substitute for eEF1A in 
yeast cells. eEF1A1 expression resulted in better growth of yeast cells than eEF1A2 suggesting 
that it is able to carry out at least some of the functions of eEF1A. eEF1A2 expression however, 




resulted in the complete retardation of growth suggesting that it is completely unable to fulfil 
any of the roles required of it by the yeast cell. This is a very strong indication that eEF1A1 
and eEF1A2 have different functional profiles, which would explain why they are differentially 
expressed during development and in different tissue types. Furthermore the inability of 
eEF1A2 to function in yeast could be due to its decreased affinity for both GTP and its GEF 
eEF1B, reinforcing that eEF1A2 may have evolved to favour one of its extra functions over its 
canonical role during translation elongation. 




Chapter 6: Transcriptome analysis of TEF1 
overexpressing cells 
  





We have observed that eEF1A overexpression in both yeast and HEK293 cells can induce 
growth defects, and genomic and cytoskeletal aberrations. We have also observed that in 
yeast, TEF1 overexpression has a plethora of other effects on a wide array of cellular 
components and pathways. To assess the global effects of TEF1 overexpression on cells we 
carried out a transcriptome analysis using microarrays. We chose to use this method as it 
would provide us with a large data set that could elucidate the transcriptional alterations 
associated with elevated levels of TEF1. 
6.1.1 The affymetrix Yeast 2.0 GeneChip 
It is well known that cellular functions can be controlled through the regulated expression of 
genes in response to a variety of signalling pathways. Microarray is a common method for 
observing gene expression profiles on a global scale. This method allowed us to visualise the 
effects of TEF1 overexpression upon mRNA levels relative to wild type. In order to generate 
these data total RNA was isolated from yeast cells during log phase growth. The RNA samples 
were sent to Source Biosciences for them to perform the remaining steps of the microarray 
process. Following reverse transcription reactions the cDNA template was hybridised to an 
Affymetrix Yeast 2.0 GeneChip array. The raw data obtained from analyses carried out by 
Source Biosciences were then processed using the Bioconductor plugin, affylmgui (Wettenhall 
et al., 2006) following the worked example found at 
http://bioinf.wehi.edu.au/affylmGUI/Doc/estrogen.html and Affymetrix Expression Console 
Software found at 
http://www.affymetrix.com/estore/browse/level_seven_software_products_only.jsp?prod
uctId=131414#1_3. A cut off point was established for genes that were designated to have 




significantly altered expression; this was denoted as those genes with a B-statistic greater 
than 1.5. This analysis resulted in a total of 319 significantly up-regulated genes and 61 
significantly down-regulated genes in the presence of TEF1 overexpression. 
6.2 Pre-processing of data 
Prior to any analysis or quality assessment of microarray data, the raw unprocessed data must 
be pre-processed to ensure that it is of the highest possible quality and free from variation 
due to background noise and variation introduced by technical replicates. 
6.2.1 Background correction 
As with most fluorescence-based assays, background fluorescence is a problem for 
microarrays. It is likely to occur even if slides are only treated with labelled sterile water which 
is then hybridised to the array causing a low level of fluorescence to still be detected by the 
scanner. Other sources of background fluorescence are non-specific binding of the labelled 
sample, noise from the scanner or deposits left behind after washing. To reduce background 
noise we used the Robust Multi-Array Average (RMA) algorithm (Bolstad et al., 2003). This 
algorithm corrects the raw intensity values by log2 transformation and quantile 
normalisation. It then fits a linear model to the normalised data in order to obtain an 
expression measure for each probe set on each array. 
6.2.2 Normalisation 
Normalisation is used to adjust the data for technical variation, rather than for biological 
differences between the samples. Due to the nature of the assay the hybridisation process 
will always result in variations leading to scaling differences between the fluorescence 
intensity levels across arrays. The normalisation process corrects for these differences in 
fluorescence intensity by comparing like for like. 




6.3 Quality assessment of the microarray data set 
Prior to any biological interpretation of the microarray data set there were a variety of 
methods employed to ensure that the data was robust. The first step was to perform 
background correction and normalisation of the raw data as described in section 6.2 above. 
This was because the raw unprocessed data was likely to contain variation due to the variable 
nature of technical replication. Normalisation of the raw data removed a large amount of the 
variation in order to guarantee that all interpretation was performed on data that was robust. 
Following normalisation, an array of quality assessment steps was performed to ensure that 
the data were of the highest possible quality. We employed several statistical methods to 
check the integrity of the raw and normalised data, and visual analysis of artificially generated 
images of the residuals was performed to check for any defects present on the chip surface. 
We also checked RNA degradation to check the quality of the mRNA that was used for the 
hybridisation. 
6.3.1 Visualising residual images 
Prior to any further analysis synthetic images were generated using the affylmgui package 
ĂŶĚƚŚĞ “/ŵĂŐĞƋƵĂůŝƚǇƉůŽƚ ?ĐŽŵŵĂŶĚ. These allowed us to visualise the gene chips to check 
for any physical damage that may result in aberrant readings. Damage may have occurred 
through handling or during manufacture. Common abnormalities that cause aberrant 
readings are scratches or fingerprints on the coverslip, bubbles under the coverslip, or diffuse 
artefacts arsing from irregularities in washing. 
Inspection of our residual images (see figure 6.1 a-e) revealed that all of our gene chips 
appeared to be well prepared with the exception of 6.1-d which appeared to have an 
abnormality caused by either irregular washing or a bubble trapped under the coverslip. 




Other artefacts such as empty patches and striations were observed but they are common 
across all affymetrix gene chips. 
 
Figure 6.1, Synthetic images of residuals. Images show negative residuals as blue and positive as red. These 
images allowed us to visualise the gene chips and inspect them for any aberrations that may result in abnormal 
values. 
 
6.3.2 RNA degradation plot 
The next quality assessment step was to ensure that the mRNA used for the array was of 
sufficient quality. RNA degradation can occur during preparation resulting in a poor measure 
ŽĨŐĞŶĞĞǆƉƌĞƐƐŝŽŶ ?ĞŐƌĂĚĂƚŝŽŶďĞŐŝŶƐĂƚƚŚĞ ? ?ĞŶĚĂŶĚƉƌŽŐƌĞƐƐĞƐ towĂƌĚƐƚŚĞ ? ?ĞŶĚ ?ƚŚŝƐ
allowed us to easily measure degradation using oligonucleotide arrays. Sequential numbering 
ŽĨƉĞƌĨĞĐƚŵĂƚĐŚ ?WD ?ƉƌŽďĞƐĨƌŽŵƚŚĞ ? ?ĞŶĚ of the targeted mRNA ƚƌĂŶƐĐƌŝƉƚƚŽƚŚĞ ? ?ĞŶĚ
allowed a graphical representation of mRNA degradation (see figure 6.2). RNA degradation is 




ƌĞƉƌĞƐĞŶƚĞĚďǇĞůĞǀĂƚĞĚǀĂůƵĞƐĂƚ ƚŚĞ  ? ?ĞŶĚĐŽŵƉĂƌĞĚƚŽ ƚŚĞ  ? ?ĞŶĚ ?,ŝŐŚĞƌ ƋƵĂůŝƚǇZE
typically exhibits a slope between 0.5 and 1.7, and slopes that are greater than twice this 
value are considered to be due to excessive degradation of mRNA resulting in poor quality 
results. 
Figure 6.2 shows that the RNA used for this array was not excessively degraded, meaning that 
all samples were of good quality. The RNA also exhibited similar degradation slopes across 
the five samples (three wild type and two TEF1 overexpression) showing that there was 
agreement between the gene chips, and because all the arrays are similar then comparisons 
within genes across the arrays are still likely to be valid even if RNA degradation had occurred. 
 
Figure 6.2, RNA degradation plot. A plot of the five RNA samples analysed using microarray. All samples 
exhibited a similar slope suggesting degradation at a similar rate.  
 




6.3.3 Statistical analysis of microarray data 
The strength in microarray analysis is that it allows us to monitor the expression of almost the 
entire yeast genome simultaneously (5,841 of the 6,334 genes). However, because of the 
enormous quantity of data generated from such a small number of replicates it is vital to 
interrogate the robustness of the data acquired. To achieve this we had put our data through 
a variety of statistical analyses that are presented here. 
6.3.3.1 Box plots generated using affylmGUI on R 
Visualising the data in a box plot is a quick method to compare the probe intensity levels 
between arrays. When using box plots it is vital to understand what each point on the plot 
means; each end of the box represents the upper and lower quartiles (the median of the 
upper and lower half of the data sets). The line across the middle of the box is the median of 
the data set for that array. The horizontal lines that are connected to the box by the 
 “ǁŚŝƐŬĞƌƐ ?ƌĞƉƌĞƐĞŶƚƚŚĞůĂƌŐĞƐƚĂŶĚƚŚĞƐŵĂůůĞƐƚĚĂƚĂƉŽŝŶƚƐƚŚĂƚĂƌĞŶŽƚĐŽŶƐŝĚĞƌĞĚƚŽďĞ
outliers. With outliers (not shown) defined as values that are 1.5 times the interquartile range 
from the first of the third quartile (these are the edges of the box). 
Using this method it was easy to check that all data, following normalisation, had similar 
intensity levels, and that there was no variation to cause a problem when processing the data 









Figure 6.3, Box plots of raw and normalised data. a- A box plot of the raw data indicating that there was 
little variation across the assays prior to normalisation. b- A box plot of the RMA processed data showing that 
following normalisation all arrays had similar probe intensity. 
 
Using box plots also allowed us to visualise probe level analysis. For this we performed 
Relative Log Expression (RLE) (see figure 6.4 a) that shows the deviation of gene expression 
level for each array, from the median gene expression level for that gene across all arrays. If 
an array has a quality problem then it will exhibit different values from the other arrays in the 
assay. We also calculated the Normalised Unscaled Standard Error (NUSE) (Wilson et al., 
2004) (see figure 6.4 b) . This shows the chip-wise distribution of standard error estimates 
that are obtained for each gene on each array. Both of these checks confirmed that although 
there is variation between the wild type and TEF1 overexpression strains, all data fell within 
acceptable error ranges. 
 
 





Figure 6.4, Box plots of RLS and NUSE data. a- A box plot of the RLE data indicating that one of the TEF1^ 
expression samples showed slightly altered gene expression levels. b- A box plot of the NUSE data suggesting 
that the TEF1^ strains contained more standard errors than the wild type strains. 
 
6.4 Interpretation of microarray data 
Following the rigorous checks to ensure that our microarray data were robust we then sorted 
the significant data (genes up or down-regulated with a B-stat greater than 1.5) into groups 
for processing using Gene Ontology (GO) Slim Mapper. This method allows understanding of 
a collection of genes by grouping them according to one of three biological criteria. Sets of 
genes were uploaded to the website (http://www.yeastgenome.org/cgi-
bin/GO/goSlimMapper.pl) and then sorted by; cellular component (e.g. nucleus, 
mitochondria, etc), molecular function (e.g. signal transducer activity, enzyme binding, etc) 
or biological process (e.g. protein folding, rRNA processing, etc). Clustering of genes into these 
groups allowed us to check for enrichment of specific terms relating to sub-groups. Once it 
had assigned terms to the groups of genes the Slim Mapper also showed us which GO terms 
were significantly enriched based on the frequency of gene clustering. This was assessed by 




comparing gene cluster frequency to whole genome frequency. From this a ratio was 
generated of cluster frequency to genome frequency, with anything greater than 1.5 being 
enriched in the cluster. Here we present only the data that we have defined as enriched (a 
complete list of both up and down-regulated genes can be found in the appendix (see 
appendix- App.3) 
6.4.1 GO Slim Mapper analysis of significantly up-regulated genes 
A total of 319 genes were found to be significantly up-regulated as defined by the restrictions 
previously discussed. This group of genes were uploaded to the GO Slim Mapper and then 
processed as described in section 6.4. The first term that the genes were clustered in were 
biological processes (see table 6.2). This showed enrichment for 19 biological processes. The 
most enriched process from the up-regulated gene cluster was carbohydrate transport and 4 
of the 6 genes group (HXT1, HXT6, HXT7 and HXT9) in this process belong to the HXT family 
of genes involved in hexose uptake. A reassuring observation with these data was that the 
majority of the processes concur with previous observations made during this research. For 
example there are several processes that are linked to metabolic processes and the cells 
response to apparent starvation for example generation of precursor metabolites and energy, 
cellular amino acid metabolic process, carbohydrate metabolic process and response to 
starvation. The highest enrichment was observed in carbohydrate transport with 6 of the 319 








Table 6.2 - Go-Slim mapped biological processes generated by the up-regulated microarray 
data set 







Gene(s) Up regulated 
carbohydrate 
transport 




6 - 1.9% 37 - 0.6% 3.17 TPS1,NTH1,TPS2,HSP104,TSL1,S
NF2 
lipid transport 9 - 2.8% 55 - 0.9% 3.11 DRS2,SWH1,OSH2,DNF2,DNF1,S
UT1,PRY3,UPS1,FAA1 
cytokinesis 13 - 4.1% 95 - 1.5% 2.73 CDC15,BOI1,SDS24,BOI2,DSE2,S
WE1,MYO3,CHS5,VRP1,MYO5,Z
DS1,BNI1,THP1 
response to osmotic 
stress 
12 - 3.8% 88 - 1.4% 2.71 CYC8,GPD1,NRG1,GPP2,GRE3,SL
N1,MYO3,SSK1,MYO5,TCO89,HS
P82,OPY2 
endocytosis 12 - 3.8% 96 - 1.5% 2.53 DRS2,SWH1,ECM21,SDS24,OSH2
,DNF2,DNF1,MYO3,ENT2,VRP1,
MYO5,SCD5 
amino acid transport 5 - 1.6% 47 - 0.7% 2.29 BAP2,RTC2,AVT6,AUA1,MUP3 
cellular amino acid 
metabolic process 




















9 - 2.8% 96 - 1.5% 1.87 SUT1,SIP2,CLG1,PCL5,TAX4,ATG2
,SNF2,OPY2,ATG13 





14 - 4.4% 160 - 2.5% 1.76 ADH5,GLK1,GLC3,RGI1,IGD1,SHY
1,TDH1,GLG1,GSY2,YLR345W,ISF
1,PFK2,IDH1,IDH2 




response to heat 6 - 1.9% 69 - 1.1% 1.73 TPS1,TPS2,AHA1,HSF1,HSP104,SI
N3 
exocytosis 4 - 1.3% 48 - 0.8% 1.63 SWH1,OSH2,MYO3,MYO5 
cell wall organization 
or biogenesis 
15 - 4.7% 199 - 3.1% 1.52 ROT2,YPS7,KIC1,MHP1,TAX4,GO
N7,MYO3,YPS3,CHS5,MYO5,KRE
1,HRD1,HPF1,TCO89,FLC1 
































319 genes that had a B-Stat greater than 1.5 were analysed and processes that were enriched 1.5 times higher 
in the cluster than is found in the genome, are displayed here. Data is presented in enrichment order. Also 
includes gene cluster of unknown process. 
 
The second term that the up-regulated genes were clustered by was molecular function (see 
table 6.3). Clustering by function resulted in 12 functions that were enriched in our up-
regulated gene set. The most significantly enriched function was hydrolase activity, acting on 
glycosyl bonds, which was increased three-fold compared to genomic levels. Several of the 
functions within table 6.3 suggested that TEF1 overexpressing cells had to respond to nutrient 
deprivation, as suggested by the data in table 6.1. Many of the functions listed are related to 
recycling cellular nutrients for use elsewhere, there are genes that are involved in 
carbohydrate storage in the form of trehalose such as TSL1 and TPS1, and genes that are 
involved in the degradation of trehalose such as NTH1, which is required for thermotolerance 
and mediation of resistance to other cellular stresses (Zähringer et al., 1997). 




Table 6.3 - Go-Slim mapped molecular functions generated by the up-regulated microarray 
data set 







Gene(s) Up regulated 
hydrolase activity, acting 
on glycosyl bonds 
7 - 2.2% 45 - 0.7% 3.14 YPC1,ROT2,NTH1,DSE2,PNP1,HP
F1,YDC1 
transferase activity, 
transferring alkyl or aryl 
(other than methyl) 
groups 
5 - 1.6% 39 - 0.6% 2.67 ARO3,ARO1,RAM2,MET17,MRS6 
enzyme binding 7 - 2.2% 55 - 0.9% 2.44 ECM21,CYC8,DST1,SSK1,SCD5,M
RS6,GIP3 
hydrolase activity, acting 
on carbon-nitrogen (but 
not peptide) bonds 
7 - 2.2% 63 - 1% 2.2 RIB1,YPC1,HIS7,HIS4,PNC1,OXP1,
YDC1 
lyase activity 9 - 2.8% 86 - 1.4% 2 ARO1,TRP2,TCD1,ARG4,YHR112C
,APN1,YKL151C,SRY1,MET17 










8 - 2.5% 96 - 1.5% 1.67 TPS1,HIS7,TRP4,GLC3,GLG1,PNP
1,GSY2,TSL1 
nucleic acid binding 
transcription factor 
activity 
13 - 4.1% 159 - 2.5% 1.64 LYS14,NRG1,UME6,ACA1,HSF1,
MGA1,STP2,RSF2,BAS1,LEU3,TAF
8,TFC7,RLM1 
kinase activity 15 - 4.7% 198 - 3.1% 1.50 CDC15,GLK1,ARO1,MSS4,HOM3,
SAK1,SIP2,THR1,KIC1,PKP1,SLN1,
TPK1,SWE1,YLR345W,PFK2 
signal transducer activity 3 - 0.9% 39 - 0.6% 1.5 GPR1,SLN1,SSK1 





319 genes that had a B-Stat greater than 1.5 were analysed and processes that were enriched 1.5 times higher 
in the cluster than is found in the genome, are displayed here. Data is presented in enrichment order. 
 
The final term that the up-regulated genes were clustered by was cellular component (see 
table 6.4). Clustering by component resulted in 6 components that were enriched in our up-
regulated gene set. The most enriched component was the peroxisome with enrichment 
increased two-fold compared to genomic levels. GPD1 is an NAD-dependent glycerol-3-
phosphate dehydrogenase that plays a major role in lipid biosynthesis via the reduction of 




dihydroxyacetone phosphate to glycerol-3-phosphate, simultaneously oxidising NADH to 
NAD+ (see figure 6.5). PNC1 is known to play a role in the NAD+ salvage pathway converting 
nicotinamide to nicotinic acid (Ghislain et al., 2002). PEX21, PEX14 and PEX30 are all 
peroxisome related proteins. GPD1, PNC1 and PEX21 are all known to increase in expression 
in response to DNA replication stress (Tkach et al., 2012). CIT2 is a peroxisomal isozyme 
involved in the glyoxylate cycle catalysing the condensation of acetyl coenzyme A and 
oxaloacetate to form citrate (Kim et al., 1986; Lewin et al., 1990) and LPX1 is a peroxisomal 




























Gene(s) Up regulated 
peroxisome 7 - 2.2% 69 - 1.1% 2 CIT2,GPD1,PNC1,PEX14,PEX21,PEX30,LPX1 
plasma 
membrane 










18 - 5.7% 237 - 3.7% 1.54 CDC15,BOI1,ABP1,OSH2,SEC31,BOI2,KIC1,CA
P2,SWE1,SKG3,ENT2,CHS5,VRP1,MYO5,ZDS1,
BNI1,YPT11,FLC1 





















319 genes that had a B-Stat greater than 1.5 were analysed and processes that were enriched 1.5 times higher 
in the cluster than is found in the genome, are displayed here. Data is presented in enrichment order. Also 









Figure 6.5, Glycerol-3-phosphate dehydrogenase reaction mechanism. This reaction shows how Gpd1 
reduces dihydroyacetone to glycerol-3-phosphate, whilst simultaneously oxidising NADH to NAD+. 
 
6.4.2 GO Slim Mapper analysis of significantly down-regulated genes 
A total of 61 genes were found to be significantly down-regulated as defined by the 
restrictions previously discussed. This group of genes were uploaded to the GO Slim Mapper 
and then processed as described in section 6.4. The first term that the genes were clustered 
in were biological processes (see table 6.5). This table shows enrichment for 17 biological 
processes and a large group of 17 genes that belong to unknown processes. A large proportion 
of the biological processes found to be down-regulated in the TEF1 overexpression strain 
were involved in RNA processing including transcription from RNA polymerase I and III 










Table 6.5 - Go-Slim mapped biological processes generated by the down-regulated 
microarray data set 







Gene(s) Down regulated 
mitochondrial 
translation 
5 - 8.2% 137 - 2.2% 3.73 PET122,RRF1,PTH1,MRPL38,
MRPL33 
transcription from 
RNA polymerase I 
promoter 
2 - 3.3% 64 - 1.0% 3.3 RRN3,RPB10 
carbohydrate 
transport 
1 - 1.6% 33 - 0.5% 3.2 HXT17 
pseudohyphal 
growth 
2 - 3.3% 69 - 1.1% 3 PGU1,HMS1 
transcription from 
RNA polymerase III 
promoter 
1 - 1.6% 39 - 0.6% 2.67 RPB10 
snoRNA processing 1 - 1.6% 40 - 0.6% 2.67 RRP45 
ribosomal small 
subunit biogenesis 
3 - 4.9% 129 - 2.0% 2.45 LOC1,FCF2,FYV7 
rRNA processing 7 - 11.5% 297 - 4.7% 2.45 RRP45,NUG1,LOC1,FCF2,FYV
7,RMP1,PUS7 
protein folding 2 - 3.3% 90 - 1.4% 2.36 EMC5,CUR1 
ribosomal large 
subunit biogenesis 




1 - 1.6% 45 - 0.7% 2.29 NUG1 
tRNA processing 2 - 3.3% 105 - 1.7% 1.94 FMT1,PUS7 
mitochondrion 
organization 




1 - 1.6% 60 - 0.9% 1.78 DED1 




1 - 1.6% 66 - 1.0% 1.6 RRN3 
sporulation 2 - 3.3% 132 - 2.1% 1.57 SPO73,RIM9 
biological process 
unknown 










61 genes that had a B-Stat greater than 1.5 were analysed and processes that were enriched 1.5 times higher 
in the cluster than is found in the genome, are displayed here. Data is presented in enrichment order. 
 




The second term that the down-regulated genes were clustered by was molecular function 
(see table 6.6). Clustering by function resulted in 10 functions that were enriched in our down-
regulated gene set with a group of 30 genes of unknown function. Most of the functions in 
ƚĂďůĞ  ? ? ?ĐŽŶƐŝƐƚĞĚŽĨŽŶůǇĂƐŝŶŐůĞŐĞŶĞ ?ǁŝƚŚŽŶůǇ “ƚƌĂŶƐůĂƚŝŽŶĨĂĐƚŽƌĂĐƚŝǀŝƚǇ ?ŶƵĐůĞŝĐĂĐŝĚ
ďŝŶĚŝŶŐ ? ĂŶĚ “ƉƌŽƚĞŝŶďŝŶĚŝŶŐƚƌĂŶƐĐƌŝƉƚŝŽŶĨĂĐƚŽƌĂĐƚŝǀŝƚǇ ?ĐŽŶƐŝƐƚŝŶŐŽĨƚǁŽŐĞŶĞƐ ?dǁŽŽĨ
the genes PET122 and RRF1 encode mitochondrial proteins, Pet122 is a mitochondrial 
translational activator that is specific for the COX3 mRNA (Naithani et al., 2003). Rrf1 is 
essential for mitochondrial translation and respiratory function as it is a mitochondrial 
ribosome recycling factor (Kanai et al., 1998; Teyssier et al., 2003). Rrn3 is required for 
transcription of rDNA by RNA polymerase I. Whi5 binds SCB (Swi4/6-dependent cell cycle box) 
binding factor at SCB target promoters in early G1 to repress G1 transcription, this repression 














Table 6.6 - Go-Slim mapped molecular function generated by the down-regulated 
microarray data set 















2 - 3.3% 53 - 0.8% 4.13 SSS1,SBH1 
signal transducer 
activity 
1 - 1.6% 39 - 0.6% 2.67 IZH4 
hydrolase activity, 
acting on glycosyl 
bonds 
1 - 1.6% 45 - 0.7% 2.29 PGU1 
protein binding, 
bridging 
1 - 1.6% 49 - 0.8% 2 ERG28 
enzyme binding 1 - 1.6% 55 - 0.9% 1.78 RRN3 
isomerase activity 1 - 1.6% 58 - 0.9% 1.78 PUS7 




2 - 3.3% 128 - 2.0% 1.65 RRN3,WHI5 
molecular function 
unknown 









61 genes that had a B-Stat greater than 1.5 were analysed and processes that were enriched, that is present 
at a higher frequency in the cluster than is found in the genome, are displayed here. Data is presented in 
enrichment order. 
 
The final term that the down-regulated genes were clustered by was cellular component (see 
table 6.7). Clustering by component resulted in four components that were enriched in our 
down-regulated gene set and a large group of 13 genes from unknown cellular components. 
Excluding the extracellular region which comprises of a single gene PGU1, the most enriched 
cellular component was the nucleolus. Similar to biological processes of the down-regulated 
genes (table 6.5) the majority of the genes that are categorised as nucleolar are related to 




ribosomal biogenesis and rRNA processing; RRP45, NOP16, NUG1, LOC1, RRT14, FCF2, FYV4, 
RMP1 and RPB10.  
Table 6.7 - Go-Slim mapped cellular component generated by the down-regulated 












Gene(s) Down regulated 
extracellular 
region 
1 - 1.6% 27 - 0.4% 4 PGU1 













7 - 11.5% 405 - 6.4% 1.8 RFT1,SSS1,ERG28,SBH1,VMA21,EMC5,COS10 
61 genes that had a B-Stat greater than 1.5 were analysed and processes that were enriched, that is present 
at a higher frequency in the cluster than is found in the genome, are displayed here. Data is presented in 
enrichment order. 
 
6.4.3 Transcription factor analysis using Yeastract 
Following interrogation of the microarray dataset using GO we then asked the question, was 
there a set of transcription factors up or down-regulated in the significantly altered genes 
that could induce the majority of the observed differences through transcriptional regulation. 
To perform this analysis we utilised an online tool called Yeastract (YEAst Search for 
Transcriptional Regulators And Consensus Tracking) (Teixeira et al., 2014). This is a curated 
database of more than 206,000 regulatory associations between transcription factors and 
target genes in S.cerevisiae.  
Data acquired from the GO analysis was utilised to elucidate transcription factors that 
regulated processes in the up and down-regulated data sets by inputting clusters from certain 




processes into the Yeastract site along with the up and down-regulated transcription factors 
from the microarray data set in the potential transcription factor field. We were then able to 
visualise the interaction network between transcription factors and regulated genes using the 
visualise network command on the Yeastract website. 
6.4.4.1 Regulatory transcription factors of carbohydrate processing 
As one of the largest clusters from the GO analysis, the 27 genes found to be up-regulated 
and involved in carbohydrate processing were analysed using Yeastract. This allowed us to 
visualise the interactions between specific transcription factors and the up-regulated genes 
that are involved in carbohydrate processing. First we compared the inhibitory transcription 
factors to the carbohydrate processing cluster. We took the top four inhibitory TFs and 
mapped a network with the cluster of genes from carbohydrate processing (see figures 6.6 a 
and b). Figure 6.6 a shows the inhibitory effect of Rpn4 (Regulatory Particle Non-ATPase) on 
the up-regulated genes involved in carbohydrate processing. RPN4 itself is found at slightly 
lower levels (approximately 4%) in the TEF1 overexpression strain, reinforcing its position as 
an inhibitory TF of these up-regulated genes. Rpn4 is known to stimulate expression of 
proteasome genes, and it in turn is regulated by the 26S proteasome by a negative feedback 
mechanism. Rpn4 levels are known to increase and it is known to translocate to the nucleus 
upon DNA replication stress (Xie and Varshavsky, 2001; Tkach et al., 2012). The second 
inhibitory TF that is shown (see figure 6.6 b) is Zap1 (Zinc-responsive Activator Protein 1). Zap1 
is a TF that binds to zinc-responsive promoters to induce transcription of genes in the 
presence of zinc (such as ADH5). Zap1 is also known to repress other genes in low zinc. Zap1 
was found at similar levels in the TEF1 overexpression strain. 





Figures 6.6, Network of inhibitory transcription factors and up-regulated genes involved in 
carbohydrate processing. Red lines and red nodes indicate what genes are regulated by the selected 
transcription factor, green lines and green nodes indicate if any other the other transcription factors in the 
network regulate the selected transcription factor. 6.6-a shows the regulatory network of Rpn4. 6.6-b shows 
the regulatory network of Zap1. 
 




Following analysis of the inhibitory TFs we analysed the activating TFs. We found that there 
were 18 enriched TFs that activated the up-regulated genes involved in carbohydrate 
processing (see figure 6.7). Of the eighteen TFs, seventeen were found to be transcribed at 
elevated levels in the TEF1 overexpression strain, with only WTM2 detected at lower levels in 
the microarray data set. The most prolific TF was Cbf1 this was found to activate 16 of the 23 
genes involved in carbohydrate processing as well as 4 of the other TFs in the network. Cbf1 
is required for chromosome segregation and is associated with kinetochore proteins (Cai and 
Davis, 1990). Cbf1 levels are known to increase in response to DNA replication stress (Tkach 
et al., 2012). 
Due to the quantity of significant, activating TFs a table containing a summary of their 
functions is presented below (see table 6.8). Upon analysis of the functions of all 18 TFs there 
is no single function that appears to be more prevalent than any other suggesting that up-









Figure 6.7, Network of activating transcription factors and up-regulated genes in carbohydrate 
processing. Red lines and red nodes indicate what genes are regulated by the selected transcription factor, 
green lines and green nodes indicate if any other the other transcription factors in the network regulate the 
selected transcription factor. This figure shows the regulatory network of Cbf1. 
 
Table 6.8 - Transcription factors that are involved in activating the carbohydrate processing 
cluster of genes 
Gene 
Name 
% increase of 




Helix-loop-helix protein that binds the motif CACRTG, 
which is present at several sites including MET gene 
promoters and centromere DNA element I (CDEI); 
required for nucleosome positioning at this motif; targets 
Isw1p to DNA 
CUP2 8 
Copper-binding transcription factor; activates 
transcription of the metallothionein genes CUP1-1 and 
CUP1-2 in response to elevated copper concentrations 





Forkhead family transcription factor with a minor role in 
the expression of G2/M phase genes; negatively 
regulates transcriptional elongation; positive role in 
chromatin silencing at HML and HMR; regulates donor 
preference during switching 
FLO8 2.8 
Transcription factor required for flocculation, diploid 
filamentous growth, and haploid invasive growth; 
genome reference strain S288C and most laboratory 
strains have a mutation in this gene 
HEL2 7.1 
Protein of unknown function that may interact with 
ribosomes, based on co-purification experiments;green 
fluorescent protein (GFP)-fusion protein localizes to the 
cytoplasm; contains a RING finger domain 
HOT1 3.2 
Transcription factor required for the transient induction 
of glycerol biosynthetic genes GPD1 and GPP2 in 
response to high osmolarity; targets Hog1p to 
osmostress responsive promoters; has similarity to 
Msn1p and Gcr1p 
MAC1 1 
Copper-sensing transcription factor involved in 
regulation of genes required for high affinity copper 
transport 
MGA2 5.5 
ER membrane protein involved in regulation of OLE1 
transcription, acts with homolog Spt23p; inactive ER 
form dimerizes and one subunit is then activated by 
ubiquitin/proteasome-dependent processing followed by 
nuclear targeting 
RDS1 4.5 
Zinc cluster protein involved in conferring resistance to 
cycloheximide 
RGM1 8.3 
Putative transcriptional repressor with proline-rich zinc 
fingers; overproduction impairs cell growth 
RLM1 16.1 
MADS-box transcription factor, component of the 
protein kinase C-mediated MAP kinase pathway involved 
in the maintenance of cell integrity; phosphorylated and 
activated by the MAP-kinase Slt2p 
RPI1 5.3 
Putative transcriptional regulator; overexpression 
suppresses the heat shock sensitivity of wild-type RAS2 
overexpression and also suppresses the cell lysis defect 
of an mpk1 mutation 
SKO1 6 
Basic leucine zipper (bZIP) transcription factor of the 
ATF/CREB family, forms a complex with Tup1p and Ssn6p 
to both activate and repress transcription; cytosolic and 
nuclear protein involved in osmotic and oxidative stress 
responses 
WTM2* <2.5 
Transcriptional repressor involved in regulation of 
meiosis and silencing; contains WD repeats 
YER130C 15.4 Hypothetical protein 





Putative zinc cluster protein; deletion confers sensitivity 
to Calcufluor white, and prevents growth on glycerol or 
lactate as sole carbon source 
YLR278C 9 an essential gene 
YPR196W 2 Putative maltose activator 
Genes are sorted by alphabetic order, alongside the change in expression level from wild type to TEF1 
overexpressing cells, and the protein description. 
 
6.4.4.2 Regulatory transcription factors of amino acid metabolism 
GO analysis revealed the amino acid metabolism process contained a cluster of 27 genes 
similar to that of carbohydrate processing. We processed these using Yeastract as described 
in section 6.4, allowing us to visualise the interactions between specific transcription factors 
and the up-regulated genes that are involved in amino acid metabolism. First we compared 
the inhibitory transcription factors to the amino acid metabolism cluster. This analysis 
revealed only two enriched inhibitory TFs, Leu3 and Met32, that are known to have an effect 
on the genes in the amino acid metabolism cluster (see figure 6.8). Leu3 is a zinc-knuckle, 
repressing and activating transcription factor. It is known to regulate genes involved in 
ammonia assimilation but also is a primary regulator of branched chain amino acid (BCAA) 
synthesis. In the presence of high levels of leucine it represses BCAA synthesis, with an 
accumulation of the leucine intermediary, alpha-isopropylmalic acid, causing Leu3 to act as 
an activator of BCAA synthesis (Baichwal et al., 1983; Friden and Schimmel, 1988; Sze et al., 
1992). LEU3 RNA levels were 10% higher in TEF1 overexpressing cells than wild type. Met32 
is a zinc-finger DNA-binding transcription factor that is involved in the transcriptional 
regulation of methionine biosynthetic genes (Blaiseau et al., 1997). MET32 RNA levels were 
at levels 4.5% higher in TEF1 overexpressing cells than wild type. 
 







Figure 6.8 Network of inhibitory transcription factors and up-regulated genes in amino acid 
metabolism. Red lines and red nodes indicate what genes are regulated by the selected transcription factor, 
green lines and green nodes indicate if any other the other transcription factors in the network regulate the 
selected transcription factor. This figure shows the regulatory network of Leu3. 
 
 
Following analysis of the TF that inhibited the transcription of the genes involved in amino 
acid metabolism, we next analysed the activating TFs. We found that there were three 
enriched TFs that regulated genes from the amino acid metabolism cluster, but, that they 
were only involved in the activation of 6 of the 27 genes from the cluster (see figure 6.9). The 
three TFs were Rgt2, Ssn3 and Sua7. Rgt2 is a plasma membrane, high glucose sensor involved 




in the induction of hexose transporters (Ozcan et al., 1996; Ozcan et al., 1998). Rgt2 RNA 
levels were 3.2% higher in the TEF1 overexpressing strain compared to the wild type. Ssn3 is 
involved in glucose repression, it is also a cyclin-dependent protein kinase involved in the 
phosphorylation of the RNA polymerase II C-terminal domain (Liao et al., 1995; Balciunas and 
Ronne, 1995). Ssn3 RNA levels were 3.7% lower in the TEF1 overexpressing strain compared 
to the wild type. Sua7 is an essential, general transcription factor that is required for 
transcription initiation and start site selection by RNA polymerase II (Pinto et al., 1992; Pinto 
et al., 1994). Sua7 RNA levels were 0.8% higher in the TEF1 overexpressing strain compared 
to the wild type. The six genes regulated by Rgt2, Ssn3 and Sua7 are MET17, HOM3, HIS4, 
CIT2, ARG4 and ARG7. Arg4 and Arg7 catalyse steps of the arginine biosynthesis pathway. 
Met17 is required for methionine and cysteine biosynthesis and His4 is catalyses steps 2, 3, 9 
and 10 of histidine biosynthesis. Hom3 is an aspartokinase that is known to catalyse the first 
step in the common biosynthesis pathway of threonine and methionine. Cit2 catalyses the 
condensation of acetyl coenzyme A and oxaloacetate to form citrate. Citrate is known to be 
the precursor to glutamine, glutamate, arginine, proline, and lysine.  
 





Figure 6.9, Network of inhibitory transcription factors and up-regulated genes in amino acid 
metabolism. Red lines and red nodes indicate what genes are regulated by the selected transcription factor, 
green lines and green nodes indicate if any other the other transcription factors in the network regulate the 
selected transcription factor. This figure shows the regulatory network of Ssn3 
. 
6.4.4.3 Regulatory transcription factors of ribosomal biosynthesis 
GO analysis revealed a cluster of 12 down-regulated genes involved in ribosomal biosynthesis. 
Using Yeastract we found that there are seven activating TFs that regulate this cluster at 
enriched levels in comparison to their genomic regulatory levels (see figure 6.10). The seven 
activating TFs were Aro80, Cup9, Esc2, Gal11,  Sds3, Taf14 and Thi2 (see table 6.9). There were 
no inhibitory TFs that were enriched for the gene cluster from ribosomal biosynthesis. 





Figure 6.10, Network of inhibitory transcription factors and up-regulated genes in amino acid 
metabolism. Red lines and red nodes indicate what genes are regulated by the selected transcription factor, 
green lines and green nodes indicate if any other the other transcription factors in the network regulate the 











Table 6.9 - Activating transcription factors which regulate the down-regulated genes of 
ribosomal biosynthesis. 
Gene name % increase in 
TEF1^ cells 
Description 
ARO80 4.1 Zinc finger transcriptional activator of the Zn2Cys6 family; 
activates transcription of aromatic amino acid catabolic 
genes in the presence of aromatic amino acids 
CUP9 8.4 Homeodomain-containing transcriptional repressor of 
PTR2, which encodes a major peptide transporter; 
imported peptides activate ubiquitin-dependent 
ESC2 1.9 Protein involved in mating-type locus silencing, interacts 
with Sir2p; probably functions to recruit or stabilize Sir 
proteins 
GAL11 8.3 Component of the Mediator complex; interacts with RNA 
polymerase II and the general transcription factors to form 
the RNA polymerase II holoenzyme; affects transcription 
by acting as target of activators and repressors 
SDS3 <3.3 Component of the Rpd3p/Sin3p deacetylase complex 
required for its structural integrity and catalytic activity, 
involved in transcriptional silencing and required for 
sporulation; cells defective in SDS3 display pleiotropic 
phenotypes 
TAF14 0.7 Subunit of TFIID, TFIIF, INO80, SWI/SNF, and NuA3 
complexes, involved in RNA polymerase II transcription 
initiation and in chromatin modification; contains a YEATS 
domain 
THI2 <0.1 Zinc finger protein of the Zn(II)2Cys6 type, probable 
transcriptional activator of thiamine biosynthetic genes 
 
6.5 Analysis of microarray data suggests that aneuploidy is not due to 
a chromosomal duplication 
Data presented in previous chapters suggest that overexpression of eEF1A induces 
aneuploidy phenotypes. We have utilised our microarray data, together with data previously 
published by Torres et al. (2007) to reveal that eEF1A overexpression does not result in a 
single chromosomal duplication event. 




As we have previously shown by FACS analysis and microscopy (section 4.2.2), overexpression 
of eEF1A results in cells with large, bright nuclei, and an increase in genomic content. We have 
hypothesised that this may be due to a relaxation of chromosomal condensation resulting in 
an increase in the uptake of PI and DAPI. 
However, analysis of our microarray data indicated that cells expressing elevated levels of 
eEF1A contained a disproportionate level of significantly up-regulated genes (319) to down-
regulated genes (61). Upon comparison of the entire microarray data set (see figure 6.11-b) 
it is clear that a large proportion of the genome is up-regulated in TEF1 overexpressing cells 
relative to wild type. Interestingly we do not see single chromosomal amplification as can be 
seen in figure 6.11-a, which was generated using data known to originate from a strain 
containing a duplication of chromosome IV (Torres et al., 2007). 
This demonstrates that almost the entire genome is amplified in the presence of elevated 









Figure 6.11, Mapping of gene expression levels relative to wild type cells. Ȃa shows amplification of 
chromosome IV generated from data from a study on aneuploidy yeast. b- shows levels of gene expression in 
TEF1 overexpressing cells, this shows that eEF1A levels do not result in entire chromosomal amplification, but 
that in fact, almost, the entire genome appears to be amplified. 
 
6.6 Discussion 
Using microarray analysis we have assessed whole cell transcription to verify the up or down-
regulation of entire cellular processes. We performed stringent statistical analysis to ensure 
that all the data pursued for interpretation were robust and as free from background noise 
as possible. Subsequent data interrogation was only performed on data that were statistically 
significant and that was enriched by at least 1.5 fold relative to its control. 
Data were initially ranked by the degree of change in expression level. This low level 
interrogation of the data revealed that cells overexpressing TEF1 up-regulated transcription 
of genes related to carbohydrate processing, and down-regulated genes involved in 
transcription and translation. The results of this preliminary analysis concurs with our earlier 
hypothesis (see section 3.4) that cells overexpressing TEF1 sense they are in a nutrient 
deprived environment and are starving. This response to starvation may trigger the cells to 




produce storage carbohydrates such as trehalose whilst simultaneously decreasing the rate 
of cell growth to conserve resources. 
GO analysis of the microarray data confirmed conclusions from the preliminary analysis that 
carbohydrate processing was increased, and transcription and translation were down-
regulated. The most enriched process from the up-regulated data set was carbohydrate 
transport, and carbohydrate processing was the largest process cluster containing 27 genes. 
Most of the up-regulated processes all appeared to be in relation to cells responding to a 
perceived decrease in available nutrients. Cells overexpressing TEF1 were observed to up-
regulate a range of processes involved in carbohydrate and amino acid biosynthesis and 
transport, and several processes that were responses to various stresses including heat stress 
and starvation. In contrast down-regulated processes that were elucidated by GO analysis 
included an array of processes essential for cell growth. The majority of the down-regulated 
processes were involved in transcription and translation suggesting cells sensed they lacked 
the available nutrients necessary for sustained growth. Comparison of the up and down-
regulated processes presents compelling evidence that the cells are either unable to utilise 
nutrients available to them, or that they are unable to sense that they are available to them. 
Analysis of the TFs involved in the regulation of the processes discussed revealed that cells 
were making a concerted effort to achieve the alterations observed. Most of the processes 
had several TFs with significantly altered transcription levels that resulted in large clusters of 
genes with increased or decreased transcription. Many of the transcription factors that had 
elevated transcription as measured by the microarray are known to increase in level in 
response to DNA replication stress. This response has been highlighted throughout this study 
and will be further discussed in Chapter 8. Regulation of amino acid biosynthesis by Leu3 was 




assigned by Yeastract as a repressive interaction. However, as discussed (see section 6.4.4.2), 
it is only in the presence of high levels of leucine that Leu3 acts as a repressor of branched 
chain amino acid synthesis. Interestingly, when in the presence of high levels of the leucine 
intermediate, alpha-isopropylmalic acid, Leu3 acts as an activator of BCAA synthesis, 
suggesting that Leu3 may not be having a repressive effect on the transcription of all the 
genes highlighted in figure 6.8.  




Chapter 7: Metabolome analysis of TEF1 
overexpressing cells 
  





Data from the previous chapters suggest that TEF1 overexpression in yeast results in 
alterations to cell growth due to a variety of effects of eEF1A overexpression. We have shown 
that elevated levels of eEF1A result in aberrant organisation of both the actin and tubulin 
cytoskeletons. Our data also illustrated that larger and brighter nuclei were observed upon 
eEF1A overexpression when visualised using propidium iodide suggesting that eEF1A 
overexpression leads to chromosomal abnormalities. We also observed that increased 
cellular respiration and decreased cell viability resulted from eEF1A overexpression. When 
grown in selective media cells suppress plasmid copy number and display reduced growth 
rate. However, upon addition of leucine to the media we observed rapid plasmid loss, 
suggesting that high levels of eEF1A are toxic to the cell. 
Analysis of the microarray data suggested that cells overexpressing TEF1 react as if they are 
starving. This may result from a lack of available nutrition or from defective signalling within 
the cell as a result of eEF1A overexpression. 
dŽĨƵƌƚŚĞƌĞǆƉůŽƌĞƚŚĞ “ĂƉƉĂƌĞŶƚ ƐƚĂƌǀŝŶŐ ?ƉŚĞŶŽƚǇƉĞǁe asked if cells actually had depleted 
levels of essential metabolites. To answer this we performed global metabolome analysis 
using NMR, which allowed us to visualise individual and global metabolite levels in both wild 
type and TEF1 overexpressing cells. Because the yeast vacuole is a major reservoir for 
nutrients, we also visualised the vacuole by fluorescence microscopy to check for vacuolar 
aberrations in the TEF1 overexpressing cells, which could result in the cells inability to access 
any nutrients that are stored inside. 
Metabolite profiling was performed using proton (1H) NMR spectroscopy and chemical shifts 
ranging from +14 to -4 ppm were assigned to produce a spectrum for each sample. A 




reference peak at 0 ppm was added to eaĐŚ ƐĂŵƉůĞ ďǇ ƚŚĞ ĂĚĚŝƚŝŽŶ ŽĨ  ? ? ʅD ^^  ? ? ? ?-
dimethyl-silapentane-1-sulfonic acid) after sample preparation, but before running through 
the NMR. Metabolite samples were dissolved in D2O allowing deuterium to exchange with 
the protons present in the OH peaks ensuring exchangeable hydrogens were removed from 
the spectra. All proton spectra presented were processed using excitation sculpting (Hwang 
and Shaka, 1995) in order to suppress the water peak at 4.3 ppm. Two dimensional (2D) 
proton and carbon NMR spectroscopy was performed on, one of each of the wild type and 
TEF1 overexpression samples (see figure 7.1-a and b). These allowed us to identify 
compounds using the methods described in section 7.3.2.1. One-dimensional (1D) proton 
NMR spectroscopy was then performed on all twelve samples allowing us to compare peak 
intensity across samples, and quantify metabolite levels (see figure 7.2) 





Figure 7.1, 2D 1H and 13C spectra for wild type cells. 7.2-a is the 2D proton spectrum and 7.2-b is the 2D 
carbon spectrum. These were overlaid with the TEF1 spectra to show differences in peak position, but also for 
identification purposes as described in section 7.3.2.1. The blue and green peaks represent positive (blue) and 
negative (green) intensity.






Figure 7.2, Alignment of 1D proton spectra for the wild type and TEF1 overexpression cells. There were six wild type samples (bottom) and six TEF1 overexpressing 
samples (top). The samples were processed so that the DSS peak at 0 ppm was aligned. 




7.2 Identification and assignment of metabolite peaks 
The 1D proton spectra were overlaid to check for differences in peak intensity, and the 
appearance or disappearance of peaks from the wild type to the TEF1 overexpression strain 
(see figure 7.3). Using figure 7.3 as an example we can see three different effects of TEF1 
overexpression on metabolite levels. To the left of the spectra there is a group of peaks that 
has shifted towards the higher end of the spectrum, overexpression of TEF1resulted in shifts 
to both the higher and the lower ends of the spectrum. The quintet in the centre of the 
spectrum shows a metabolite that has decreased in level in the TEF1 overexpression strain. 
Overall, TEF1 overexpression induced both increases and decreases in metabolite levels. The 
final example on the right of the spectrum shows a doublet present in the wild type sample, 
which disappears in the TEF1 overexpression strain. TEF1 overexpression also induced the 
appearance and disappearance of several peaks throughout the spectrum. 
 
Figure 7.3, wild type and TEF1 overexpression spectra overlaid. A single wild type (blue) and TEF1 
overexpression strain (red) have been overlaid. This figure only shows peaks from 1.3-2 ppm. The three points 
highlighted on the spectrum shows a group of peaks shift, a doublet that disappears in the TEF1 overexpression 
strain, and a quintet that is at lower abundance in the TEF1 overexpression strain than the wild type. The 
large blue peak at 1.9 ppm is from acetic acid, in the TEF1 overexpression strain this has shifted to the left just 
out of the image. 




7.2.1 Identification of altered peaks using AMIX 
The entire spectrum was processed using AMIX software which automatically detected 
differences in peak intensity between wild type and TEF1 overexpression cells across the 
entire data set, although it was unable to account for peaks that had shifted. The output from 
AMIX was a graphical output that showed increases or decreases in peak intensity in the TEF1 
overexpression strain relative to wild type cells. This output was manually compared to the 
wild type and TEF1 overexpression spectra to assess if peaks had altered in intensity or had 
shifted, it was then annotated accordingly (see figure 7.4, for entire loading comparison see 
appendix App.5a-e). 
 
Figure 7.4, Differences in peak intensity as detected by AMIX. The output from AMIX was compared to the 
spectra of wild type and TEF1 overexpression cells to assess whether intensity differences were due to altered 
metabolite levels or to peak shifts. These were annotated using coloured boxes, green boxes indicate peaks 
that are of a different intensity, red boxes indicate peaks that have shifted from wild type to TEF1 
overexpression cells, and orange boxes indicate peaks that have both shifted and altered in intensity. 
 




7.2.2 Assignment of metabolites 
Following identification of peaks that were altered from the wild type to the TEF1 
overexpression samples we had to assign peaks to metabolites. As this is a fledgling technique 
online repositories were sparsely populated with standard metabolites, and the majority of 
assignments were made by utilising a variety of sources.  
7.2.2.1 Tools for metabolite assignment 
The primary tools for metabolite assignment were online databases consisting of previously 
analysed metabolites. These were useful in identifying potential metabolites of interest, but 
analysis using such databases appeared to be prone to error and misidentification. The first 
database was the Madison Metabolomics Consortium Database (MMCD) 
(http://mmcd.nmrfam.wisc.edu/). Using this website we were able to search by compound 
name, if we had a tentative idea of the metabolite, or we could search by peak shift (ppm) 
and the database would generate a list of potential metabolites based on their proximity to 
the peak shifts we had submitted. The second database that we utilised was the Yeast 
Metabolome Database (YMDB) (www.ymdb.ca). This database was not as comprehensive as 
the MMCD, but it had several metabolites that we were unable to find using MMCD. The final 
database utilised was the mining tool, Metabominer 
(http://wishart.biology.ualberta.ca/metabominer/). This was an executable package rather 
than accessed online and allowed interrogation of all of the peaks within a single spectrum. 
The peak list was input into the software and it attempted to find peaks in patterns that were 
comparable to metabolites contained in its database. It then generated a list of potential 
candidates allowing us to highlight peaks of interest (see figure 7.5). 





Figure 7.5, An overview of metabominer. This shows the 2D proton spectrum of the wild type sample (blue 
dots). The list to the right is of potential metabolites present in the sample. Highlighted in red are the peaks 
that the software has predicted correlate to histidine. 
 
We also utilised the NMR prediction software ACD Predictor 
(http://www.acdlabs.com/products/adh/nmr/nmr_pred/). This allowed us to draw chemical 
structures of metabolites that we thought we may have discovered in a spectrum. The 
software then generated a predicted peak shift list as well as drawing the predicted spectrum 
(see figure 7.6). Although a powerful tool its major drawback was that this was all based on 
prediction, rather than acquired data, and it occasionally made errors. 
 





Figure 7.6, Output from ACD NMR predictor. This shows the predicated peak shifts for valine along with the 
origin of each peak on the chemical structure. The table to the lower right lists the shifts along with the 
confidence limts. 
 
The next tool used for peak assignment was CcpNmr Analysis 
(http://www.ccpn.ac.uk/software/analysis). CcpNmr is a graphics-based program which 
allows NMR spectrum visualisation, resonance assignment and data analysis. This software 
was utilised to visualise both the 1D and 2D spectra simultaneously. This allowed us to pick 
peaks from the 1D spectrum that had been highlighted by the AMIX analysis and find them in 
the 2D spectrum. The 2D spectrum was generated using Total Correlation Spectroscopy 
(TOCSY) which is a method for, in theory, correlating all of the spins in a set of mutually 
coupled spins, allowing identification of an entire set of resonances from a single metabolite. 




Once a peak from the 1D spectrum had been identified in the 2D spectrum we could then 
identify other peaks coupled to this peak allowing us to decipher the structure of the 
unknown metabolite (see figure 7.7). Coupling of peaks using the 2D spectrum was performed 
by tracing a vertical, or horizontal line from the initially identified peak (number 1 in figure 
7.7), once another peak is encountered (peak 2) a horizontal line was traced back to the 
diagonal revealing the peak at 1.39 ppm (peak 3) is coupled to the peak at 4.35 ppm (peak 1). 
The process is repeated until no more peaks can be coupled together. In this example only 
the peak at 8.25 ppm (peak 5) can be coupled via peak 4. It is possible that a peak may also 
exist between peaks 2 and 4 (shown in red) although depending on the abundance of the 
metabolite and the sensitivity of the machine this may not be present. 
 
Figure 7.7, Demonstration of coupled peak shifts using alanine. How peak assignment is performed using 
the 2D spectra. This shows the proton peak shifts of the ɲ and ɴ carbons together with the protons of the amine 
group. In order to identify these as peaks from a single compound we had to use the CCPNMR software to draw 
horizontal and vertical lines from each peak allowing us to visualise proton coupling. 
 




7.3 Metabolite identification and quantification 
Following identification of peaks that were different between the wild type and TEF1 
overexpression strain, and by utilising all the tools at our disposal to reliably identify as many 
metabolites as possible, we had confidently assigned 19 metabolites (see table 7.1 and figure 
7.8), and made a further 15 tentative assignments (see appendix App.6). Confident 
assignments were those that showed consensus across multiple tools used for assignment, 
tentative assignments were those that displayed conflict using multiple tools. The majority of 
metabolites identified were amino acids, with several other metabolites identified. 
Table 7.1 - Metabolite assignments 
Metabolite Peaks Identified (ppm in wild type) 
3-hydroxycinnamic acid 6.86, 7.16, 7.3 
Acetic acid 1.9 
Alanine 3.75 
AMP/ATP 6.12 
Arginine 1.83, 3.22 
Aspartate 2.64, 2.79, 3.87 
Glutamate 3.71 
Isoleucine 0.92, 0.99, 1.29, 1.43 
Isopropylmalic acid 0.84, 0.89 
Leucine 0.94, 0.95, 1.69 
Lysine 1.45, 3.01 
NADH 2.9 
NAD/NADP 6.03, 6.07, 8.18, 8.54, 8.83, 9.15, 9.32 
Threonine 1.3 
Trehalose 5.18 
Tryptophan 3.54, 3.64 
Valine 0.97, 1.02, 2.33 
A list of the 19 confident metabolite assignments made from the NMR spectra. 





Figure 7.8, Aligned spectra with metabolite annotations. The total spectra for wild type and TEF1 overexpressing cells with annotations for known metabolites. 




7.3.1 Metabolite quantification and generation of a small compound library 
Following assignment of metabolites that we were confident with, we then aimed to quantify 
them. This required that we identified unique peaks for each metabolite, and that we know 
how many protons were represented by each peak. We used Bruker TopSpin data analysis 
software for each sample. This software allowed the interrogation of data at high resolution 
facilitating the identification of peaks from one metabolite that may be overlaid with peaks 
from another metabolite. 
With the ability to visualise spectra at high resolution there were still problems identifying 
peaks in crowded regions. One region of particular interest, 0.9-1.0 ppm, contained peaks 
ĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽƚŚĞɷĂŶĚɶĐĂƌďŽŶƐŽĨƚŚĞďƌĂŶĐŚĞĚĐŚĂŝŶĂŵŝŶŽĂĐŝĚƐůĞƵĐŝŶĞ ?ŝƐŽůĞƵĐŝŶĞ
and valine. As previously discussed the addition of leucine to media rescued the viability and 
growth defects observed in yeast when TEF1 was overexpressed. Also, Leu3 was discussed as 
a regulatory transcription factor of the up-regulated genes involved in BCAA biosynthesis. 
Leu3 is known to act as a repressor in leucine rich environments and an activator in high levels 
of the leucine biosynthesis intermediate isopropylmalic acid (also assigned in the NMR 
spectra). This led us to ask the following three questions. If levels of isopropylmalic acid or 
levels of leucine were affecting Leu3, was it acting as an activator or a repressor? Also if we 
were able to identify altered levels of leucine in the TEF1 overexpressing cells, was it higher? 
And if leucine was higher, how did leucine supplementation rescue the phenotypes previously 
mentioned? 
To assist in finding peaks unique to leucine we began to generate a metabolite database. We 
prepared samples of leucine, isoleucine and valine to analyse using NMR (see figure 7.9). This 
gave us standards that allowed us to compare to our spectra simply by overlaying the 




spectrum of the known amino acid with the spectrum containing the unknown peaks. This 
method proved to be very efficient and so we expanded the metabolite database to include 
all amino acids as well as some other metabolic compounds of interest (see figure 7.10 for an 
example of an overlay using this method). A list of metabolite standards generated for use in 
this study can be found in the Appendix 7). Utilising the metabolite database we were able to 
identify unique peaks for 12 of the 19 certain assignments we had made (see table 7.2). 
Figure 7.9, Isoleucine, leucine and valine standards. Isoleucine, leucine and valine samples were prepared 
and mixed at 80 µM, 20 µM and 40 µM respectively. This facilitated identification of unique peaks. The peaks 
      Ɂ ?       
purposes. The leucine peaks are two sets of doublets overlaid in a triplet arrangement, and the left peak of the 
Ɂ ?Ǥ 





Figure 7.10, Aspartate standard laid over a wild type spectrum. The wild type spectrum is shown in blue, 
with the aspartate standard overlaid (the red spectrum). The boxed window shows the DSS zero for each 
sample, these are not overlaid as the environment of the sample preparations differed resulting in a shift of 








Table 7.2 - Unique peaks that allowed metabolite quantification 
Metabolite Peak Shift Number of peaks used for 
quantification 
Isopropylmalic acid 0.842 2 
Isoleucine 0.925 3 
Leucine 0.946 1 
Valine 0.974 2 
Threonine 1.302 2 
Alanine 1.459 2 
Acetic acid 1.9 1 
Glutamate 2.33 6 
Aspartate 2.797 4 
NADH 2.906 3 
Lysine 3.006 3 
Trehalose 5.183 2 
 
To calculate metabolite concentration we used the DSS peak at 0 ppm which provided us with 
a peak of known concentration  ? ? ?ʅD ?. We compared the DSS peak intensity to the intensity 
of the unique peaks of the other metabolites and using the equation described in the 
Materials and methods (section 2.5.4.5) we were able to express metabolite levels as a molar 
concentration(see figure 7.11). Reassuringly there were some metabolites that were up-
regulated and some that were down-regulated in the TEF1 overexpression strain indicating 
ƚŚĂƚ ƚŚĞ ĞǆƚƌĂĐƚŝŽŶ ƉƌŽĐĞƐƐ ǁĂƐ ĞĨĨĞĐƚŝǀĞ ŝŶ ďŽƚŚ ƐƚƌĂŝŶƐ ĂŶĚ ǁĞ ŚĂĚŶ ?ƚ ůŝďĞƌĂƚĞĚ Ă
disproportionate level of metabolites from one strain relative to the other. Metabolites we 
found at significantly increased levels in the TEF1 overexpression strain were alanine, valine, 
the leucine biosynthesis intermediary isopropylmalic acid, and trehalose. NADH was the only 
metabolite identified that had significantly decreased levels in the TEF1 overexpression strain. 





Figure 7.11, Metabolite concentrations in wild type and TEF1 overexpression strains. Metabolite 
concentration was calculated per sample, with each sample containing approximately 1.54 x 108 
cells.*=p<0.05, **=p<0.01,***=p<0.001. 
 
7.3.1.1 eEF1A levels affect levels of amino acids 
All branched chain amino acids exhibited a large increase in their levels in the TEF1 
overexpression cells. Leucine showed a 35.2% increase, valine showed a 55.3% increase, 
isoleucine showed a 38.6% increase, and the leucine intermediate isopropylmalic acid showed 
a 55% increase. As well as these increases, an increase was also detected in alanine of 19.2%. 
It is known that leucine, isoleucine, valine and alanine are all derived from pyruvate (see figure 




7.12). Unfortunately we were unable to confidently identify pyruvate using NMR and so are 
unable to provide an estimate of pyruvate levels in the cell. We were able to identify and 
quantify threonine, a precursor to isoleucine found at 38.6% higher in TEF1 overexpressing 
cells, which was found to be present at levels 7% lower in TEF1 overexpressing cells than wild 
type suggesting that accumulation of the BCAAs is not due to a reduced need for them, but 
rather a concerted global effort to increase levels. When taken together with the microarray 
data analysis that ranked amino acid biosynthesis as one of the most increased processes in 
cells overexpressing TEF1 (see sections 6.9 and 6.10), this strengthens the argument for TEF1 
levels affecting cellular metabolism. 
 
Figure 7.12, Pyruvate family.  Biosynthesis pathway for pyruvate derivatives alanine, and the branched 
chain amino acids leucine, isoleucine and valine. 
 




Furthermore increased levels of isopropylmalic acid (the leucine biosynthesis intermediate) 
suggest that Leu3 (discussed in 6.4.2.2) may not be acting as an inhibitor BCAA biosynthesis 
as discussed, but in fact be acting as an activator. Leu3 is known to act as a regulator of genes 
involved in BCAA biosynthesis (Friden and Schimmel, 1988). It acts as a repressor in leucine 
rich environments and an activator in isopropylmalic acid rich environments (Sze et al., 1992). 
As both leucine and isopropylmalic acid are increased it is unclear how Leu3 is acting in TEF1 
overexpressing cells, but as all BCAAs are increased it is logical to assume that Leu3 is likely to 
be acting as an activator of BCAA biosynthesis. 
7.3.1.2 eEF1A levels affect levels of the storage carbohydrate trehalose 
Trehalose is found in TEF1 overexpressing cells at levels almost three-fold higher than in wild 
type (Fig 7.11). As previously discussed (see section 3.4), TEF1 overexpressing cells exhibited 
a starvation phenotype with up-regulation of several processes involved in metabolite 
biosynthesis. The disaccharide trehalose is canonically described as a storage carbohydrate, 
readily available when cells require a carbohydrate source upon recommencing growth. It is 
also known as a protectant against desiccation and heat shock in yeast (Singer and Lindquist, 
1998). How trehalose protects against these stresses is not fully understood, but it is thought 
that it protects cells by stabilising proteins in their native state, preventing denaturation. It is 
also thought to suppress aggregation of denatured proteins in a similar manner (Singer and 
Lindquist, 1998). 
Trehalose accumulation has also been recorded in cells with retarded growth, and it is 
thought that duration of the G1 phase may influence the rate of trehalose accumulation 
(Paalman et al., 2003). We have observed a reduction in growth rate of approximately 20% in 
cells overexpressing TEF1 (see fig. 3.4), and an increase in cell volume of a similar quantity. 




Although cell cycle analysis was not performed during this study, the increased cell size 
observed upon the overexpression of TEF1 suggests that cells with elevated levels of eEF1A 
may possess a cell cycle with an extended G1 phase. However, given the data presented in 
this thesis suggesting that cells overexpressing TEF1 are responding to starvation, the likely 
explanation for trehalose accumulation is that cells are simply responding to a lack of 
accessible nutrients. 
Due to the observable in increase in the level of BCAAs, including leucine, upon 
overexpression of TEF1, the question arose of how leucine supplementation alleviates 
phenotypes that are induced in the presence of elevated levels of eEF1A (see section 3.2). If 
cells overexpressing TEF1 already have increased levels of leucine compared to wild type, how 
can adding leucine rescue these phenotypes? Were cells sequestering leucine in defective 
vacuoles rendering it inaccessible, or was leucine present in the cytoplasm and cells were 
unable to detect it.  
7.4 The effects of TEF1 overexpression on vacuoles 
To answer the question of whether cells contained inaccessible leucine within defective 
vacuoles we performed fluorescence microscopy, and took a preliminary look at metabolite 
levels from isolated vacuoles. 
7.4.1 TEF1 overexpression causes vacuolar aberrations 
Observation of wild type and TEF1 overexpressing cells by fluorescence microscopy using the 
fluorescent vacuolar dye Blue CMAC (7-amino-4-chloromethylcoumarin) and the vacuole 
localised Gtr2-GFP revealed that TEF1 overexpression resulted in severe vacuolar aberrations 
(see figure 7.13). Wild type Gtr2-GFP cells presented a homogenous distribution of both GFP 
and DAPI signals throughout the vacuole, containing one to two large spherical vacuoles per 




cell. Upon overexpression of TEF1 we observed fragmentation of vacuoles, with translocation 
of Gtr2 to the vacuolar membrane, blue CMAC also appeared limited in its ability to enter the 
cells. This suggested that elevated eEF1A levels were having a negative effect on vacuoles 
resulting in the inability of small compounds to enter and exit.  
 
Figure 7.13, Fluorescence microscopy of Gtr2-GFP and TEF1 overexpression stained with Blue CMAC. 
Upon TEF1 overexpression the vacuoles fragment, Gtr2 migrates to the vacuolar membrane and Blue CMAC 
appears unable to enter the vacuole. Cell boundary is in yellow and vacuoles are highlighted by arrows. 
 
7.4.2. TEF1 overexpression results in high quantities of metabolites 
accumulating in the vacuole 
Analysis of the vacuole by fluorescence microscopy demonstrated that overexpression of 
TEF1 resulted in aberrant vacuoles that were unable to take up the dye Blue CMAC (Fig 7.13). 
This led us to ask if the increased levels of detectable metabolites in TEF1 overexpressing cells 
was due to an accumulation of inaccessible metabolites in defective vacuoles. To answer this 
we performed vacuole isolations followed by metabolite extractions on the vacuolar fraction 
(see Materials and methods 2.5.4.2). 




Due to the fact that we were only analysing metabolite levels isolated from the vacuoles, we 
harvested six times more cells for the vacuolar metabolite samples to facilitate ease of 
detection using NMR. As this was a preliminary experiment to check the efficacy of the 
protocol there were only single samples run for both the wild type and the TEF1 
overexpression strains. 
A comparison of the spectra from the vacuolar metabolite preparations and the whole cell 
extract showed that were significant differences in the observable peaks (see figure 7.14) (For 
the entire vacuolar spectra and comparison to the whole cell extraction see appendix App.8a-
e). The peaks that we had assigned to isopropylmalic acid were no longer detectable in the 
wild type sample, and were very low in the TEF1 overexpression sample. There were other 
differences across the spectra in both assigned and unassigned metabolites. We were still 
able to detect trehalose in both of the vacuolar extractions (see figure 7.15) suggesting that 
the cells were attempting to suppress its levels by degradation using the vacuolar trehalase 
Ath1. It was anticipated that trehalose would be present at lower levels in the vacuole as the 
glycoside hydrolase enzyme, trehalase localises to the vacuole (Keller et al., 1982) and can 
catalyse the conversion of trehalose to glucose.






Figure 7.14, Alignment of wild type and TEF1 overexpression whole cell and vacuolar metabolite preparations. Samples have been aligned at 0 ppm and spectra 
are displayed showing 0-2 ppm. Highlighted is the difference in isopropylmalic acid levels between the whole cell and the vacuolar metabolite preparations. 
 






Figure 7.15, Alignment of wild type and TEF1 overexpression whole cell and vacuolar metabolite preparations. Samples have been aligned at 0 ppm (inset) and 
spectra are displayed showing 5.05-5.25 ppm. Trehalose has been highlighted to show that it was still detectable in the vacuolar metabolite preparation. Although 
trehalose peaks from the vacuolar extract appear greater in intensity than the whole cell extract this is due to metabolites being extracted from six times more cells. When 
quantified this is corrected for.




Similar to the whole cell metabolite extracts we performed quantification on the vacuolar 
metabolites that we had identified unique peaks for, but as these were only performed as 
single experiments no statistical analyses could be performed to ensure the significance of 
the data (see figure 7.16). 
Analysis of the branched chain amino acids showed that in the vacuole, leucine, isoleucine 
and isopropylmalic acid were present at lower levels in the TEF1 overexpression strain relative 
to the wild type. Leucine levels decreased by 9.1%, isoleucine levels dropped by 32.5%, and 
isopropylmalic acid was undetectable in wild type vacuoles, but still present at 18.96 
ʅŵŽůĞƐ ? ? ? ? ? ǆ  ? ?8 cells in TEF1 overexpression cells. Valine levels increased in the TEF1 
overexpression strain by 25.1%. Threonine showed a 23.2% decrease in levels in the TEF1 
overexpression strain. Alanine, glutamate and lysine showed no difference in levels between 
wild type and TEF1 overexpression cells. Similar to the global metabolome analysis, trehalose 
showed the largest difference with a 246% increase in TEF1 overexpression cells. 
 
 





Figure 7.16, Vacuolar metabolite concentrations in wild type and TEF1 overexpression strains. 




Following indications that elevated levels of TEF1 affect cell metabolism we utilised NMR 
spectroscopy to analyse metabolite levels in wild type and TEF1 overexpression cells. 
Although still in the development stages this method showed promise in its ability to provide 
us with high resolution details about the metabolic flux of the cell in the presence of 
endogenous and elevated levels of eEF1A. Together with the transcriptome data from chapter 
6, this method had the potential to provide data for entire pathways allowing us to visualise 
the precise points in biosynthetic pathways that are influenced by elevated levels of eEF1A. 
Whole cell metabolite concentrations concurred with transcriptome data and indicated that 
cells overexpressing TEF1 are up-regulating metabolite biosynthesis in response to perceived 




starvation (merging of these data will be discussed further in the final chapter). The majority 
of the quantified metabolites were present at elevated concentrations in the TEF1 
overexpression strain relative to the wild type, with only acetic acid and NADH showing a 
decrease in levels. 
The presence of leucine at elevated levels posed the question ?  “,ow could leucine 
supplementation rescue phenotypes caused by TEF1 overexpression if leucine is already 
available in abunĚĂŶĐĞƌĞůĂƚŝǀĞƚŽƚŚĞǁŝůĚƚǇƉĞ ? ? We hypothesised that TEF1 overexpression 
resulted in leucine accumulation in the vacuole and that, for an as yet unexplained reason, 
the cell was unable to access it. Using fluorescence microscopy we revealed that TEF1 
overexpression results in vacuole fragmentation and membrane aberrations that prevent the 
vacuolar dye Blue-CMAC entering (Fig 7.13). It seems that these vacuolar defects also 
prevented the cells from accessing any of the metabolites that were sequestered within the 
vacuole as our preliminary analysis of metabolite levels within the vacuole revealed that most 
metabolites were present at elevated levels in cells overexpressing TEF1 (Fig 7.16). 
Further evidence that cells with elevated levels of eEF1A were responding to starvation came 
from the significant increase in trehalose and isopropylmalic acid levels. In both the whole 
cell extractions and the vacuolar extraction, cells overexpressing TEF1 resulted in levels of 
trehalose more than 250% higher than wild type. As discussed trehalose is known to perform 
a variety of roles in the cell (see section 7.3.1.2), but its primary role is a storage carbohydrate 
that is produced upon depletion of glucose in the environment. This suggests that cells are 
unable to sense or utilise the glucose available to them and so are implementing measures to 
commence growth when more favourable conditions are encountered. Furthermore, 
elevated levels of isopropylmalic acid correlated with the transcriptome analysis suggesting 




cells were increasing the rate of BCAA synthesis. An increase in the rate of BCAA synthesis 
again correlates with the cells inability sense or access nutrients that are readily available to 
them.  
We have presented data that implicates elevated levels of eEF1A in the generation of 
defective vacuoles. These defective vacuoles appear to contain levels of many amino acids at 
higher levels than wild type vacuoles, yet cells with increased TEF1 expression are unable to 
utilise them. We propose that metabolites that are contained within these defective vacuoles 
are completely inaccessible to the cell, as demonstrated by the inability of Blue-CMAC to 
enter the vacuole. Because of this metabolite deprivation, cells respond by attempting to 
increase amino acid and carbohydrate production. However, these attempts at recovering 
metabolite levels appear to be in vain as only upon the supplementation of leucine to the 
media did we observe a detectable rescue in growth rate (see section 3.2.2).




Chapter 8: Final Discussion  




Although its canonical role in translation elongation is well characterised, the moonlighting 
functions of eEF1A are yet to be fully understood. As one of the most abundant proteins in 
the cell, accounting for between 3 and 10 % of all soluble proteins, understanding the 
additional roles that eEF1A performs in the cell is essential. It is known that overexpression 
of the human isoform, eEF1A2, induces tumour growth making understanding the 
interactions of this highly conserved protein necessary. 
During this study we sought to utilise the highly amenable budding yeast S. cerevisiae, to 
elucidate novel interactions and pathways that eEF1A may be involved in. We have used both 
classical phenotypic analysis, and modern, global, transcriptome and metabolome analysis to 
describe putative interactions between eEF1A and other essential cellular components, as 
well as characterising alterations in metabolic pathways in response to elevated levels of 
eEF1A. Furthermore we characterised eEF1A2 overexpression in HEK293 cells to observe if 
any interactions observed in yeast were conserved through to humans. The results of these 
experiments are discussed below. 
8.1 eEF1A overexpression causes spindle defects resulting in DNA 
replication stress 
Previous studies on TEF1 overexpression in yeast revealed that elevated levels of eEF1A 
resulted in cytoskeletal aberrations and slowed growth (Munshi et al., 2001). It was 
demonstrated that eEF1A was able to bundle actin and that point mutations in eEF1A could 
inhibit its ability to do this, in some cases simultaneously rescuing any growth defects 
observed (Gross and Kinzy, 2005). 
To further investigate the interaction between eEF1A and actin we utilised an array of strains 
deleted for genes known to interact with or control the function of actin. Overexpression of 




TEF1 in these deletion strains was assessed by its effect on growth rate and it was recognised 
that components of the dynactin complex demonstrated enriched synthetic interaction with 
eEF1A when assessed using this method (see figure 4.3 a-c). Further investigation into the 
interactions between the dynactin complex and eEF1A revealed that upon deletion of ARP1, 
the backbone of the dynactin complex, we saw a rescue of the spindle defect observed in 
TEF1 overexpression strains (see figure 4.6 a-d). However, although the ȴĂƌƉ ? strain rescued 
the spindle defect, we still observed chromosomal instability as highlighted by the peak shifts 
in the FACS analysis of DNA content (see figure 4.4 a-l).  
We also observed that, when visualised by fluorescence microscopy, the TUB4-GFP strain 
exhibited brighter spindle pole bodies in the TEF1 overexpression strain relative the wild type. 
Tub4 protein abundance is known to increase in response to DNA replication stress (Tkach et 
al., 2012). It is possible that the effects of eEF1A overexpression on spindle organisation, and 
chromosomal segregation has the potential to activate stress response pathways in an 
attempt to recover from this defect. 
Further evidence that cells were responding to DNA replication stress exerted by elevated 
levels of TEF1 came from the transcription factor analysis of the microarray data (see section 
6.4.3). We found that the transcription factor Cbf1, known to activate carbohydrate 
processing, including trehalose storage, was present at elevated levels in our microarray data. 
Cbf1 is also known to be required for proper chromosome segregation (Cai and Davis, 1990). 
As TEF1 overexpressing cells contain elevated levels of Cbf1 this suggests that cells are indeed 
responding to DNA replication stress.  




8.2 eEF1A toxicity causes suppression of plasmid copy number 
resulting in cell starvation 
The chromosomal abnormalities, together with cells entering quiescence appear to result in 
a toxic effect on cells overexpressing TEF1. We have found that cells with elevated levels of 
eEF1A have a reduced viability, and that they express high levels of plasmid loss usually 
associated with plasmid toxicity.  
As previously described (see section 3.4) we suggest that the TEF1 overexpression was toxic 
to yeast cells. In agreement with this hypothesis our studies revealed that when grown in 
selective, -leu media, cells containing a cŽŶƐƚŝƚƵƚŝǀĞůǇ ĞǆƉƌĞƐƐĞĚ ?  ?ʅ ?LEU2::TEF1 plasmid 
stably over-expressed, low levels of eEF1A and the LEU2 plasmid throughout growth, from 
lag, to log, and finally stationary phase, as detected by western blotting and qPCR. However, 
in non-selective, leucine rich media, the absence of any selective pressure in favour of the 
LEU2 plasmid resulted in rapid selection against the TEF1 overexpression plasmid with levels 
decreasing to one fifth of those grown in selective media. These data suggest that in the 
absence of leucine, cells containing the TEF1 overexpression plasmid are required to precisely 
balance a need for the LEU2 gene on the plasmid with the toxicity conferred by the elevated 
levels of TEF1 also encoded for on the plasmid. Furthermore accumulation of the leucine 
biosynthesis intermediate, isopropylmalic acid, suggests that cells are not producing sufficient 
3-isopropylmalate dehydrogenase (LEU2) resulting in a bottle neck in the synthesis pathway. 
Our data suggest that TEF1 toxicity is strong enough to induce selective plasmid loss in cells 
grown in media containing leucine, and that cells grown in media without leucine appear to 
suppress plasmid copy number as low as possible to reduce the toxic effects of increased 
levels of eEF1A. We also observed the control plasmid present at significantly higher levels, 




suggesting that the copy number of the TEF1 overexpression plasmid may not be maintained 
at levels high enough to synthesise levels of leucine sufficient for normal cell growth (see 
figure 8.1). In section 8.3 we will discuss the data we have presented that suggest that cells 
overexpressing TEF1 sense they are starving and, in response, activate amino acid 
biosynthesis. 
 
Figure 8.1, Demonstration of plasmid copy number levels with TEF1 acting as an active suppressor of 
plasmid copy number. This is to demonstrate the suppressive effect of TEF1 overexpression on plasmid copy 
number. Wild type cells containing the control plasmid are subject to random plasmid segregation, because 
there is no selective pressure against the plasmid, plasmid copy number varies greatly because plasmid loss is 
random. Because elevated levels of TEF1 are toxic to the cell there is a strong selective pressure against it. In 
cells that are grown in media lacking leucine they must balance the toxic effects of TEF1 with the minimal 
level of the plasmid required to encode LEU2 (represented by the green line). In TEF1 overexpressing cells 
grown in media containing leucine, the LEU2 gene on the plasmid is no longer required for leucine synthesis 
and so the only selective pressure on the plasmid is the negative pressure of TEF1 overexpression.  The green 
line represents the minimum plasmid copy number that cells need to maintain in order to grow in a leucine 
deplete environment. The red line represents the suppressive effect the elevated levels of TEF1 has on the cell, 
and the high levels of plasmid loss that are associated with the toxicity. Values are arbitrary and not 
representative of actual plasmid copy number. 
 
Further evidence of amino acid deprivation is the accumulation of trehalose observed in the 
TEF1 overexpression strains. Trehalose is a disaccharide storage carbohydrate that is readily 
broken down upon encountering favourable growth conditions allowing cells to rapidly re-
commence growth. We have shown that trehalose levels in cells overexpressing TEF1 are 
almost three-fold higher than in wild type, and that transcriptome levels of the trehalose 
synthase complex are also higher in these cells (see figure 8.2). 




Interestingly, interrogation of the microarray data also revealed that both NTH1 and ATH1 
transcripts were present at elevated levels, 13 % and 11 % compared to the wild type 
respectively, in TEF1 overexpressing cells. Both Nth1 and Ath1 are known to degrade 
trehalose. Nth1 (neutral trehalase) degrades cytoplasmic trehalose at a pH optimum of 
around 7.0, whilst Ath1 (acid trehalase) is required for degradation of vacuolar trehalose with 
a pH optimum around 4.5 (Destruelle et al., 1995; Zähringer et al., 1997).  
It is possible that, because we see an increase in trehalose degradation, as well as trehalose 
accumulation in TEF1 overexpressing cells, trehalose synthesis is a by-product of up-
regulation of Cbf1. Cbf1 is the transcription factor known to up-regulate trehalose 
biosynthesis that is also known to increase in abundance due to DNA replication stress (Tkach 
et al., 2012). However, together with other metabolite and transcriptome data discussed 
here, we suggest that the accumulation is likely to be the result of both direct effects of eEF1A 
on DNA replication, and of the toxic effects of this stress resulting in low LEU2 plasmid copy 
number. 
 
Figure 8.2, Trehalose biosynthesis pathway. This shows the biosynthesis pathway of trehalose with 
alterations in metabolite and transcript level as detected by analysis of the microarray and NMR spectroscopy. 
Boxes in grey represent metabolites of unknown concentration. *Trehalose was actually detected at 295% 
higher in TEF1 overexpressing cells. 
 




8.3 eEF1A overexpressing cells respond to starvation through 
increasing amino acid biosynthesis. 
As discussed (see section 3.4) TEF1 overexpression induces toxic effects on cells, such as, 
chromosomal instability and DNA replication stress, exerted by eEF1A ?s interactions with the 
dynactin complex. We have already discussed (see section 3.3.2) that toxicity resulting from 
the TEF1 overexpression plasmid appears to suppress plasmid copy numbers to levels so low 
that the leucine protrophy also encoded for by the plasmid may not be able to supply leucine 
at levels sufficient to support healthy cell growth. Here we discuss the evidence that cells 
overexpressing TEF1 sense this as leucine starvation and increase branched amino acid 
biosynthesis to compensate. 
Microarray and NMR data from chapters 6 and 7, suggest that cells overexpressing TEF1 are 
up-regulating an array of biosynthesis pathways to facilitate normal growth, in the presence 
of elevated levels of eEF1A. One pathway of particular interest was the biosynthesis of 
branched chain amino acids (BCAA). During the transcriptome and metabolome analysis of 
cells overexpressing TEF1, we found that all genes involved in BCAA biosynthesis were up-
regulated as well as all down-stream metabolites, with the only metabolite in BCAA 
biosynthesis detected at lower levels being threonine. Threonine yields the isoleucine 
precursor 2-ketobutyrate through deamination, so lower levels correlate with increased 
synthesis of isoleucine (see figure 8.3). 
We also saw higher levels of the regulator of BCAA biosynthesis LEU3 and, as discussed (see 
section 7.3), the leucine biosynthesis intermediate isopropylmalic acid. Accumulation of 
isopropylmalic acid is probably due to decreased levels of LEU2 in the TEF1 overexpression 
strain. LEU2 encodes 3-isopropylmalate dehydrogenase that is required for catalysing the 




conversion of isopropylmalic acid to 2-ketoisocaproate. We hypothesise therefore, that the 
decrease in plasmid copy number in the TEF1 overexpression strain results in a positive 
feedback loop of continuous promotion of BCAA biosynthesis and isopropylmalic acid 
accumulation. 
 
Figure 8.3, Schematic of branched chain amino acid biosynthesis. This shows the biosynthesis pathway of 
the branched chain amino acids with alterations in metabolite and transcript level as detected by analysis of 
the microarray and NMR spectroscopy. Boxes in grey represent metabolites of unknown concentration. 
 
8.4 eEF1A overexpression restores dynactin function in ȟ ? mutants 
We have discussed the possible interactions between eEF1A and components of the dynactin 
complex. However, a further conclusion from this study is that eEF1A overexpression was able 
to rescue the severe spindle defect, and the aneuploidy observed in the ȴĂƌƉ ?mutant (see 




figures 4.4 and 4.6). Here we will discuss the possible mechanism by which eEF1A is able to 
achieve this. 
Within the dynactin complex Arp1 forms a short, stable octameric polymer. This is similar in 
structure to an actin filament and is capped at its barbed end with the actin capping protein 
Cap1 (Schafer et al., 1994). Act1 and Arp1 share 47.1 % identity at the polypeptide level 
(Eckley and Schroer, 2003). Furthermore, interrogation of highly purified dynactin revealed a 
ƐŝŶŐůĞɴ-actin monomer present in each dynactin molecule (Schafer et al., 1994; Eckley et al., 
1999). These data suggest that Act1 and Arp1 may share enough sequence similarity that, in 
the presence of eEF1A, they are able to substitute for the other during some canonical or non-
canonical functions. 
eEF1A is known to stabilise actin filaments resulting in bundles of actin filaments (Edmonds 
et al., 1998). We have observed that in the presence of elevated levels of eEF1A, dynactin 
function restored. We see that the aberrant spindles observed in the absence of Arp1 are 
restored to wild type spindles, and that genomic content, as assessed by FACS analysis, 
resulted in a loss of a population containing greater than 4n genomic content. We propose 
that in the absence of Arp1, short actin filaments, stabilised in the presence of elevated levels 
of eEF1A, are able to substitute for Arp1 in the dynactin complex allowing it to perform its 
function in spindle alignment. 
8.5 Human eEF1A isoforms are unable to perform translational 
functions in yeast 
As previously discussed, eEF1A is encoded by highly conserved genes from prokaryotes to 
eukaryotes. Following characterisation of eEF1A overexpression in yeast, we were interested 




in the effect of eEF1A2 overexpression in human cells (HEK293 cells) to see if phenotypes 
observed in yeast were conserved through to humans.  
Although, as discussed (see section 5.3), we saw an effect on the growth of HEK293 cells we 
were unable to confirm that any of the cytoskeletal aberrations caused by elevated levels of 
eEF1A in yeast were conserved through to humans. Interestingly however, we did see that 
upon overexpression of eEF1A2 in HEK293 cells, the chromosomal aberration observed in 
yeast, a shift in the peaks of the FACS analysis, and larger and brighter nuclei when observed 
by microscopy, was also present. This suggests that yeast and human isoforms do have similar 
interaction profiles, raising the question could human isoforms function in yeast and vice 
versa.  
To answer this question we utilised a yeast strain that had TEF2 deleted and where TEF1 was 
placed under control of a TetO7 promoter, allowing almost complete ablation of native eEF1A 
expression through addition of doxycycline to the growth medium. This was transformed with 
a plasmid expressing either yeast TEF1, or human eEF1A1 or eEF1A2 all under control of the 
strong constitutive TDH3 promoter. This allowed us to observe the effect of having the 
plasmid as the only source of eEF1A.  
Using this system revealed that, when assessed by growth, human eEF1A isoforms are unable 
to function correctly in yeast. It was observed that eEF1A1 was able to recover growth slightly 
better than eEF1A2, but neither resulted in a full recovery. This suggests that both eEF1A1 
and eEF1A2 are unable to function to their full capacity in yeast, and we propose that both 
isoforms are actually unable to fulfil one of their many crucial roles in the cell.  




Considering the polypeptide homology between yeast and human eEF1A isoforms 
(approximately 80 %) it is remarkable that human isoforms are unable to function in yeast. 
Whether it is a loss of translational function, of actin binding, or one of the other functions 
that eEF1A is involved in has yet to be elucidated. However, given the dramatic reduction in 
growth rate observed, it seems plausible that human isoforms are unable to function within 
translation in yeast. 
8.6 Conclusions and future work 
Given the abundance of eEF1A and its known involvement in a variety of cancers, 
understanding the interactions of this highly conserved translation elongation factor are 
essential. Overexpression of eEF1A2 can result in tumour growth, but the mechanism by 
which this occurs is not understood. 
Using an array of techniques we have revealed that in yeast eEF1A overexpression results in 
spindle defects that cause chromosome abnormalities, with these abnormalities appearing to 
lead to DNA replication stress. It seems that the stress induced by these chromosomal 
abnormalities is severe enough to induce toxic effects in cells that contain only a few copies 
of the plasmid encoding TEF1. Naturally cells containing high levels of eEF1A that are toxic to 
the cell are selected against resulting in a population of cells containing very low plasmid copy 
number. The resulting decrease in LEU2 expression, due to the lower plasmid copy number, 
appears to cause a bottle neck in the leucine biosynthesis pathway indicated by the increase 
in the leucine biosynthesis intermediate isopropylmalic acid. Isopropylmalic acid promotes 
LEU3 activation of branched chain amino acid biosynthesis, resulting in a positive feedback 
loop of isopropylmalic acid accumulation and promotion of BCAA biosynthesis. We 
hypothesise that the observed effects of eEF1A toxicity, have a synthetic effect together with 




the effects caused by the suppression of plasmid copy number, resulting in the observed 
growth rescue upon leucine supplementation to the media. 
Furthermore, we have observed that TEF1 overexpression results in an array of other 
metabolic alterations. We hypothesise that whilst some of these alterations are likely to be 
related to low levels of LEU2, it is probable that others are the result of the direct effects of 
TEF1 overexpression on translation, the cytoskeleton and DNA replication. We suggest that 
the observable increase in trehalose levels is probably due to a combination of cells 
responding to starvation induced by low plasmid copy number and a direct effect of DNA 
replication stress exerted by elevated levels of eEF1A disrupting spindle organisation. 
Finally, we have demonstrated that although highly conserved, human and yeast eEF1A 
isoforms appear to be diverse enough that human isoforms are unable to function in yeast 
cells. This raises the question of whether there are further residues that have yet to be 
classified that play an essential role in translation, or if one of the moonlighting roles of eEF1A 
is more essential for cell viability than previously assumed. 
Below are some of the questions that need answering following this research, and how 
answering them would further our knowledge of eEF1A interactions and functions within the 
cell. 
x How does ARP1 deletion rescue the growth defect observed upon TEF1 
overexpression? 
The synthetic interaction we observed between eEF1A and Arp1 suggests that there 
is a strong functional link between these two proteins. However, to conclusively 
answer the question, regarding the nature of this interaction, it is required that an 




assay that allows us to observe direct interactions between these two proteins is 
performed, such as a Co-Immunoprecipitation (Co-IP). If we were to perform Co-IP in 
wild type cells and ȴĂƌƉ ? cells overexpressing TEF1 we could assess if the dynactin 
complex is still intact and if it was, analysis of the bands corresponding to dynactin by 
mass spectrometry would allow us to identify the components. 
x Are trehalose levels reduced by the addition of leucine or the deletion of CBF1? 
We observed that the addition of leucine to the media resulted in a rescue to the 
growth rate of TEF1 overexpressing cells, and that the translation factor Cbf1, that 
promotes trehalose biosynthesis, was also elevated in these cells. It would be useful 
to determine whether trehalose levels return to wild type levels following leucine 
addition or CBF1 deletion as this would tell us if trehalose accumulation is the result 
of cells responding to low plasmid levels, or DNA replication stress caused by elevated 
levels of eEF1A. 
x Is the extra eEF1A in the system contributing to translation, or is it being utilised 
elsewhere? 
We observed that eEF1A overexpression had a dramatic effect on a wide array of 
cellular processes. By performing ribosomal profiling we could observe a global profile 
of ribosomes in the cell allowing us to identify if they are being utilised for translation. 
In cells overexpressing TEF1 we would anticipate that there should be an increase in 
80S ribosomes, and polysomes if the extra eEF1A in the system is contributing to 
translation. 
x Is yeast eEF1A able to function in human cells? 
We have demonstrated that human eEF1A isoforms are unable to function in yeast 
suggesting a difference in the functionality of eEF1A between these two species. It 




would be interesting to see if yeast eEF1A is able to replace human isoforms as this 
may elucidate functions of either isoform that is essential in one species but not the 
other. 
x How does TEF1 overexpression rescue the ȴĂƌƉ ? growth defect? 
We observed that deletion of ARP1 resulted in severe spindle aberrations and 
aneuploidy, with TEF1 overexpression rescuing both these defects. We hypothesised 
that elevated levels of eEF1A may achieve this through stabilisation of actin into short 
octamers, that were able to substitute for Arp1 as the backbone of the dynactin 
complex, resulting in restoration of dynactin function. Further analysis of this is 
required to ascertain if actin does indeed replace Arp1 in dynactin, and if it does, does 
this have any other effects on the dynactin complex. 
x What is the chromosomal abnormality that is causing the nuclei to appear larger when 
observed down the microscope, and causes a shift of the peaks in the FACS analysis? 
We observed a conserved aneuploidy phenotype from yeast to human cells. However, 
although we have speculated that this may be due to either a global up-regulation of 
a large proportion of genes, or an increase in dye uptake due to relaxed chromosomal 
packaging, he were unable to definitively answer this question. How we would be able 
to assess this is uncertain as most assays to quantify genomic content rely on uptake 
of a dye. However, as this is likely to be the driving force behind the toxicity associated 
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Appendix Chapter 2 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
A BY4741 (WT) ȴĂƌĐ ? ? ȴďŝƚ ? ȴĐĂƉ ? ȴũŶŵ ? ȴƐĂĐ ? ȴǀƌƉ ? 
B BY4741 + Tef1 ȴĂƌĐ ? ?A?dĞĨ ? ȴďŝƚ ?A?dĞĨ ? ȴĐĂƉ ?A?dĞĨ ? ȴũŶŵ ?A?dĞĨ ? ȴƐĂĐ ?A?dĞĨ ? ȴǀƌƉ ?A?dĞĨ ? 
C ȴĂďƉ ? ? ? ȴĂƌŬ ? ȴďŝƚ ? ? ȴĐƌŶ ? ȴůƐď ? ȴƐĐƉ ? ȴǇŬĞ ? 
D ȴĂďƉ ? ? ?A?dĞĨ ? ȴĂƌŬ ?A?dĞĨ ? ȴďŝƚ ? ?A?dĞĨ ? ȴĐƌŶ ?A?dĞĨ ? ȴůƐď ?A?dĞĨ ? ȴƐĐƉ ?A?dĞĨ ? ȴǇŬĞ ?A?dĞĨ ? 
E ȴĂĐĨ ? ȴďŶŝ ? ȴĂƌƉ ? ȴĐǇŬ ? ȴŵƐď ? ȴƐůĂ ? ȴǇƐĐ ? ? 
F ȴĂĐĨ ?A?dĞĨ ? ȴďŶŝ ?A?dĞĨ ? ȴĂƌƉA?dĞĨ ? ȴĐǇŬ ?A?dĞĨ ? ȴŵƐď ?A?dĞĨ ? ȴƐůĂ ?A?dĞĨ ? ȴǇƐĐ ? ?A?dĞĨ ? 
G ȴĂŝŵ ? ? ȴĂƌƉ ? ȴďŶƌ ? ȴĞŶĚ ? ȴŵǇŽ ? ȴƐůŽ ? ȴƐŝǁ ? ? 
H ȴĂŝŵ ? ?A?dĞĨ ? ȴĂƌƉ ?A?dĞĨ ? ȴďŶƌ ?A?dĞĨ ? ȴĞŶĚ ?A?dĞĨ ? ȴŵǇŽ ?A?dĞĨ ? ȴƐůŽ ?A?dĞĨ ? ȴƐŝǁ ? ?A?dĞĨ ? 
I ȴĂŝŵ ? ȴĂƌƉ ? ȴďƐƉ ? ȴĞŶƚ ? ȴƉůƉ ? ȴƐƉĂ ?  
J ȴĂŝŵ ?A?dĞĨ ? ȴĂƌƉ ?A?dĞĨ ? ȴďƐƉ ?A?dĞĨ ? ȴĞŶƚ ?A?dĞĨ ? ȴƉůƉ ?A?dĞĨ ? ȴƐƉĂ ?A?dĞĨ ? 
K ȴĂŝŵ ? ȴĂƌƉ ? ȴďƵĚ ? ȴĞŶƚ ? ȴƌŐĚ ? ȴƚƉŵ ? 
L ȴĂŝŵA?dĞĨ ? ȴĂƌƉ ?A?dĞĨ ? ȴďƵĚ ?A?dĞĨ ? ȴĞŶƚ ?A?dĞĨ ? ȴƌŐĚ ?A?dĞĨ ? ȴƚƉŵ ?A?dĞĨ ? 
M ȴĂŝƉ ? ȴďĂŐ ? ȴďǌǌ ? ȴŐĞĂ ? ȴƌǀƐ ? ? ? ȴƚƐĐ ? ? 
N ȴĂŝƉ ?A?dĞĨ ? ȴďĂŐ ?A?dĞĨ ? ȴďǌǌ ?A?dĞĨ ? ȴŐĞĂ ?A?dĞĨ ? ȴƌǀƐ ? ? ?A?dĞĨ ? ȴƚƐĐ ? ?A?dĞĨ ? 
O ȴĂĚƉ ? ȴďďĐ ? ȴĐĂƉ ? ȴŐŝƉ ? ȴƐĂĐ ? ȴƚǁĨ ? 
P ȴĂĚƉ ?A?dĞĨ ? ȴďďĐ ?+ Tef1 ȴĐĂƉ ?A?dĞĨ ? ȴŐŝƉ ?A?dĞĨ ? ȴƐĂĐ ?A?dĞĨ ? ȴƚǁĨ ?A?dĞĨ ? 
 






App.2 Array of viable actin mutant strains with TEF1 overexpressed. Strains that had been deleted for 
genes known to interact with, or control the function of actin were assayed for synthetic interactions with 
eEF1A. Strains were arranged horizontally in biological triplicate. Cells containing the control plasmid were 





Appendix Chapter 6 
App 3, table of complete microarray data set. This shows the complete set of up and down regulated genes found in this study. 
Genes up regulated Genes down regulated 
YAL001C YEL052W YJL090C YMR244W YDL037C YLR333C 
YAL002W YEL053C YJL092W YMR247C YNR072W YCR095C 
YAL005C YEL055C YJL093C YMR247W-A YMR230W-A YDL166C 
YAL009W YEL056W YJL094C YMR250W YOL141W YOR381W-A 
YAL010C YEL057C YJL095W YMR251W YGR035C YHR085W 
YAL011W YEL058W YJL097W YMR251W-A YIL046W-A YDR471W 
YAL012W YEL059C-A YJL098W YMR252C YHR022C-A YOR080W 
YAL013W YEL060C YJL099W YMR255W YNR075W YHL001W /// 
YKL006W 
YAL014C YEL061C YJL100W YMR257C YJR151W-A YBL041W 
YAL015C YEL062W YJL101C YMR258C YLR412C-A YIL090W 
YAL016C-B YEL063C YJL102W YMR259C YBR298C-A YGR174W-A 
YAL017W YEL065W YJL103C YMR261C YDR545W /// 
YEL076C 
YJR010C-A 
YAL020C YEL066W YJL106W YMR262W YML123C YNL067W-B 
YAL021C YEL069C YJL108C YMR263W YBL013W YOR293W 
YAL023C YEL070W /// 
YNR073C 
YJL110C YMR264W YMR063W YGL050W 
YAL024C YEL071W YJL112W YMR265C YKL095W YGL030W 
YAL026C YEL075C /// 
YER189W 
YJL116C YMR266W YGL258W YGR027C 






YAL028W YER003C YJL121C YMR268C YLR047C YMR228W 
YAL029C YER004W YJL122W YMR270C YPR119W YBR111W-A 
YAL030W YER007C-A YJL123C YMR271C YHR136C YGR215W 
YAL031C YER007W YJL124C YMR272C YOR204W YPL227C 
YAL032C YER008C YJL126W YMR273C YML058W-A YDR303C 
YAL033W YER010C YJL128C YMR275C YMR101C YBR282W 
YAL034C YER011W YJL129C YMR276W YMR117C YNL331C 
YAL034W-A YER013W YJL130C YMR277W YDR320C-A YDL240W 
YAL035W YER014C-A YJL131C YMR278W YHR189W YBR175W 
YAL036C YER014W YJL132W YMR280C YOL136C YFL053W 
YAL037C-A YER016W YJL133C-A YMR281W YLR363W-A YJL047C-A 
YAL037W YER017C YJL133W YMR287C YGR006W YDR454C 
YAL038W YER018C YJL134W YMR289W YER153C YLR403W 
YAL041W YER019W YJL136C YMR291W YJR153W YBR252W 
YAL042W YER020W YJL137C YMR293C YHL018W YCR020W-B 
YAL043C YER023W YJL138C /// YKR059W YMR295C YBR090C YER051W 
YAL044C YER024W YJL139C YMR296C YKL125W YGR103W 
YAL044W-A YER027C YJL141C YMR297W YGR040W snR73 /// YMR013W-
A 
YAL046C YER028C YJL147C YMR298W YJR154W YMR161W 
YAL047C YER032W YJL149W YMR299C YLR030W YHR197W 
YAL049C YER033C YJL151C YMR300C YGR174W-A YHR064C 
YAL051W YER034W YJL154C YMR301C YMR032W YER031C 
YAL053W YER035W YJL158C YMR302C YPR094W YER048W-A 
YAL054C YER037W YJL159W YMR303C YFR032C YIL138C 
YAL058W YER040W YJL160C YMR304W YPL166W YDL210W 
YAL060W YER041W YJL161W YMR305C YIL027C YPR151C 





YAL062W YER047C YJL164C YMR307W YHR105W YOR369C 
YAL063C /// 
YAR050W 
YER048C YJL165C YMR308C YPR158W YJL156C 
YAL065C YER049W YJL167W YMR310C YOR387C YMR002W 
YAL067C YER052C YJL171C YMR311C YML108W YIL004C 
YAL067W-A YER053C YJL172W YMR312W YOR210W YLR063W 
YAL068C YER053C-A YJL174W YMR313C YOL101C YDL232W 
YAL068C /// 
YBL108C-A 
YER054C YJL176C YMR314W YLR393W YJR051W 
YAR007C YER055C YJL177W YMR315W YER087C-B YPL027W 
YAR009C /// 
YBL005W-B 
YER059W YJL178C YMR316W YFL031W YKL100C 
YAR014C YER060W YJL181W YMR317W YGR272C YPR060C 
YAR015W YER061C YJL184W YMR318C YGL029W YML129C 
YAR019C YER062C YJL185C YMR322C /// 
YOR391C  
YHL048C-A YLR369W 
YAR020C YER063W YJL186W YMR323W /// 
YOR393W  
YML003W YPR052C 
YAR027W YER064C YJL187C YNL001W YNL147W YDR524C-B 
YAR028W YER066W YJL191W YNL003C YPL130W YGR154C 
YAR029W YER067W YJL192C YNL004W YLR275W YNL275W 
YAR031W YER068W YJL193W YNL005C YMR272W-B YKL006W 
YAR033W /// 
YGL051W 
YER069W YJL196C YNL007C YOL002C YPR043W 
YAR035W YER070W YJL197W YNL008C YPL201C YKL143W 
YAR042W YER071C YJL198W YNL011C YPR108W-A YER065C 







YER075C YJL201W YNL014W YBR152W YHR116W 
YAR064W /// 
YHR213W-B 
YER076C YJL203W YNL015W YDL157C YOR186W 
YAR068W /// 
YHR214W-A 
YER077C YJL204C YNL016W YLR264C-A YPL019C 
YAR070C /// 
YHR214C-E 
YER079W YJL206C YNL018C YKR083C YGL220W 
YAR071W /// 
YHR215W 
YER081W YJL207C YNL018C /// 
YNL034W 
YDR492W YBR143C 





YER083C YJL213W YNL020C YBR120C YGR106C 
YBL001C YER088C YJL217W YNL021W YPL162C YJL127C-B 
YBL002W YER089C YJL218W YNL023C YPR201W YER074W /// YIL069C 
YBL003C YER090W YJL219W YNL027W YOR180C YOR232W 
YBL003C /// 
YDR225W 
YER091C YJL219W /// 
YOL156W 
YNL031C YER046W YGR049W 
YBL004W YER093C YJR001W YNL032W YER085C YKL104C 
YBL005W YER094C YJR003C YNL034W YBL100W-C YKL217W 
YBL005W-B /// 
YBR012W-B  
YER095W YJR005W YNL035C YBR257W YNL133C 
YBL005W-B /// 
YBR012W-B  
YER096W YJR006W YNL037C YGR105W YMR060C 
YBL005W-B /// 
YDR261C-D  
YER099C YJR007W YNL039W YOR315W YNR043W 
YBL006C YER101C YJR008W YNL040W YGR079W YPL257W 





YBL009W YER103W YJR014W YNL042W YLR068W YNL062C 
YBL010C YER104W YJR015W YNL042W-B /// 
YOL013W-A  
YOR243C YLR146C 
YBL011W YER105C YJR016C YNL045W YDR523C YBL107W-A /// 
YER138W-A  
YBL015W YER106W YJR017C YNL049C YOR313C YLR019W 
YBL016W YER107C YJR019C YNL050C YNL162W-A YML073C 
YBL017C YER109C YJR021C YNL051W YHR081W YNL308C 
YBL019W YER110C YJR024C YNL053W YHR196W YPL043W 
YBL021C YER111C YJR025C YNL054W YNL024C-A YMR084W 
YBL022C YER113C YJR030C YNL055C YEL048C YJL190C 
YBL024W YER114C YJR031C YNL056W YLR435W YBR291C 
YBL027W YER115C YJR032W YNL058C YMR188C YHR084W 
YBL029C-A YER116C YJR033C YNL059C YGR046W YAR008W 
YBL029W YER118C YJR035W YNL061W YLR204W YGR024C 
YBL030C YER119C YJR039W YNL063W YLR408C YJL143W 
YBL031W YER120W YJR040W YNL065W YAR023C YJL179W 
YBL032W YER122C YJR042W YNL066W YOL154W YNR032W 
YBL033C YER123W YJR043C YNL067W YLR346C YKL184W 
YBL034C YER124C YJR044C YNL068C YMR286W YGR155W 
YBL037W YER125W YJR045C YNL069C YGL247W YJL117W 
YBL042C YER128W YJR046W YNL071W YBL111C /// 
YDR545W 
YOR189W 
YBL043W YER129W YJR047C YNL072W YHL020C YMR274C 
YBL045C YER130C YJR048W YNL073W YIL099W YDL098C 
YBL046W YER132C YJR049C YNL074C YDR536W YLR438C-A 
YBL047C YER134C YJR050W YNL076W YJL144W YMR212C 





YBL050W YER141W YJR054W YNL082W YHR072W-A YIL106W 
YBL051C YER143W YJR057W YNL085W YGR271C-A YDR167W 
YBL052C YER144C YJR058C YNL086W YLR262C YOR075W 
YBL055C YER145C YJR059W YNL087W YDR524W-C YPL108W 
YBL056W YER146W YJR060W YNL088W YPR046W YEL054C 
YBL058W YER147C YJR061W YNL090W YMR040W YDR381C-A 
YBL059C-A YER149C YJR064W YNL091W YLR037C YIL014W 
YBL059W YER150W YJR065C YNL092W YCR028C YHR153C 
YBL061C YER151C YJR066W YNL093W YJL194W YMR177W 
YBL063W YER152C YJR067C YNL094W YLR254C YBL023C 
YBL064C YER154W YJR069C YNL095C YOR021C YER060W-A 
YBL066C YER155C YJR070C YNL096C YDR496C YAL022C 
YBL067C YER156C YJR072C YNL097C-B YML119W YKL074C 
YBL069W YER157W YJR073C YNL098C YDR256C YLR426W 
YBL071C-B YER158C YJR074W YNL099C YER039C-A YDL130W 
YBL071W-A YER159C YJR075W YNL100W YGR108W YBR191W 
YBL072C YER162C YJR076C YNL102W YBR065C YGL106W 
YBL075C YER163C YJR077C YNL103W YLR145W YOR346W 
YBL076C YER164W YJR078W YNL104C YLR051C YBL039C 
YBL078C YER165W YJR079W YNL106C YPR153W YDL136W /// 
YDL191W 
YBL079W YER166W YJR080C YNL108C YDR432W YNL302C /// YOL121C 
YBL080C YER167W YJR083C YNL115C YNL307C YPL051W 
YBL081W YER169W YJR085C YNL116W YPR166C YJL072C 
YBL084C YER170W YJR088C YNL117W YDR191W YEL069C 
YBL085W YER171W YJR090C YNL118C YFR001W YGL263W 
YBL086C YER172C YJR091C YNL123W YGR204C-A YDR375C 





YBL088C YER176W YJR093C YNL125C YBR211C YGR038W 
YBL089W YER177W YJR094C YNL126W YMR253C YBR195C 
YBL091C YER178W YJR095W YNL127W YJR097W YLR276C 
YBL091C-A YER179W YJR096W YNL128W YIL040W YJL058C 
YBL093C YER182W YJR098C YNL130C YML037C YNL075W 
YBL095W YER183C YJR099W YNL130C-A YIL071C YIL069C 
YBL098W YER184C YJR100C YNL132W YCR100C YDL081C 
YBL100W-A /// 
YBL100W-B 
YER188C-A YJR103W YNL135C YKR034W YLR196W 
YBL100W-B /// 
YCL019W 
YFL002C YJR104C YNL136W YDR075W YGR273C 
YBL101C YFL003C YJR105W YNL137C YOR025W YGL112C 
YBL102W YFL004W YJR107W YNL138W YGR030C YKL195W 
YBL103C YFL008W YJR108W YNL139C /// YNL140C YPL113C YBR173C 
YBL104C YFL009W YJR109C YNL141W YKL068W-A YOR272W 
YBL105C YFL010C YJR110W YNL142W YDL243C YLR064W 
YBL106C YFL010W-A YJR111C YNL144C YKL058W YDR014W 
YBL109W /// 
YDR544C 
YFL012W YJR112W YNL146C-A YER142C YBL036C 
YBL111C /// 
YDR545W 
YFL013C YJR112W-A YNL146W YCL056C YGR057C 
YBL111C /// 
YDR545W 
YFL014W YJR113C YNL152W YML041C YLR312W-A 
YBL112C /// YBL113C  YFL016C YJR114W YNL154C YMR015C YJL166W 
YBL113C /// 
YDR545W  
YFL018C YJR115W YNL156C YPL038W-A YDR082W 
YBL113W-A /// 
YDR545C-A 





YBR001C YFL020C YJR117W YNL160W YNL038W YPR137W 
YBR003W YFL021W YJR119C YNL161W YER006W YIR018C-A 
YBR004C YFL022C YJR120W YNL163C YGL127C YDR361C 
YBR005W YFL023W YJR121W YNL165W YIL016W YMR159C 
YBR007C YFL024C YJR122W YNL166C YOR344C YDR519W 
YBR008C YFL025C YJR125C YNL167C YIL127C YML100W-A 
YBR010W YFL026W YJR126C YNL168C YGL041C-B YEL073C 
YBR011C YFL027C YJR127C YNL172W YLR456W YAL064W 
YBR013C YFL028C YJR129C YNL173C YGR211W YOR312C 
YBR014C YFL029C YJR130C YNL175C YNL222W YMR294W 
YBR015C YFL030W YJR131W YNL176C YDR071C YNL265C 
YBR017C YFL033C YJR132W YNL178W YGR236C YIR024C 
YBR018C YFL034C-A YJR133W YNL180C YKL055C YNL029C 
YBR020W YFL034C-B YJR134C YNL181W YGL246C YOR056C 
YBR022W YFL034W YJR135C YNL182C YER015W YDL070W 
YBR023C YFL036W YJR137C YNL183C YIL158W YPR107C 
YBR025C YFL037W YJR138W YNL185C YLR168C YNL254C 
YBR026C YFL038C YJR139C YNL186W YOL077W-A YKL119C 
YBR028C YFL039C YJR140C YNL187W YLL009C YPR020W 
YBR030W YFL041W YJR142W YNL189W YDR184C YDR362C 
YBR031W /// 
YDR012W 
YFL042C YJR144W YNL190W YBR091C YGR118W 
YBR035C YFL044C YJR147W YNL191W YCR024C-B YMR284W 
YBR036C YFL045C YJR148W YNL192W YGL054C YDR402C 
YBR037C YFL047W YJR149W YNL193W YDL205C YGL129C 
YBR039W YFL048C YJR150C YNL194C YGR126W YER043C 
YBR040W YFL050C YJR151C YNL195C YNR020C YDL042C 





YBR042C YFL054C YKL002W YNL199C YPL146C YGL008C 
YBR043C YFL059W /// 
YNL333W 
YKL006C-A YNL200C YMR269W YDR012W 
YBR045C YFL060C /// YNL334C YKL007W YNL201C YLR220W YPL249C-A 
YBR046C YFL062W /// 
YGR295C /// 
YNL336W 
YKL008C YNL202W YGL240W YDR508C 
YBR047W YFL067W YKL010C YNL204C YJR055W YKL116C 
YBR048W YFR002W YKL012W YNL206C YPL225W YCR031C 
YBR049C YFR003C YKL013C YNL208W YJL214W YJR143C 
YBR052C YFR006W YKL014C YNL209W YGR036C YOR340C 
YBR053C YFR007W YKL015W YNL210W YBR196C-A YMR071C 
YBR054W YFR008W YKL017C YNL214W YDR042C YML099C 
YBR055C YFR009W YKL019W YNL215W YJL035C YDR339C 
YBR056W YFR010W YKL020C YNL217W YPL211W YFL055W 
YBR058C YFR012W YKL022C YNL221C YBL026W YBL044W 
YBR059C YFR012W-A YKL023W YNL224C YKL050C YDR228C 
YBR060C YFR013W YKL024C YNL227C YHR086W-A YOR245C 
YBR061C YFR014C YKL025C YNL229C YNR062C YKL185W 
YBR063C YFR015C YKL026C YNL230C YOR183W YML026C 
YBR067C YFR016C YKL027W YNL233W YDR078C YKR009C 
YBR068C YFR017C YKL028W YNL236W YOL163W YPL119C 
YBR070C YFR018C YKL029C YNL237W YBR153W YAR002C-A 
YBR071W YFR019W YKL032C YNL238W YGR092W YGL044C 
YBR072C-A YFR021W YKL033W YNL239W YLR462W YHR004C 
YBR072W YFR022W YKL034W YNL240C YBL040C YOR153W 
YBR073W YFR023W YKL035W YNL241C YMR003W YDR030C 





YBR076W YFR025C YKL042W YNL243W YMR155W YPR138C 
YBR077C YFR026C YKL047W YNL245C YBR271W YGL171W 
YBR079C YFR027W YKL048C YNL246W YOR083W YBR016W 
YBR080C YFR028C YKL051W YNL247W YNL277W-A YLR359W 
YBR081C YFR029W YKL052C YNL248C YGR183C YMR098C 
YBR082C YFR030W YKL054C YNL250W YOR032C YDR083W 
YBR083W YFR031C YKL057C YNL255C YLR421C YNL084C 
YBR084C-A YFR031C-A /// 
YIL018W 
YKL059C YNL257C YOL059W YDR348C 
YBR084W YFR032C-A YKL060C YNL258C YDR031W YBR009C /// 
YNL030W 
YBR085W YFR032C-B YKL061W YNL260C YCR102C YER175W-A 
YBR086C YFR033C YKL063C YNL261W YPL165C YBR164C 
YBR087W YFR034C YKL064W YNL263C YIL098C YLR264W 
YBR089C-A /// 
YBR090C 
YFR035C YKL067W YNL264C YDR383C YKL065C 
YBR097W YFR036W YKL068W YNL267W YPR101W YLR074C 
YBR101C YFR038W YKL069W YNL268W YNL112W YDR120C 
YBR102C YFR039C YKL070W YNL269W YMR056C YDR322W 
YBR103W YFR040W YKL071W YNL270C YBR180W YKL192C 
YBR104W YFR041C YKL072W YNL271C YBL039W-B YLR038C 
YBR105C YFR043C YKL073W YNL273W YBR255C-A YAL055W 
YBR106W YFR044C YKL075C YNL274C YIL103W YCL038C 
YBR107C YFR045W YKL079W YNL277W YDR086C YCR054C 
YBR108W YFR046C YKL080W YNL278W YDL121C YDR450W 
YBR109C YFR047C YKL081W YNL280C YNR032C-A YPR133C 
YBR110W YFR048W YKL084W YNL281W YMR239C YHR021W-A 





YBR112C YFR051C YKL086W YNL284C YPR100W YFR057W 
YBR115C YFR053C YKL087C YNL287W YKL001C YDL175C 
YBR117C YFR055W YKL088W YNL288W YCL042W YPL118W 
YBR118W /// 
YPR080W 
YGL001C YKL089W YNL289W YFL051C YIL139C 
YBR119W YGL002W YKL091C YNL291C YHL039W YJL170C 
YBR121C YGL003C YKL092C YNL292W YDR201W YMR225C 
YBR123C YGL004C YKL093W YNL293W YDR033W YLL012W 
YBR126C YGL006W YKL094W YNL294C YOR045W YLR133W 
YBR128C YGL007C-A YKL096C-B YNL295W YJL136W-A YKL039W 
YBR130C YGL009C YKL096W YNL297C YLR108C YLR453C 
YBR132C YGL011C YKL099C YNL298W YBR268W YGR263C 
YBR133C YGL012W YKL101W YNL300W YNL119W YDR345C 
YBR135W YGL013C YKL103C YNL301C YIL170W /// 
YOL156W 
YGL086W 
YBR136W YGL014W YKL105C YNL301C /// YOL120C YFL056C YCL031C 
YBR137W YGL015C YKL106C-A YNL304W YGR230W YMR140W 
YBR139W YGL016W YKL106W YNL305C YAR073W /// 
YHR216W 
YDL155W 
YBR140C YGL017W YKL108W YNL306W YOR158W YGR071C 
YBR141C YGL018C YKL109W YNL309W YBR258C YLR060W 
YBR142W YGL019W YKL110C YNL310C YEL020W-A YEL034W 
YBR145W YGL020C YKL112W YNL311C YHR152W YLR287C 
YBR146W YGL022W YKL114C YNL312W YBL008W-A YPR056W 
YBR147W YGL023C YKL117W YNL314W YKL170W YBR089C-A 
YBR148W YGL025C YKL120W YNL315C YOR262W YNL212W 






YBR150C YGL027C YKL124W YNL317W YOR258W YAR069C /// 
YHR214C-D 
YBR151W YGL028C YKL126W YNL318C YPL119C-A YCR028C-A 
YBR157C YGL031C YKL127W YNL321W YOL142W YGR060W 
YBR159W YGL032C YKL128C YNL322C YKL009W YPL005W 
YBR160W YGL033W YKL129C YNL323W YLR401C YJL189W 
YBR161W YGL035C YKL132C YNL325C YPL179W YOR224C 
YBR166C YGL036W YKL133C YNL326C YNL113W YKL041W 
YBR168W YGL037C YKL134C YNL327W YDR021W YPL267W 
YBR169C YGL039W YKL135C YNL329C YER019C-A YLR154C 
YBR170C YGL040C YKL139W YNL330C YKL130C YPR082C 
YBR172C YGL043W YKL140W YNR001C YNL110C YNL079C 
YBR176W YGL045W YKL141W YNR002C YGR142W YNL225C 
YBR177C YGL047W YKL142W YNR003C YDL248W /// 
YJR161C 
YPL094C 
YBR179C YGL049C YKL145W YNR006W YNL002C YDL088C 
YBR182C YGL051W YKL146W YNR007C YIR031C YKR023W 
YBR182C-A YGL053W YKL148C YNR008W YDR399W YPR041W 
YBR183W YGL056C YKL149C YNR009W YDR249C YGR278W 
YBR185C YGL058W YKL150W YNR010W YLR104W YDR529C 
YBR186W YGL059W YKL151C YNR011C YGR177C YDL083C 
YBR187W YGL062W YKL152C YNR012W YDR512C YNR074C 
YBR193C YGL065C YKL154W YNR013C YDL160C YOR281C 
YBR194W YGL066W YKL155C YNR014W YBL020W YEL026W 
YBR196C YGL067W YKL157W YNR015W YPL036W YJL051W 
YBR197C YGL071W YKL159C YNR016C YJL052C-A YKL156W 





YBR200W YGL076C /// 
YPL198W 
YKL168C YNR018W YHR168W YDR013W 
YBR201W YGL078C YKL171W YNR019W YPL018W YOL127W 
YBR204C YGL079W YKL172W YNR021W YPL245W YDR285W 
YBR205W YGL081W YKL173W YNR023W YHL024W YDR121W 
YBR207W YGL082W YKL174C YNR026C YGL209W YHR053C /// 
YHR055C 
YBR208C YGL083W YKL180W YNR027W YPR200C YOR117W 
YBR212W YGL085W YKL181W YNR029C YOR166C YLR085C 
YBR213W YGL087C YKL182W YNR030W YNL244C YOR003W 
YBR214W YGL090W YKL183W YNR031C YAL040C YIR022W 
YBR215W YGL091C YKL186C YNR033W YDR091C YDR115W 
YBR216C YGL092W YKL188C YNR034W YOR349W YLR061W 
YBR218C YGL093W YKL189W YNR034W-A YDR275W YDR370C 
YBR219C /// YBR220C YGL094C YKL191W YNR035C YDR072C YNL122C 
YBR220C YGL095C YKL193C YNR036C YBL090W YLR226W 
YBR221C YGL096W YKL194C YNR037C YER026C YJL125C 
YBR221W-A YGL097W YKL197C YNR038W YCR003W YKL176C 
YBR222C YGL100W YKL198C YNR039C YMR077C YML082W 
YBR223C YGL101W YKL201C YNR040W YHR157W YOL019W-A 
YBR225W YGL104C YKL203C YNR041C YNL169C YCL036W 
YBR227C YGL105W YKL204W YNR044W YDL038C YGR072W 
YBR228W YGL107C YKL205W YNR045W YBR233W-A YDR300C 
YBR229C YGL108C YKL206C YNR046W YOR190W YML126C 
YBR230C YGL110C YKL207W YNR047W YKR075C YDR441C 
YBR230W-A YGL111W YKL208W YNR049C YHR052W YOR172W 
YBR233W YGL114W YKL209C YNR050C YBL038W YML088W 





YBR235W YGL117W YKL211C YNR052C YJR011C YGR209C 
YBR236C YGL119W YKL212W YNR054C YOR150W YJR082C 
YBR239C YGL121C YKL213C YNR055C YNL213C YDR387C 
YBR240C YGL122C YKL214C YNR056C YBR098W YLR285W 
YBR241C YGL124C YKL215C YNR057C YKL166C YDR528W 
YBR242W YGL125W YKL218C YNR058W YJL115W YLR107W 
YBR243C YGL126W YKL219W YNR059W YDR437W YNL253W 
YBR245C YGL128C YKR001C YNR060W YKL122C YJL104W 
YBR246W YGL130W YKR002W YNR064C YIL160C YBR293W 
YBR248C YGL131C YKR003W YNR065C YIR021W YCR002C 
YBR249C YGL133W YKR007W YNR066C YMR256C YJR094W-A 
YBR251W YGL134W YKR008W YNR067C YMR180C YKR057W 
YBR254C YGL136C YKR010C YNR068C YBR210W YMR319C 
YBR255W YGL137W YKR011C YNR069C YBR129C YDR511W 
YBR256C YGL138C YKR013W YOL003C YPL226W YLR395C 
YBR260C YGL139W YKR014C YOL004W YDR280W YDR146C 
YBR261C YGL140C YKR015C YOL005C YDR196C YOL038W 
YBR262C YGL141W YKR016W YOL006C YML048W YDR062W 
YBR265W YGL143C YKR018C YOL007C YPL013C YMR030W 
YBR269C YGL144C YKR019C YOL008W YDR079W YGL064C 
YBR270C YGL145W YKR020W YOL013C YER139C YBR298C 
YBR272C YGL146C YKR021W YOL013W-A YDL179W YDL128W 
YBR273C YGL148W YKR022C YOL015W YER140W YAR018C 
YBR274W YGL150C YKR025W YOL016C YJR062C YLR125W 
YBR275C YGL151W YKR026C YOL017W YOL010W YHR021C 
YBR276C YGL153W YKR027W YOL020W YGL192W YGL226W 
YBR278W YGL154C YKR028W YOL021C YNL153C YGR220C 





YBR281C YGL156W YKR031C YOL025W YDR195W YOR089C 
YBR284W YGL157W YKR036C YOL026C YIL037C YEL044W 
YBR285W YGL158W YKR037C YOL027C YER180C-A YOR038C 
YBR286W YGL159W YKR038C YOL028C YLR190W YDL247W 
YBR287W YGL160W YKR041W YOL029C YDL085W YIL091C 
YBR289W YGL162W YKR042W YOL030W YOR009W YLR370C 
YBR290W YGL163C YKR043C YOL031C YIL008W YML102W 
YBR295W YGL164C YKR044W YOL032W YHR066W YPL191C 
YBR296C-A YGL166W YKR045C YOL033W YNL107W YDR404C 
YBR297W YGL167C YKR046C YOL034W YLR221C YHR132W-A 
YBR299W /// 
YGR292W 
YGL168W YKR048C YOL036W YML077W YIL101C 
YBR302C /// 
YML132W 
YGL170C YKR049C YOL040C YLR154W-E YDR302W 
YCL001W-A YGL172W YKR050W YOL043C YML054C YFL017C 
YCL001W-B YGL173C YKR052C YOL044W YBR200W-A YIL118W 
YCL002C YGL174W YKR054C YOL047C YLL054C YGR059W 
YCL004W YGL176C YKR055W YOL048C YPL242C YER186C 
YCL008C YGL178W YKR058W YOL049W YBR021W YHL011C 
YCL009C YGL179C YKR061W YOL051W YKL090W YHL026C 
YCL010C YGL180W YKR062W YOL052C YDR045C YLR167W 
YCL014W YGL181W YKR063C YOL052C-A YBR066C YIL035C 
YCL016C YGL183C YKR066C YOL053W YML046W YOR044W 
YCL017C YGL184C YKR067W YOL054W YMR080C YLR353W 
YCL018W YGL185C YKR069W YOL055C YOL038C-A YDR227W 
YCL021W-A YGL186C YKR070W YOL056W YBR162W-A YPR061C 
YCL024W YGL187C YKR071C YOL058W YHR194W YIL148W 





YCL026C-A YGL189C YKR076W YOL062C YJR022W YML009C 
YCL026C-B YGL191W YKR077W YOL063C YOR147W YOR351C 
YCL027W YGL194C YKR078W YOL064C YGL038C YER056C 
YCL028W YGL195W YKR079C YOL065C YIL166C YKL018W 
YCL029C YGL196W YKR080W YOL066C YIL064W YOR386W 
YCL030C YGL197W YKR082W YOL068C YMR134W YOR237W 
YCL032W YGL198W YKR084C YOL069W YHR148W YOR063W 
YCL033C YGL200C YKR086W YOL070C YDL212W YOR274W 
YCL035C YGL201C YKR087C YOL071W YHR175W-A YIL146C 
YCL037C YGL202W YKR089C YOL072W YER112W YDL008W 
YCL039W YGL203C YKR090W YOL073C YDL153C YDR494W 
YCL040W YGL205W YKR091W YOL075C YDR386W YOR141C 
YCL043C YGL206C YKR092C YOL076W YGR016W YLR172C 
YCL044C YGL207W YKR093W YOL078W YER009W YOL098C 
YCL045C YGL208W YKR095W YOL081W YHR139C YGR283C 
YCL047C YGL211W YKR095W-A YOL082W YFR037C YNL251C 
YCL048W YGL212W YKR096W YOL083W YIL143C YMR093W 
YCL049C YGL215W YKR097W YOL084W YIL049W YNL010W 
YCL050C YGL216W YKR098C YOL087C YHR159W YDR192C 
YCL051W YGL219C YKR099W YOL088C YCR068W YGR148C 
YCL052C YGL221C YKR100C YOL089C YMR292W YDL059C 
YCL057W YGL222C YKR101W YOL090W YGL010W YER098W 
YCL058C YGL223C YKR102W YOL091W YPL064C YDL015C 
YCL059C YGL224C YKR103W YOL093W YHR038W YOL149W 
YCL061C YGL227W YKR104W YOL095C YBR202W YNL231C 
YCL063W YGL228W YLL001W YOL096C YAR003W YGR205W 
YCL064C YGL229C YLL002W YOL097C YKL082C YPL030W 












YGL233W YLL006W YOL103W YNL009W YDR525W-A 
YCR004C YGL235W YLL006W-A YOL104C YDR366C YMR072W 
YCR005C YGL236C YLL007C YOL107W YKR017C YMR171C 
YCR007C YGL237C YLL008W YOL108C YDR412W YHR141C /// 
YNL162W 
YCR008W YGL241W YLL010C YOL109W YML053C YBR217W 
YCR009C YGL242C YLL011W YOL110W YDL069C YPR073C 
YCR010C YGL243W YLL013C YOL111C YGL262W YJL111W 
YCR011C YGL244W YLL015W YOL112W YGR076C YOL086C 
YCR012W YGL245W YLL018C YOL113W YHR005C-A YKL222C 
YCR017C YGL248W YLL018C-A YOL114C YOR212W YDL183C 
YCR018C YGL249W YLL019C YOL116W YPL052W YDR064W 
YCR019W YGL250W YLL021W YOL117W YDR502C YDR173C 
YCR020C YGL251C YLL022C YOL119C YBR122C YDR221W 
YCR021C YGL252C YLL023C YOL120C YAL059W YLR114C 
YCR023C YGL254W YLL024C YOL121C YER074W-A YNL025C 
YCR024C YGL257C YLL025W YOL122C YDR276C YBR237W 
YCR026C YGL258W-A YLL025W YOL123W YEL003W YDR067C 
YCR030C YGL259W YLL026W YOL125W YNL234W YGR055W 
YCR032W YGR001C YLL027W YOL126C YMR079W YBL097W 
YCR033W YGR004W YLL029W YOL128C YLL034C YDR182W-A 
YCR034W YGR005C YLL031C YOL129W YOR043W YNL328C 
YCR036W YGR007W YLL032C YOL131W YBR296C YGL238W 
YCR037C YGR008C YLL033W YOL132W YDR364C YER021W 





YCR042C YGR012W YLL038C YOL135C YJL173C YDL215C 
YCR043C YGR013W YLL039C YOL138C YJL107C YPL209C 
YCR044C YGR014W YLL040C YOL139C YLR307W YHR010W 
YCR046C YGR015C YLL041C YOL140W YLL014W YHL013C 
YCR048W YGR017W YLL043W YOL143C YLR002C YER131W 
YCR051W YGR019W YLL048C YOL144W YER072W YGR082W 
YCR052W YGR020C YLL050C YOL145C YLR385C YDR427W 
YCR053W YGR021W YLL051C YOL146W YGL070C YGL068W 
YCR059C YGR023W YLL052C YOL147C YGR234W YIL074C 
YCR060W YGR026W YLL053C YOL148C YDL045W-A YOR305W 
YCR061W YGR028W YLL055W YOL151W YER042W YIR015W 
YCR063W YGR029W YLL056C YOL152W YLR154C-H /// 
YLR156C-A  
YDL241W 
YCR065W YGR032W YLL057C YOL155C YKR068C YKL221W 
YCR067C YGR033C YLL058W YOL155W-A YJR102C YJL162C 
YCR069W YGR035W-A YLL061W YOL158C YOR268C YOR031W 
YCR071C YGR041W YLL062C YOL159C YOR148C YML018C 
YCR073C YGR042W YLL063C YOL159C-A YBR058C-A YGR002C 
YCR073W-A YGR043C YLL064C /// 
YNR076W 
YOL162W YAL056W YPR165W 
YCR075C YGR044C YLL066W-B YOL164W YCR020C-A YJR056C 
YCR076C YGR047C YLR001C YOL164W-A YGL077C YBR131W 
YCR077C YGR052W YLR004C YOL166W-A YMR065W YOR390W /// 
YPL279C 
YCR079W YGR053C YLR006C YOR001W YOL057W YKL033W-A 
YCR081W YGR054W YLR007W YOR002W YER044C-A YGR010W 
YCR083W YGR056W YLR010C YOR005C YOR032W-A YPR179C 





YCR086W YGR061C YLR013W YOR008C YNL024C YNL157W 
YCR088W YGR062C YLR014C YOR008C-A YDR243C YMR321C /// 
YPL273W 
YCR089W YGR065C YLR015W YOR010C YPL172C YJL155C 
YCR091W YGR066C YLR016C YOR011W YGL084C YER148W 
YCR092C YGR067C YLR017W YOR011W-A YER126C YLR180W 
YCR093W YGR068C YLR018C YOR012W YLR262C-A YOR114W 
YCR094W YGR075C YLR020C YOR016C YBR138C YGL021W 
YCR099C YGR078C YLR021W YOR017W YCL034W YDR060W 
YCR104W /// 
YIR041W 
YGR080W YLR022C YOR018W YOL045W YCR027C 
YCR106W YGR081C YLR023C YOR019W YEL015W YDR273W 
YCR107W YGR083C YLR024C YOR022C YBL074C YMR288W 
YCR107W YGR085C YLR026C YOR023C YCR097W YLR066W 
YCR107W /// 
YOL165C 
YGR085C /// YPR102C YLR027C YOR027W YCR075W-A YPL218W 
YCR108C YGR086C YLR028C YOR028C YMR279C YGR261C 
YDL002C YGR088W YLR029C YOR030W YLR008C YJR084W 
YDL005C YGR089W YLR032W YOR033C YKR024C YIL104C 
YDL007W YGR090W YLR034C YOR034C YHR060W YAR061W /// 
YHR212W-A 
YDL010W YGR091W YLR035C YOR034C-A YOR365C YGL063W 
YDL012C YGR093W YLR037C YOR035C YLR367W YHR002W 
YDL013W YGR094W YLR039C YOR037W YNR063W YPL024W 
YDL014W YGR095C YLR042C YOR040W YKR005C YHL003C 
YDL017W YGR096W YLR044C YOR042W YLR298C YPL099C 
YDL018C YGR097W YLR045C YOR046C YLR003C YNL006W 





YDL021W YGR099W YLR048W YOR049C YBR301W YMR158W 
YDL022W YGR100W YLR050C YOR051C YNL083W YJR005C-A 
YDL024C YGR102C YLR052W YOR054C YJR002W YGR077C 
YDL025C YGR104C YLR053C YOR057W YDR299W YLL049W 
YDL027C YGR109C YLR055C YOR059C YLR466C-B YGL080W 
YDL028C YGR109W-A /// 
YGR109W-B /// 
YIL080W /// YIL082W 
/// YIL082W-A 
YLR056W YOR061W YGR275W YOR129C 
YDL029W YGR109W-B /// 
YIL080W 
YLR057W YOR065W YGR262C YLR268W 
YDL031W YGR109W-B /// 
YIL080W /// 
YIL082W-A 
YLR058C YOR066W YBR294W YDR458C 
YDL033C YGR110W YLR059C YOR068C YOL023W YHR170W 
YDL035C YGR111W YLR067C YOR069W YPL053C YJR004C 
YDL036C YGR112W YLR069C YOR070C YPL271W YBR092C 
YDL039C YGR116W YLR070C YOR071C YJR106W YOR095C 
YDL040C YGR117C YLR071C YOR072W-B YGL055W YPL202C 
YDL045C YGR119C YLR072W YOR073W YER036C YNL138W-A 
YDL046W YGR120C YLR073C YOR074C YBR033W YLR163C 
YDL047W YGR121C YLR075W YOR076C YLR147C YPR048W 
YDL048C YGR122W YLR077W YOR077W YBR056W-A YJR123W 
YDL053C YGR124W YLR078C YOR078W YLR117C YJR068W 
YDL054C YGR125W YLR079W YOR079C YDL020C YJR053W 
YDL055C YGR127W YLR080W YOR081C YDR183W YMR022W 
YDL056W YGR129W YLR081W YOR084W YOL014W YDR023W 





YDL058W YGR132C YLR086W YOR087W YLR423C YGL255W 
YDL060W YGR133W YLR087C YOR090C YLR225C YDR212W 
YDL064W YGR134W YLR088W YOR091W YJL157C YGL006W-A 
YDL066W YGR136W YLR089C YOR092W YER173W YGR143W 
YDL072C YGR138C YLR090W YOR093C YER180C YLR283W 
YDL073W YGR138C /// YPR156C YLR091W YOR097C YMR290C YDL219W 
YDL074C YGR140W YLR092W YOR098C YOL077C YML069W 
YDL076C YGR141W YLR093C YOR099W YOR004W YAR035C-A 
YDL077C YGR144W YLR095C YOR104W YDR281C YMR061W 
YDL078C YGR146C YLR096W YOR108W YCR101C YML038C 
YDL079C YGR146C-A YLR097C YOR109W YDR087C YMR194W 
YDL080C YGR150C YLR098C YOR110W YBR167C YLR418C 
YDL082W YGR153W YLR099C YOR111W YHR089C YBR095C 
YDL086W YGR156W YLR099W-A YOR112W YOR067C YER093C-A 
YDL087C YGR157W YLR100W YOR113W YBR247C YBL025W 
YDL089W YGR158C YLR102C YOR115C YGL005C YDL067C 
YDL091C YGR161C YLR105C YOR118W YGR128C YDR382W 
YDL093W YGR162W YLR106C YOR119C YHR079C-A YKL056C 
YDL095W YGR163W YLR109W YOR120W YJR136C YPL145C 
YDL099W YGR165W YLR113W YOR122C YJL006C YKL179C 
YDL100C YGR166W YLR115W YOR123C YMR033W YOR194C 
YDL101C YGR167W YLR116W YOR124C YNL111C YMR235C 
YDL102W YGR169C YLR119W YOR125C YGR084C YBL035C 
YDL103C YGR169C-A YLR121C YOR126C YOR260W YDR283C 
YDL104C YGR170W YLR126C YOR127W YPR187W YJL183W 
YDL105W YGR172C YLR127C YOR128C YER078W-A YPL260W 
YDL106C YGR173W YLR128W YOR130C YCL055W YOR131C 





YDL109C YGR178C YLR130C YOR134W YDR111C YFL007W 
YDL110C YGR179C YLR131C YOR136W YOR107W YJL069C 
YDL111C YGR180C YLR132C YOR137C YHR187W YCL054W 
YDL113C YGR181W YLR134W YOR138C YNL077W YDR162C 
YDL115C YGR184C YLR135W YOR140W YBR238C YDR174W 
YDL116W YGR185C YLR136C YOR142W YHR037W YMR039C 
YDL117W YGR186W YLR137W YOR144C YDL160C-A YNR071C 
YDL119C YGR187C YLR138W YOR151C YMR010W YIR012W 
YDL120W YGR188C YLR139C YOR152C YDR179C YDR125C 
YDL122W YGR189C YLR141W YOR154W YGL116W YCL005W-A 
YDL123W YGR191W YLR142W YOR155C YLR165C YEL069C /// 
YNR072W 
YDL124W YGR192C YLR143W YOR156C YNR004W YBR171W 
YDL125C YGR193C YLR144C YOR160W YNL070W YBL068W 
YDL126C YGR194C YLR148W YOR161C YBR219C YCR087C-A 
YDL127W YGR195W YLR149C YOR161C-C YLR036C YJR089W 
YDL129W YGR196C YLR150W YOR162C YCL057C-A YAL008W 
YDL130W-A YGR199W YLR151C YOR163W YDL065C YLR120C 
YDL131W YGR200C YLR152C YOR164C YCL001W YOL166W-A 
YDL132W YGR201C YLR153C YOR168W YMR282C YIL076W 
YDL134C YGR203W YLR154W-F YOR173W YML081C-A YBR288C 
YDL135C YGR204W YLR155C /// YLR157C 
/// YLR158C /// 
YLR160C 
YOR174W YPL042C YOR294W 









YDL139C YGR208W YLR157W-E YOR176W YNL148C YOR385W 
YDL140C YGR213C YLR162W YOR177C YBL054W YBR184W 
YDL141W YGR214W YLR162W-A YOR179C YGR212W YOL080C 
YDL142C YGR217W YLR164W YOR181W YNL121C YOL011W 
YDL144C YGR218W YLR166C YOR184W YJL096W YGR087C 
YDL145C YGR221C YLR170C YOR185C YER012W YFR011C 
YDL146W YGR223C YLR173W YOR187W YGR121W-A YJL145W 
YDL149W YGR225W YLR174W YOR188W YFR004W YBR191W /// 
YPL079W 
YDL150W YGR226C YLR175W YOR191W YLR049C YBR188C 
YDL154W YGR227W YLR176C YOR192C YPL071C YBR263W 
YDL156W YGR229C YLR177W YOR192C-C YOR269W YJL146W 
YDL159W YGR231C YLR178C YOR193W YDL063C YGR135W 
YDL159W-A YGR233C YLR179C YOR195W YBR165W YLL046C 
YDL161W YGR235C YLR181C YOR196C YDL247W /// 
YJR160C 
YML118W 
YDL164C YGR237C YLR182W YOR197W YAL025C YOR062C 
YDL165W YGR238C YLR183C YOR201C YKR056W YOL115W 
YDL168W YGR239C YLR186W YOR202W YPR169W YFL046W 
YDL169C YGR240C YLR187W YOR205C YKR051W YKL162C 
YDL170W YGR240C-A YLR188W YOR207C YER168C YAL003W 
YDL171C YGR244C YLR189C YOR208W YGL226C-A YBR125C 
YDL173W YGR245C YLR192C YOR209C YBR264C YDR498C 
YDL174C YGR246C YLR193C YOR211C YHR191C YGR171C 
YDL176W YGR247W YLR194C YOR213C YML005W YPR040W 
YDL177C YGR248W YLR195C YOR214C YGR123C YMR145C 
YDL178W YGR249W YLR199C YOR215C YFL040W YOL092W 





YDL181W YGR251W YLR203C YOR217W YDR139C YPR199C 
YDL182W YGR252W YLR206W YOR219C YGR063C YOR178C 
YDL185W YGR253C YLR207W YOR220W YGL256W YMR309C 
YDL186W YGR254W YLR208W YOR221C YLR415C YMR028W 
YDL188C YGR255C YLR209C YOR222W YDR346C YBR078W 
YDL189W YGR256W YLR210W YOR223W YJL012C YLR292C 
YDL190C YGR257C YLR211C YOR226C YGR284C YMR203W 
YDL193W YGR258C YLR214W YOR227W YPR104C YFR031C-A 
YDL194W YGR260W YLR215C YOR228C YPL017C YBL107C 
YDL195W YGR266W YLR216C YOR230W YNL081C YNL272C 
YDL197C YGR268C YLR219W YOR231W YJR036C YOR339C 
YDL198C YGR270W YLR222C YOR233W YDR469W YDL061C 
YDL199C YGR271W YLR223C YOR236W YOR143C YPL263C 
YDL200C YGR274C YLR227C YOR238W YJL023C YNL097C 
YDL202W YGR276C YLR228C YOR239W YNL131W YFR052W 
YDL203C YGR277C YLR231C YOR241W YKL167C YDR177W 
YDL204W YGR279C YLR234W YOR244W YNL052W YPL104W 
YDL206W YGR281W YLR237W YOR246C YHR138C YPL193W 
YDL207W YGR282C YLR238W YOR247W YMR183C YPL047W 
YDL216C YGR285C YLR239C YOR250C YHR167W YLR368W 
YDL217C YGR287C YLR240W YOR251C YDR377W YHR005C 
YDL218W YGR288W YLR242C YOR253W YLR094C YMR152W 
YDL220C YGR289C YLR244C YOR254C YDL003W YCR057C 
YDL222C YHL002W YLR246W YOR255W YCL067C /// YCR039C 
/// YCR096C 
YLL035W 
YDL223C YHL004W YLR247C YOR256C YLR065C YHR076W 
YDL224C YHL006C YLR248W YOR264W YOR145C YOR308C 





YDL226C YHL008C YLR250W YOR267C YDL049C YBR158W 
YDL227C YHL009C YLR251W YOR270C YFL017W-A YMR217W 
YDL229W YHL009W-A /// 
YHL009W-B /// 
YJL113W /// YJL114W 
/// YPL060C-A 





YLR256W YOR273C YHR100C YGL099W 
YDL230W YHL010C YLR257W YOR275C YJL030W YIL065C 
YDL231C YHL014C YLR258W YOR278W YBR231C YLR191W 
YDL233W YHL015W-A YLR259C YOR280C YBR029C YOL061W 
YDL234C YHL017W YLR260W YOR284W YDR309C YOR316C-A 
YDL235C YHL019C YLR263W YOR285W YOR376W-A YLR350W 
YDL236W YHL021C YLR265C YOR286W YER056C-A YML105C 
YDL237W YHL023C YLR266C YOR288C YLR229C YPR109W 
YDL238C YHL025W YLR267W YOR289W YIL011W YIL105C 
YDL239C YHL027W YLR270W YOR290C YOL067C YNL320W 
YDL244W /// 
YFL058W /// YJR156C 
/// YNL332W 
YHL028W YLR271W YOR291W YBR192W YKL216W 
YDL246C /// 
YJR159W 
YHL029C YLR272C YOR292C YDR161W YDR410C 
YDR001C YHL030W YLR273C YOR293C-A YBR038W YKR035W-A 
YDR003W YHL031C YLR277C YOR295W YOR036W YGR149W 
YDR003W-A YHL032C YLR278C YOR296W YKR039W YCR015C 
YDR004W YHL033C YLR281C YOR297C YDR328C YLR284C 
YDR005C YHL033C /// YLL045C YLR285C-A YOR298C-A YLR241W YMR074C 





YDR009W YHL035C YLR288C YOR299W YLR103C YER092W 
YDR011W YHL036W YLR289W YOR301W YKL003C YLR372W 
YDR016C YHL038C YLR290C YOR302W YHR039C-A YKL021C 
YDR017C YHL040C YLR291C YOR303W YDR101C YLR406C 
YDR018C YHL042W YLR293C YOR304W YCR082W YPR102C 
YDR019C YHL043W YLR295C YOR306C YDR497C YDL148C 
YDR020C YHL044W YLR297W YOR307C YHL012W YPR155C 
YDR022C YHL047C YLR299W YOR310C YAR033W YMR146C 
YDR025W YHL048W YLR300W YOR311C YCR066W YOR352W 
YDR026C YHR001W YLR301W YOR316C YER074W YML001W 
YDR027C YHR001W-A YLR303W YOR317W YOR159C YNL134C 
YDR028C YHR003C YLR304C YOR320C YER136W YNL216W 
YDR032C YHR006W YLR305C YOR321W YGR286C YEL019C 
YDR034C YHR007C YLR306W YOR322C YHR035W YNL046W 
YDR034W-B YHR007C-A YLR307C-A YOR323C YMR233W YAL064W-B 
YDR035W YHR008C YLR308W YOR324C YPL187W YLR452C 
YDR036C YHR009C YLR309C YOR326W YOL124C YBL014C 
YDR037W YHR011W YLR310C YOR327C YDL243C /// YFL057C YDR098C 




YHR013C YLR313C YOR329C YHL016C YNL232W 
YDR041W YHR015W YLR313C YOR330C YDR267C YLR213C 
YDR043C YHR016C YLR314C YOR332W YLL066W-B YLR243W 
YDR044W YHR017W YLR315W YOR334W YHL001W YGL161C 
YDR046C YHR018C YLR316C YOR335C YOL018C YEL013W 
YDR047W YHR019C YLR318W YOR336W YJL127C YJL168C 





YDR050C YHR022C YLR320W YOR338W YPL210C YJL208C 
YDR051C YHR023W YLR321C YOR341W YBR044C YGL060W 
YDR052C YHR024C YLR323C YOR347C YER038C YLR212C 
YDR054C YHR025W YLR324W YOR350C YHR045W YJR010W 
YDR055W YHR026W YLR326W YOR353C YNL218W YKL220C 
YDR056C YHR027C YLR327C YOR354C YPR018W YHR057C 
YDR057W YHR028C YLR328W YOR355W YGR222W YBR019C 
YDR058C YHR029C YLR329W YOR356W YHR123W YGL057C 
YDR059C YHR030C YLR330W YOR357C YER078C YLR118C 
YDR061W YHR031C YLR332W YOR358W YPR068C YER174C 
YDR063W YHR032W YLR335W YOR359W YBL060W YGR264C 
YDR065W YHR033W YLR336C YOR360C YNL149C YKL049C 
YDR066C YHR034C YLR337C YOR363C YPL239W YLR274W 
YDR069C YHR036W YLR340W YOR367W YNL256W YDL061C 
YDR070C YHR039C YLR341W YOR370C YPL156C YGL210W 
YDR073W YHR040W YLR342W YOR371C YER187W YPR057W 
YDR074W YHR041C YLR342W-A YOR372C YBR050C YPL096C-A 
YDR076W YHR042W YLR343W YOR373W YIL029C YAL016W 
YDR077W YHR043C YLR344W YOR374W YMR122W-A YNR022C 
YDR080W YHR043C /// 
YHR044C 
YLR345W YOR375C YPR024W YDR244W 
YDR081C YHR044C YLR347C YOR378W YEL030W YGL234W 
YDR084C YHR046C YLR348C YOR380W YML080W YLR054C 
YDR085C YHR047C YLR351C YOR381W YHR121W YOR259C 









YDR089W YHR049W YLR354C YOR383C YKL018C-A YAL019W 
YDR090C YHR050W YLR355C YOR388C /// 
YPL275W 
YDR254W YGR224W 
YDR092W YHR050W-A YLR356W YOR389W YPL243W YGL135W /// 
YPL220W 
YDR093W YHR051W YLR357W YOR389W /// 
YPL277C 
YLR200W YNR028W 
YDR096W YHR054C /// 
YHR056C 
YLR360W YOR389W /// 
YPL278C 
YNL211C YCL005W 
YDR097C YHR058C YLR362W YOR394C-A YNL078W YNL252C 
YDR099W YHR061C YLR364W YPL003W YLR388W YML086C 
YDR100W YHR062C YLR371W YPL004C YDL209C YFL011W 
YDR103W YHR063C YLR373C YPL006W YDL043C YIL002W-A 
YDR104C YHR068W YLR375W YPL007C YJL011C YOR342C 
YDR105C YHR069C YLR377C YPL008W YJR063W YKL163W 
YDR106W YHR070W YLR378C YPL009C YER133W YPL244C 
YDR108W YHR071W YLR380W YPL011C YER050C YDL213C 
YDR109C YHR072W YLR381W YPL012W YOL042W YIL024C 
YDR110W YHR073W YLR382C YPL014W YDL192W YDR123C 
YDR113C YHR074W YLR383W YPL015C YPR182W YGL147C 
YDR116C YHR077C YLR384C YPL016W YOL039W YPR019W 
YDR117C YHR078W YLR386W YPL020C YDL211C YMR135C 
YDR118W YHR079C YLR387C YPL021W YAR010C /// 
YBR012W-A 
YOR361C 
YDR119W YHR080C YLR389C YPL022W YDR322C-A YDR379W 
YDR122W YHR082C YLR390W YPL023C YCL066W /// 
YCR040W 
YFL001W 





YDR127W YHR087W YLR394W YPL028W YKR030W YHR147C 
YDR128W YHR088W YLR396C YPL029W YNL151C YLR218C 
YDR129C YHR092C YLR397C YPL031C YMR260C YDR240C 
YDR130C YHR094C YLR398C YPL032C YDL133C-A /// 
YDL184C 
YDR107C 
YDR131C YHR096C YLR399C YPL033C YDR373W YNL249C 
YDR132C YHR097C YLR404W YPL034W YGL169W YML115C 
YDR135C YHR098C YLR405W YPL037C YKL043W YGR145W 
YDR137W YHR099W YLR406C-A YPL038W YGR152C YDR337W 
YDR140W YHR101C YLR407W YPL039W YKR053C YMR013C 
YDR141C YHR102W YLR410W YPL040C YNL313C YKL077W 
YDR142C YHR104W YLR414C YPL041C YDR465C YJL019W 
YDR143C YHR106W YLR419W YPL045W YDR447C /// 
YML024W 
YGL189C 
YDR144C YHR107C YLR420W YPL046C YHR075C YMR241W 
YDR145W YHR108W YLR422W YPL048W YHR124W YDL097C 
YDR148C YHR109W YLR424W YPL049C YPR103W YCR045C 
YDR150W YHR110W YLR425W YPL050C YDL133W YML022W 
YDR152W YHR111W YLR427W YPL055C YKL160W YER161C 
YDR153C YHR112C YLR429W YPL056C YLR224W YGL103W 
YDR155C YHR113W YLR430W YPL057C YGL225W YDL001W 
YDR156W YHR114W YLR431C YPL058C YJR086W YOR047C 
YDR158W YHR115C YLR432W YPL059W YMR242C /// 
YOR312C 
YHR205W 
YDR159W YHR117W YLR436C YPL060W YLR205C YBR114W 
YDR160W YHR118C YLR437C YPL061W YPL254W YMR211W 





YDR164C YHR120W YLR439W YPL065W YGR118W /// 
YPR132W 
YPR173C 
YDR166C YHR122W YLR440C YPL066W YDL030W YDL201W 
YDR168W YHR126C YLR441C YPL067C YFR042W YKL165C 
YDR169C YHR127W YLR442C YPL068C YGL142C YDR513W 
YDR169C-A YHR128W YLR443W YPL072W YOR362C YLR361C 
YDR170C YHR129C YLR445W YPL074W YPL266W YER087W 
YDR171W YHR132C YLR446W YPL075W YOR287C YLR033W 
YDR176W YHR133C YLR447C YPL076W YLR083C YJR034W 
YDR178W YHR134W YLR448W YPL077C YDL137W YLR361C-A 
YDR179W-A YHR135C YLR449W YPL078C YNL207W YHR190W 
YDR180W YHR137W YLR450W YPL079W YEL021W YGR295C 
YDR181C YHR140W YLR451W YPL081W YPR001W YHR181W 
YDR182W YHR142W YLR454W YPL082C YCR072C YML064C 
YDR186C YHR143W YLR455W YPL083C YKL098W YBL092W 
YDR188W YHR146W YLR457C YPL084W YOL041C YNL188W 
YDR189W YHR149C YLR459W YPL085W YJL036W YOR096W 
YDR190C YHR150W YLR461W /// 
YOL161C 
YPL086C YBR196C-B YGL120C 
YDR194C YHR154W YML004C YPL087W YDR151C YLR411W 
YDR194W-A YHR155W YML006C YPL088W YMR285C YKL187C 
YDR197W YHR156C YML007C-A YPL089C YDR333C YDR514C 
YDR198C YHR158C YML008C YPL091W YLR388W YMR184W 
YDR200C YHR161C YML010W YPL092W YLR409C YKL062W 
YDR202C YHR162W YML011C YPL093W YDR308C YIR021W-A 
YDR204W YHR163W YML013W YPL096W YNL262W YMR133W 
YDR205W YHR164C YML014W YPL097W YOL019W YBL099W 





YDR207C YHR166C YML016C YPL100W YLL004W YPR078C 
YDR208W YHR169W YML019W YPL101W YKL037W YDR316W 
YDR211W YHR171W YML021C YPL103C YKL096W-A YEL064C 
YDR213W YHR172W YML023C YPL105C YDR210W YGR198W 
YDR214W YHR174W YML025C YPL106C YKR088C YGR003W 
YDR216W YHR176W YML027W YPL107W YKR081C YBR024W 
YDR217C YHR178W YML028W YPL109C YNL155W YKR006C 
YDR218C YHR179W YML029W YPL110C YER029C YMR208W 
YDR219C YHR182W YML030W YPL111W YGL231C YFL005W 
YDR222W YHR183W YML031W YPL112C YOR304C-A YLR376C 
YDR223W YHR184W YML032C YPL115C YMR315W-A YDL114W 
YDR224C YHR185C YML034W YPL116W YNL145W YLR245C 
YDR225W YHR186C YML035C YPL117C YGR267C YBR093C 
YDR226W YHR188C YML042W YPL120W YOR103C YER080W 
YDR229W YHR192W YML047C YPL121C YIR028W YML116W 
YDR231C YHR195W YML049C YPL122C YKL137W YOR384W 
YDR232W YHR198C YML050W YPL123C YOR020C YOR368W 
YDR233C YHR199C YML051W YPL124W YGR243W YHR144C 
YDR234W YHR200W YML052W YPL125W YJL027C YLR110C 
YDR235W YHR201C YML056C YPL126W YKR085C YBR259W 
YDR236C YHR202W YML057W YPL127C YPR161C YGR037C 
YDR237W YHR203C /// YJR145C YML059C YPL129W YJL216C YNL064C 
YDR238C YHR204W YML060W YPL132W YJL209W YGL048C 
YDR239C YHR206W YML061C YPL133C YKL138C-A YER100W 
YDR242W YHR207C YML062C YPL134C YHR059W YPL148C 
YDR245W YHR208W YML063W YPL135W YOL137W YBR094W 
YDR246W YHR209W YML066C YPL137C YCR047C YBL082C /// YBL083C 





YDR247W YHR216W YML070W YPL139C YLR009W YOR085W 
YDR248C YIL001W YML071C YPL140C YPL237W YHL015W 
YDR251W YIL002C YML072C YPL141C YKL196C YMR132C 
YDR252W YIL003W YML074C YPL143W YBR002C YKL138C 
YDR253C YIL005W YML075C YPL144W YGL175C YKL190W 
YDR255C YIL007C YML076C YPL147W YOL009C YNL048W 
YDR257C YIL009C-A YML078W YPL149W YPR133W-A YEL037C 
YDR258C YIL010W YML079W YPL150W YIR005W YIR042C 
YDR259C YIL013C YML081W YPL152W YBR162C YJR124C 
YDR260C YIL014C-A YML083C YPL152W-A YPL213W YHR199C-A 
YDR261C YIL015W YML087C YPL153C YGR206W YOL130W 
YDR263C YIL017C YML091C YPL154C YIL033C YDR533C 
YDR264C YIL018W YML092C YPL158C YOL086W-A YDL044C 
YDR265W YIL020C YML093W YPL160W YNL164C YDL052C 
YDR266C YIL021W YML094W YPL161C YLR197W YER057C 
YDR268W YIL022W YML095C YPL163C YCR016W YER086W 
YDR270W YIL023C YML096W YPL164C YBR155W YAL018C 
YDR272W YIL026C YML097C YPL167C YGR048W YMR185W 
YDR277C YIL030C YML098W YPL168W YJR141W YDR319C 
YDR282C YIL031W YML100W YPL169C YOR229W YPL186C 
YDR284C YIL034C YML101C YPL170W YOR206W YGL123W 
YDR288W YIL036W YML103C YPL174C YPL095C YNL158W 
YDR289C YIL038C YML104C YPL175W YBL018C YDR391C 
YDR291W YIL039W YML106W YPL176C YDR034C-A YDR435C 
YDR292C YIL041W YML107C YPL177C YML055W YDR532C 
YDR293C YIL042C YML109W YPL180W YIL009W YPR186C 
YDR295C YIL043C YML110C YPL181W YPR143W YMR031C 





YDR297W YIL045W YML112W YPL183W-A YMR059W YML012W 
YDR298C YIL046W YML113W YPL188W YDR363W-A YJL109C 
YDR301W YIL047C /// YIL047C-A YML114C YPL189C-A YBR250W YJL153C 
YDR304C YIL048W YML117W YPL190C YHR091C YMR283C 
YDR305C YIL050W YML121W YPL194W YLR287C-A /// 
YOR182C 
YEL017C-A 
YDR306C YIL051C YML124C YPL195W YKL178C YMR242C 
YDR307W YIL053W YML125C YPL196W YPL159C YMR153W 
YDR310C YIL055C YML127W YPL199C YPL189W YML002W 
YDR311W YIL056W YML128C YPL200W YPR113W YHR131C 
YDR313C YIL057C YML130C YPL203W YMR001C YKL011C 
YDR314C YIL060W YML131W YPL204W YER025W YNL022C 
YDR315C YIL061C YMR001C-A YPL206C YPR112C YHR014W 
YDR317W YIL062C YMR004W YPL207W YJL038C YBR088C 
YDR320C YIL063C YMR005W YPL208W YDR447C YBR198C 
YDR321W YIL066C YMR006C YPL212C YGR031W YJL050W 
YDR323C YIL067C YMR008C YPL215W YDR079C-A YGL213C 
YDR325W YIL068C YMR009W YPL216W YDL167C YDR347W 
YDR326C YIL070C YMR012W YPL217C YDR147W YPL128C 
YDR329C YIL072W YMR014W YPL219W YLR005W YKL045W 
YDR331W YIL073C YMR016C YPL221W YER117W YNL036W 
YDR332W YIL075C YMR017W YPL222W YIL019W YDL112W 
YDR334W YIL077C YMR018W YPL223C YPR098C YNR061C 
YDR335W YIL078W YMR019W YPL224C YML068W YER005W 
YDR336W YIL079C YMR020W YPL228W YPL001W YOR014W 
YDR338C YIL083C YMR021C YPL229W YDL006W YHR065C 
YDR342C /// 
YDR343C 





YDR349C YIL087C YMR024W YPL231W YOR020W-A YMR157C 
YDR350C YIL088C YMR025W YPL232W YDL085C-A YIL133C 
YDR351W YIL089W YMR026C YPL233W YKL005C YJL001W 
YDR352W YIL092W YMR027W YPL235W YGL098W YDL084W 
YDR353W YIL093C YMR029C YPL236C YIL052C YMR246W 
YDR354W YIL094C YMR035W YPL240C YBR069C YLR392C 
YDR356W YIL095W YMR036C YPL241C YDR002W YPR121W 
YDR357C YIL097W YMR037C YPL246C YOR171C YPL069C 
YDR358W YIL102C YMR038C YPL247C YIL144W YGR113W 
YDR359C YIL107C YMR041C YPL249C YPR132W YDR477W 
YDR363W YIL108W YMR042W YPL250C YOR101W YKL113C 
YDR365C YIL109C YMR043W YPL252C YOR257W YNL047C 
YDR367W YIL110W YMR044W YPL253C YDR450W /// 
YML026C 
YOR234C 
YDR368W YIL111W YMR047C YPL255W YPL155C YDL004W 
YDR369C YIL112W YMR048W YPL256C YJL180C YML054C-A 
YDR374C YIL113W YMR049C YPL258C YKL183C-A YGR241C 
YDR378C YIL114C YMR052W YPL259C YLR363C YHR103W 
YDR379C-A YIL115C YMR053C YPL262W YCR024C-A YNL290W 
YDR380W YIL116W YMR054W YPL264C YDR376W YDR279W 
YDR381W YIL117C YMR055C YPL265W YJL010C YDL107W 
YDR384C YIL119C YMR058W YPL268W YOR149C YPL054W 
YDR385W /// 
YOR133W 
YIL120W YMR062C YPL269W YDR500C YPL178W 
YDR388W YIL121W YMR064W YPL270W YLR412W YBL057C 
YDR389W YIL122W YMR067C YPL272C YLR031W YFR050C 
YDR390C YIL123W YMR068W YPL273W YIL084C YNL101W 





YDR393W YIL125W YMR070W YPL277C YNL044W YJL049W 
YDR394W YIL126W YMR073C YPL279C YPR028W YNL279W 
YDR395W YIL128W YMR076C YPR002W YKL053C-A YML020W 
YDR397C YIL129C YMR078C YPR003C YHR175W YPR108W 
YDR398W YIL130W YMR081C YPR004C YBR057C YBR280C 
YDR400W YIL131C YMR083W YPR005C YBR253W YDR462W 
YDR403W YIL132C YMR085W YPR006C YDL092W YGR070W 
YDR405W YIL134C-A YMR086W YPR008W YEL072W YNL286W 
YDR406W YIL134W YMR087W YPR009W YPL192C YDR262W 
YDR407C YIL135C YMR088C YPR010C YDL075W YDL143W 
YDR408C YIL136W YMR089C YPR011C YCR098C YAR002W 
YDR409W YIL137C YMR091C YPR013C YLR043C YLR433C 
YDR411C YIL140W YMR092C YPR015C YKL144C YNR075C-A 
YDR414C YIL142W YMR094W YPR016C YDR515W YBR085C-A 
YDR415C YIL145C YMR095C YPR017C YMR143W YMR193W 
YDR416W YIL147C YMR096W YPR021C YGR159C YDL245C /// 
YJR158W 
YDR419W YIL149C YMR097C YPR022C YDL208W YBR267W 
YDR420W YIL150C YMR099C YPR023C YMR143W YGL061C 
YDR421W YIL151C YMR100W YPR025C YBR034C YGR280C 
YDR422C YIL152W YMR102C YPR026W YDR449C YNL219C 
YDR423C YIL153W YMR104C YPR027C YBR006W YOR394W /// 
YPL282C 
YDR425W YIL154C YMR105C YPR029C YLL028W YGR210C 
YDR428C YIL155C YMR105W-A YPR030W YMR075W YOR319W 
YDR429C YIL156W YMR106C YPR031W YKL040C YJL044C 
YDR430C YIL157C YMR107W YPR032W YGL089C YPR007C 





YDR436W YIL161W YMR109W YPR034W YOR249C YDR341C 
YDR439W YIL162W YMR110C YPR035W YML058W YPR159C-A 
YDR440W YIL164C YMR111C YPR036W YGR131W YLR011W 
YDR443C YIL165C YMR112C YPR036W-A YFR005C YBR283C 
YDR444W YIL169C YMR113W YPR037C YGR147C YKL164C 
YDR446W YIL169C /// YOL155C YMR114C YPR042C YIR011C YNL177C 
YDR448W YIL172C /// YJL221C 
/// YOL157C 
YMR115W YPR045C YDR324C YBR048W /// 
YDR025W 
YDR451C YIL173W /// YJL222W YMR116C YPR047W YAL063C-A YJR041C 
YDR452W YIL176C /// YJL223C YMR118C YPR049C YPL173W YOL094C 
YDR453C YIR001C YMR119W YPR051W YGR232W YAL064C-A 
YDR456W YIR002C YMR120C YPR054W YGR202C YOR106W 
YDR457W YIR003W YMR121C YPR055W YNR070W YKR060W 
YDR459C YIR004W YMR123W YPR058W YOL001W YBR181C /// YPL090C 
YDR460W YIR006C YMR124W YPR062W YDR175C YGR216C 
YDR463W YIR007W YMR125W YPR063C YER030W YDR286C 
YDR464W YIR008C YMR126C YPR065W YJL140W YEL032W 
YDR466W YIR009W YMR127C YPR066W YOL024W YPL131W 
YDR468C YIR010W YMR128W YPR067W YJL148W YLR082C 
YDR470C YIR013C YMR129W YPR069C YBR127C YPL171C 
YDR472W YIR014W YMR131C YPR070W YNL129W YKL078W 
YDR473C YIR016W YMR136W YPR071W YBR096W YDR294C 
YDR475C YIR017C YMR139W YPR072W YMR011W YAL007C 
YDR476C YIR018W YMR142C YPR074C YBL008W YKR094C 
YDR478W YIR019C YMR144W YPR075C YPL157W YKR064W 
YDR479C YIR023W YMR148W YPR079W YJL205C YPL214C 
YDR480W YIR025W YMR149W YPR081C YOR094W YGL190C 





YDR482C YIR027C YMR154C YPR084W YOR377W YJR152W 
YDR483W YIR029W YMR156C YPR085C YOR100C YGL113W 
YDR484W YIR030C YMR158C-A YPR086W YBL005W-A /// 
YBL005W-B 
YKL004W 
YDR485C YIR032C YMR160W YPR088C YMR209C YJL073W 
YDR486C YIR033W YMR162C YPR089W YNR024W YJL043W 
YDR487C YIR034C YMR163C YPR091C YOR006C YGR168C 
YDR488C YIR035C YMR164C YPR093C YCL012C YHR067W 
YDR489W YIR036C YMR165C YPR095C YDR461W YBR062C 
YDR490C YIR037W YMR166C YPR097W YBR163W YJL091C 
YDR493W YIR038C YMR167W YPR105C YAL039C YHR213W-A 
YDR495C YIR039C YMR168C YPR106W YMR066W YDL214C 
YDR499W YJL002C YMR169C YPR110C YDR371W YOR261C 
YDR501W YJL004C YMR170C YPR111W YHR090C YDR330W 
YDR503C YJL005W YMR172W YPR114W YKR004C YEL023C 
YDR504C YJL008C YMR173W /// 
YMR173W-A 
YPR115W YJR118C YJL210W 
YDR505C YJL013C YMR174C YPR116W YML036W YMR034C 
YDR506C YJL014W YMR175W YPR117W YPL151C YOR348C 
YDR507C YJL016W YMR175W-A YPR118W YBR189W YKL107W 
YDR510W YJL020C YMR176W YPR120C YIL096C YBR156C 
YDR516C YJL024C YMR178W YPR122W YOR293W YNL042W-B 
YDR517W YJL025W YMR181C YPR124W YDR172W YMR179W 
YDR518W YJL026W YMR182C YPR125W YOL012C YMR147W 
YDR520C YJL029C YMR182W-A YPR127W YGL075C  
YDR522C YJL031C YMR186W YPR128C YDR068W  
YDR524C YJL033W YMR187C YPR129W YJL105W  





YDR530C YJL037W YMR190C YPR134W YLR025W  
YDR531W YJL039C YMR191W YPR135W YBR203W  
YDR534C YJL041W YMR192W YPR139C YLR233C  
YDR538W YJL042W YMR194C-B YPR140W YPL184C  
YDR539W YJL045W YMR195W YPR141C YHL022C  
YDR540C YJL046W YMR196W YPR144C YIL006W  
YDR541C YJL047C YMR197C YPR145W YGL253W  
YDR545W /// 
YEL076C-A  
YJL048C YMR198W YPR148C YJR101W  
YEL001C YJL052W YMR199W YPR149W YKR065C  
YEL002C YJL053W YMR200W YPR152C YCR035C  
YEL004W YJL054W YMR201C YPR154W YDR124W  
YEL005C YJL055W YMR202W YPR156C YPL010W  
YEL006W YJL056C YMR204C YPR157W YDR165W  
YEL007W YJL057C YMR205C YPR159W YGR174C  
YEL009C YJL059W YMR206W YPR160W YOR198C  
YEL011W YJL060W YMR207C YPR162C YDR372C  
YEL012W YJL061W YMR210W YPR163C YKL175W  
YEL016C YJL062W YMR213W YPR164W YLL045C  
YEL017W YJL062W-A YMR214W YPR167C YHR086W  
YEL018W YJL063C YMR215W YPR168W YER185W  
YEL020C YJL065C YMR216C YPR171W YLR417W  
YEL022W YJL066C YMR218C YPR172W YDL051W  
YEL024W YJL068C YMR219W YPR174C YCR105W  
YEL025C YJL070C YMR220W YPR175W YLR460C  
YEL027W YJL071W YMR221C YPR176C YLR466C-B  
YEL029C YJL074C YMR222C YPR178W YDR424C  





YEL035C YJL077C YMR226C YPR181C YGR074W  
YEL036C YJL077W-B YMR227C YPR183W YOR165W  
YEL038W YJL078C YMR229C YPR184W YKL016C  
YEL039C YJL079C YMR230W YPR185W YLL042C  
YEL040W YJL080C YMR231W YPR188C YHR177W  
YEL041W YJL081C YMR232W YPR189W YOR252W  
YEL042W YJL082W YMR234W YPR190C YDR438W  
YEL043W YJL083W YMR236W YPR191W YBR154C  
YEL046C YJL084C YMR237W YPR192W YNL223W  
YEL047C YJL085W YMR238W YPR193C YOL097W-A  
YEL049W YJL087C YMR240C YPR194C YOR157C  
YEL050C YJL088W YMR242W-A YPR196W YNL302C  





Appendix Chapter 7 
 
App.4-a, A comparison of 0-1ppm of 1D proton spectra of wild type and TEF1 overexpression cells. 
 









App.4-c, A comparison of 2-3ppm of 1D proton spectra of wild type and TEF1 overexpression cells. 
 







App.4-e, A comparison of 4-5ppm of 1D proton spectra of wild type and TEF1 overexpression cells. 
 







App.4-g, A comparison of 6-7ppm of 1D proton spectra of wild type and TEF1 overexpression cells. 
 







App.4-i, A comparison of 8-9ppm of 1D proton spectra of wild type and TEF1 overexpression cells. 
 







App.5-a, Loading difference of 0-2ppm of wild type and TEF1 overexpression cells. 
 







App.5-c, Loading difference of 4-6ppm of wild type and TEF1 overexpression cells. 
  





























Acetate Alanine Arginine Asparagine Aspartate 
ATP cAMP Choline 
chloride 










Glutamine Glycine GMP Histidine Isocitrate Isoleucine 
Leucine Lysine Malic 
acid 
Maltose Mannose Methionine 

















App.7, list of 47 compounds available in our metabolite database 
 






App.8-b, Comparison of 2-4ppm of whole cell and vacuolar metabolite extractions 
 






App.8-d, Comparison of 6-8ppm of whole cell and vacuolar metabolite extractions 
 
 
App.8-e, Comparison of 8-10ppm of whole cell and vacuolar metabolite extractions 
 
